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Microbubbles have been used for several decades as ultrasound 
contrast agents in diagnostic ultrasound imaging. However, their application 
in gene therapy as delivery vehicles has only recently been realised. The 
presence of microbubbles in close proximity to cells during ultrasound 
insonation can increase the efficacy of drug or gene delivery by inducing 
formation of transient, non-lethal perforations in the cell membrane, a 
process termed sonoporation.  In order to develop techniques for successful 
delivery of therapeutic agents, it is necessary to quantify the composition and 
physical characteristics of microbubbles in order to be able to determine how 
these affect the sonoporation process as required. Although several 
microbubbles are available commercially, the components of the shell of 
these proprietary microbubbles have not been disclosed. In order to study 
sonoporation and the possibility of delivering drugs and genes it became 
necessary to develop a formulation for in-house experimental microbubbles. 
These experimental in-house microbubbles have not been previously 
investigated with regard to their interaction with cells, their potential for 
sonoporation and / or their bioeffects. Characterisation of the in-house 
microbubbles was necessary prior to any attempts to use them as delivery 
vehicles in vitro, or indeed, in vivo. Confocal laser scanning microscopy 
(CLSM) was used in order to determine the size distribution of both in-house 
microbubbles and Definity® a commercially available contrast agent. 
Confocal imaging and 3-D reconstruction of in-house microbubbles indicated 
the structure, morphology and size-distribution of these membrane-bound 
microbodies. Microbubbles were later separated according to size using a 
density gradient. It was concluded that the distribution of sizes of the 
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microbubbles was in part due to the multi-lamellar nature of the 
microbubble shell.  
Cells were initially cultured in Petri dishes and insonated in the 
presence and absence of in-house microbubbles, in order to assess any 
bioeffects emerging from the application of ultrasound alone or in the 
presence of the microbubble constructs. Cells were cultured subsequently on 
an acoustically-transparent Mylar membrane, which was then “sandwiched” 
between two acetal homopolymer (Derlin) rings and placed in a specially 
designed ultrasound tank. Ultimately, cells were grown in an OptiCell™, an 
acoustically-transparent parallel membrane environment, where delivery of 
molecules of various sizes, in the presence of both in-house and Definity® 
microbubbles was investigated. Sonoporation was achieved with 
insonication of SK Hep-1 cells with a “physiotherapy machine” applying a 
power of 2.54 W / cm2 for 2-3 secs in the presence of Definity® microbubbles 
and passage of Calcein, an impermeable molecule, into the cells was detected 
using flow cytometric analysis. In addition, expression of enhanced green 
fluorescent protein (EGFP) was also detected 24 hours after insonication of 
SK Hep-1 cells in the presence of Definity® microbubbles and a linearised 
plasmid pCS2, encoding EGFP, under the same ultrasonic conditions. 
Sonoporation was also investigated with the use of a diagnostic ultrasound 
scanner, since it is more clinically relevant. Although several acoustic and 
non-acoustic parameters were investigated, sufficient sonoporation was not 
attained using this scanner. 
The bioeffects of ultrasound on cells both in vivo and in vitro have been 
extensively investigated. However, the exact cellular mechanisms that are 
affected by the application of ultrasound waves are not understood.  In this 
study, the effects of ultrasound on a number of pathways were investigated. 
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Expression of Hsp70, a cell stress protein often associated with heat-shock, 
during application of continuous wave ultrasound, suggests that cells may 
undergo heat stress. During application of  continuous wave ultrasound in 
the presence of Definity® microbubbles, expression of Hsp70 was shown to 
decrease compared to when ultrasound was applied in  the absence of 
Definity® microbubbles. In addition, expression of HO-1, a protein 
associated with hypoxic pathways was also present during application of 
ultrasound in the absence of microbubbles. These results suggest that in the 
absence of ultrasound contrast agents, insonation can cause the expression of 
proteins associated with different forms of cell stress such as heat-shock and 
hypoxia, thus initiating the apoptotic process. 
 In this thesis, it has been shown that the mean size of the in-house 
microbubbles is comparable to that of commercially available microbubbles 
such as Definity®. In addition, it has been shown that sonoporation and 
successful delivery of small molecules in the presence of Definity® 
microbubbles is achievable with the equipment and the specific system 
which was developed. This reinforces the promising role of in-house 
microbubbles as delivery vehicles for therapeutic agents. Finally, an 
investigation on the possible bioeffects of ultrasound in the presence and 
absence of ultrasound contrast agents, revealed that under acoustic 
conditions identical to those used for achieving sonoporation, cells 
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1.0 Gene therapy 
1.1 Viral gene delivery  
The first building blocks for gene therapy were implemented with the 
practice of subcloning mammalian genes into plasmids becoming a reality in 
the early 1980s (Terence 2007). Gene therapy was developed in order to serve 
as a means of restoring the normal function of genes in a large number of 
inherited and acquired genetic disorders (Friedman 1999). Its success relies 
on efficacious delivery of a therapeutic gene into a target cell, tissue or organ 
in the absence of any detrimental consequences (Li and Huang 2000). Such 
an approach requires the employment of a vector capable of gene delivery. 
Regardless of their type, vectors need to comply with some fundamental 
criteria. 
Firstly, efficient production of a high volume of vectors at minimal 
time and at low cost is very important, for example, for clinical applications 
(Somia and Verma 2000; Liu 2002). This is due to the vast number of cells 
that need to be transduced (Somia and Verma 2000). The shelf life of the 
vector is also of great concern, to circulate the product to the desired 
locations in adequate time (Verma and Weitzman 2005). 
Secondly, the size of genes may range from a few hundred to tens of 
thousands of base pairs. Supplementing the genes of interest with additional 
sequences may be at times necessary in order to maximise gene transfer and 
expression (Follenzi 2000; Zennou, Petit et al. 2000). Thus it is essential that 
vectors can accommodate genes of such large dimensions (Allocca, Doria et 
al. 2008). 
Thirdly, targeting vectors to specific types of tissue or cells, while 
evading other types of tissue or cells can prove beneficial. For example, it 
would  be desirable for vectors to avoid dendritic cells, which play a role in 
inducing immune responses (Fields 2000). In cases of cancer therapy, 
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delivery of therapeutic molecules is required only to the malignant cells. The 
ability of a vector to detect the target cell, tissue or organ would also assist in 
attaining its target and in facilitating gene transfer (Douglas 1996; Wickham 
1996; Rajotte D. 1998). 
Another crucial factor limiting gene therapy is the presence of 
immunogenic responses. The emergence of an immune response would 
mean arresting the activity of the vector and subsequently halting gene 
transfer (Somia and Verma 2000). Although immune responses are most 
commonly seen in the presence of viral vectors, induction of inflammatory 
molecules has been reported for non-viral vectors (Liu 2002). Furthermore, 
activation of certain immunogenic pathways modulates suppression of gene 
expression and tissue damage (Qin 1997; Loisel 2001; Sellins 2005). 
Upon successful gene delivery, it is important that the effects of gene 
therapy remain present for a specified period of time or permanently, 
depending on the specifications of the disease (Lewis 1992; Bukrinsky 1993). 
This can only be ensured if the therapeutic gene is either integrated into the 
chromosomal genome of the target cell or settles in the nucleus of the cell 
and is consistently passed on to daughter cells (Kotin, Siniscalco et al. 1990; 
Inoue 1999; Carter 2000). 
Finally, genetic therapy is required for a multitude of diseases that 
occur in all types of cells within the human body. It is thus of great 
importance that the vector can efficiently deliver genes to all types of cells 
regardless of whether they are dividing or non-dividing cells (Kafri 1997; 
Zufferey 1997).  
A multitude of gene delivery studies using either viral or non-viral 
vectors have taken place, with both types of vectors exhibiting complications 
(Smith, Mehaffey et al. 1993; Setoguchi, Jaffe et al. 1994; Yang, Li et al. 1995; 
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Yang, Nunes et al. 1995; Jans 2000; Kircheis, Wightman et al. 2001; Lyman 
2002). Throughout the millions of years of their existence, viruses have had 
the time to perfect their gene delivery approach thus allowing them to 
successfully integrate into a cell’s genome without destroying the host cell 
(Rubanyi 2001). Hence, viral vectors are regarded as the predominant 
candidate for a successful gene delivery study. The main viruses employed 
in gene delivery studies are retroviruses, lentiviruses, adenoviruses and 
adeno-associated viruses (Edelstein 2008). 
 
1.1.1 Retroviruses 
Retroviruses are a group of viruses that contain RNA instead of DNA, 
thus they need to generate DNA before proceeding into replication of their 
genetic material. Retroviruses encompass certain genes that are necessary for 
integrating into the genome of the host cell (Monse, Laufs et al. 2006; 
Mousnier, Kubat et al. 2007; Montini, Cesana et al. 2009). Provided that only 
this set of genes is functioning, then it is possible for the virus to integrate 
with the host genome without replicating itself yet at the same time allowing 
for the gene of interest to be expressed (Kafri 1997; Zufferey 1997). The 
advantage of using retroviral vectors is that they are able to integrate with 
the host genome in a stable manner, thus resulting in a sustained gene 
delivery (Agosto, Yu et al. 2007; Deichmann, Hacein-Bey-Abina et al. 2007; 
Felice, Cattoglio et al. 2009). However, although there are currently over 300 
clinical trials utilizing retroviral vectors for gene delivery, this approach still 
exhibits several limitations including the vectors’ ability to infect only non-
dividing cells, their low titres and the prospect of random insertion of viral 






.Lentiviruses are a family of complex Retroviruses (Swanstrom 1997). 
They take their name (lenti = slow) from the gradual development of the 
infection they induce (Lever, Strappe et al. 2004). Lentiviruses were also 
considered as suitable vectors for gene delivery due to their ability to 
integrate into both dividing and non-dividing cells (Cockrell AS 2007; 
Edelstein 2008). Thus, a large number of lentiviruses have been studied, 
including, HIV-1, HIV-2, EIAV (equine infectious anaemia virus) and FIV 
(feline immunodeficiency virus) (Rizvi 1992; Olsen 1998; Sadaie 1998; 
Johnston 1999; Mitrophanous 1999; Wang 1999; Curran 2000; Mangeot 2000; 
Schnell 2000; Griffin 2001; Stitz 2001; Brooks 2002; Takahashi 2002; Kobayashi 
2003; Loewen 2003). In addition, lentiviruses have a large packaging capacity, 
which enables the insertion of large sized therapeutic genes (Lever, Strappe 
et al. 2004). The low levels of immunogenic activity seen with lentiviruses are 
also advantageous (Sandrin, Russell et al. 2003; Toelen, Deroose et al. 2007). 
Nonetheless, immunogenic responses should be rigorously evaluated for 
each study as they form the main hurdle of gene delivery. On the other hand, 
random insertional mutagenesis, which can lead to carcinogenesis, is of 
major concern (Linda, Niels et al. 1986). Finally, the limited capacity of 
lentiviruses to diffuse through tissues creates a further obstacle in their 
potential role as gene delivery vectors (Lever, Strappe et al. 2004).  
 
1.1.3 Adenoviruses 
Another family of viruses amongst the list of promising vectors for 
gene therapy are adenoviruses. Their ability to infect both dividing and non-
dividing cells and their ability to express high levels of the therapeutic gene 
were amidst the traits that made them favourable for gene delivery (Fields, 
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Knipe et al. 1996; Doetsch, Caillι et al. 1999). However, the development of 
immune responses by the host is one of the traits that prevented 
adenoviruses from fulfilling their role as gene delivery vectors. The 
development of severe inflammatory toxicities in several studies, following 
the death of a clinical trial patient with partial ornithine transcarbamylase 
(OTC) deficiency (Raper, Chirmule et al. 2003) dampened successful 
treatments and served as a reminder of the potential disastrous effects of host 
immune responses. 
 
1.1.4 Adeno associated viruses 
              Adeno associated viruses also exhibited a number of advantages for 
serving as gene delivery vectors, including their ability to penetrate into 
various tissues due to their small size, their ability to express in numerous 
cell types and their ability to integrate into the host’s chromosome (Lynch 
1997; Chiorini 1999; Lieber, Steinwaerder et al. 1999; Xiao 1999). However, 
their low rates of infection, small packaging capacity and the presence of 
adeno associated viral antibodies in 80 % of the adult population; diminish 
their rate of success as gene delivering vectors (Mselli-Lakhal 1998; Lieber, 
Steinwaerder et al. 1999; Berkowitz 2001; Olsen 2001). 
 
1.1.5 Viral gene therapy limitations 
 Although viruses have evolved mechanisms for integrating into the 
host cells without evoking their death, all families of viruses, such as 
retroviruses, adenoviruses and adeno-associated viruses, have yet to 
overcome a number of complications before fulfilling their role as efficient 
gene delivery vectors. The main concerns with employment of viral vectors 
for gene therapy are the potential of immunogenicity, insertion mutagenesis, 
oncogenesis and the presence of high levels of toxicity (Shigeru Kawakami 
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2008). Several clinical trials so far have resulted in the death or the 
development of cancer in patients, only to accentuate the extent of the 
problem with such an approach (Lehrman 1999; Hacein-Bey-Abina, Von 
Kalle et al. 2003; Check 2005). Additional predicaments associated with the 
use of viral vectors also include limitations to the size of gene that can be 
packaged into viruses and complication of their production (Bett, Prevec et al. 
1993; Zufferey. R, Dull et al. 1998; McCarty, Monahan et al. 2001). 
  The safety concerns associated with the use of viral gene vectors 
have shifted the focus towards non-viral vectors for the use of gene delivery. 
The latter can serve as more efficient gene therapy vectors in the absence of 
immunogenic responses (Robbins and Ghivizzani 1998; Shigeru Kawakami 
2008). In addition, non-viral vectors are easy to produce and can be adapted 
to fulfil specific target requirements (Behr 1994; Boussif, Zanta et al. 1996). 
The ease of large-scale production also serves as a motive for using non-viral 
vectors (Li and Huang 2000; Makiya Nishikawa 2001). Moreover, non-viral 
vectors fail to integrate into the cellular genome, therefore minimising the 
likelihood of insertional mutagenesis (Kaminski, Huber et al. 2002).  
 
1.2 Non-viral gene therapy 
 Non-viral gene therapy involves the use of DNA vectors (plasmid 
DNA) that can be administered to patients directly by either tissue or 
systemic injection in order to reach the target cells and express the 
therapeutic gene products (Ledley 1994). Although non-viral vectors are 
safer to use than viral vectors in terms of toxicity and immunogenicity, a 
number of other hurdles have emerged. These include the negative charge of 
DNA and its large size that block it from crossing any unimpaired membrane 
boundaries (Ledley 1994). Furthermore, the presence of cellular nucleases 
halt cytoplasmic transport of DNA before it can reach the nucleus and get 
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access to the cell’s reproductive machinery (Mir 1999; Rizzuto 1999; Fattori 
2002). Therefore, the key to a successful non-viral gene delivery is to find the 
balance between inducing irreversible cell damage and obtaining nuclear 
entry (Cheng-Huang, Yeh et al. 2008).  
 
1.2.1 Techniques for non-viral therapy 
Several methods have been explored in order to overcome the hurdles 
stated above. These can be broadly categorized into (a) delivery by physical 
techniques and (b) delivery mediated by chemical carriers (Shigeru 
Kawakami 2008).  
 
1.2.1.1 Physical techniques 
Physical techniques promote entry of DNA vectors into cells via 
diffusion through transiently impaired cell membranes by applying a 
physical force on the target cell membrane (Yang 1990; Van Wamel, Kooiman 
et al. 2006a). The use of a gene gun, electroporation and ultrasound are 
amongst the most accepted physical techniques applied (Makiya Nishikawa 
2001; Gao 2007; Shigeru Kawakami 2008). 
One of the physical methods used for enhancing the efficiency of non-
viral vectors is the employment of a gene gun. This involves coating of heavy 
metal particles (predominantly gold beads) with the selected DNA vector. 
Pressurised gas is then applied to the particles, thrusting the former towards 
the target cells or tissue (Gao 2007; Shigeru Kawakami 2008). The extensive 
force of the particles enables them to penetrate a few millimetres deep into 
the tissue (Yang, Burkholder et al. 1990). The DNA vectors that have been 
placed on the particles are thus deposited into the target cells.  Efficiency of 
this method has been reported to range from 10 to 20 % in skin epidermal 
cells and from 1 to 5 % for muscle cells and lasting from 14 days up to 60 
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days after bombardment respectively (Yang 1990; Williams. R. S. 1991; 
Zelenin 1997). However, the major drawback of this approach is the shallow 
penetration into the target area, thus limiting this approach to superficial 
layers such as skin, mucosa, and skeletal muscle (Zelenin 1997). In addition, 
in vivo application of a gene gun in skin, liver and skeletal muscle 
culminates in a short lived and diminished effect (Boretti, Leutenegger et al. 
2000; Oehen, Junt et al. 2000).  
Electroporation (also known as electropremiabilisation) produces 
transient pores on the cell membrane by application of high intensity electric 
oscillations (Cheng-Huang, Yeh et al. 2008). DNA vectors found in close 
proximity to the cell membranes are thought to able to pass through the 
plasma membrane via electrophoresis (Liu, Heston et al. 2006). Although, the 
use of electroporation has been shown to increase gene expression by 100- to 
1000- fold, there are several hindrances associated with this approach (Bigey 
2002; Gehl 2003; Bloquel 2004; McMahon 2004). Firstly, electroporation has 
been mainly used in studies correlated with skin (Zhang 2002) and skeletal 
muscle (Mir 1999; Rizzuto 1999; Fattori 2002), since the distance between the 
two electrodes cannot exceed 1 cm (Vanbever, Lecouturier et al. 1994; 
Jaroszeski, Gilbert et al. 1999). Therefore, application of electroporation to 
any internal organs would necessitate a surgical procedure in order to place 
the electrodes in close proximity of the target area (Gao 2007). Furthermore, 
the high voltage applied during electroporation can lead to irreversible tissue 
damage due to high calcium influx and thermal heating (Gissel 2001; 
Durieux 2004). Finally, application of high voltages is also likely to afflict the 
stability of genomic DNA (Durieux, Bonnefoy et al. 2004). 
Ultrasound is a modality that is already in clinical use for both 
diagnostic and therapeutic applications (Kremkau, Kaufmann et al. 1976; 
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Preston, Bacon et al. 1983; Madersbacher, Kratzik et al. 1995; Madersbacher, 
Padevilla et al. 1995; Harrison, Balcer-Kubiczek et al. 1996; Akiyama, 
Ishibashi et al. 1998; Kornbluth, Liang et al. 1998; Desser, Jeffrey et al. 1999). 
It is an efficient tool as it is of low cost, simple and safe (Liu 2002) . In the mid 
1990s, the potential role of ultrasound in gene delivery was discovered 
(Shigeru Kawakami 2008). Ultrasound has since been shown to be an 
effective delivery method, presenting several advantages over other viral 
and non-viral methods such as electroporation (Pan, Zhou et al. 2005). The 
main advantage of ultrasound mediated gene delivery is that it exerts its 
effects with minimal invasiveness (Bachor, Gottfried et al. 1995; 
Madersbacher, Pedevilla et al. 1995; Larsen, Krasnik et al. 2002). In addition, 
ultrasound apparatus can effectively image as deep as 24 or more 
centimetres in the human body (Nelson, Perry et al. 1990). The use of 
ultrasound has been reported to result in a 10- to 20- fold increase in gene 
expression compared to that achieved by naked DNA (Lawrie, Brisken et al. 
2000). Ultrasound mediated gene transfection involves acoustic cavitation, 
which leads to formation of transient pores on the membranes of adjacent 
cells (Van Wamel, Kooiman et al. 2006b). Addition of ultrasound contrast 
agents can further increase gene delivery efficiency (Nozaki 2003; Ogawa 
2004). Ultrasound contrast agents are air filled microbubbles that oscillate 
during application of ultrasound, thus reducing cavitation threshold (Apfel 
and Holland 1991). Furthermore, ultrasound contrast agents can be used as 
vehicles for therapeutic molecules (Zarnitsyn and Prausnitz 2004). The 
proficiency of the ultrasound mediated gene delivery system is regulated by 
numerous parameters, including frequency, power, pressure and duration of 
the ultrasound wave applied, local concentration of DNA plasmid and 
ultrasound contrast agents (Huber 1999). Both continuous wave and pulsed 
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wave ultrasound have been used for intracellular delivery of molecules 
(Lawrie, Brisken et al. 1999; Miller and Quddus 2000). The generation of 
adverse effects such as mechanical and thermal damage to cells, due to 
prolonged exposures or high intensities of ultrasound are of concern (Barnett 
1994). Although ultrasound mediated gene delivery is a promising method 
for gene therapy, further research is necessary in order to achieve regulated 
and coherent gene delivery (Zarnitsyn and Prausnitz 2004). 
 
 
1.2.1.2 Chemical techniques 
Chemical approaches include the establishment of DNA into naturally 
occurring or synthetic compounds (Gao 2007). Conventionally employed 
compounds include cationic liposomes and cationic polymers (Shigeru 
Kawakami 2008). The positive charge of such compounds enables them to 
interact with the negatively charged DNA thus forming a complex (Felgner, 
Gadek et al. 1987). The former is believed to enter the cell via endocytosis (Xu 
and Szoka 1996). Although, it is believed that once entering the cell as a 
complex, the DNA is protected from nuclease degradation (Hui, Langner et 
al. 1996), Cheng-Huang Su et al. (2008) report that only 1 % of the DNA is 
able to enter the nucleus. In addition, although in vitro studies with the aid of 
cationic compounds have been compelling (Rose 1991; Felgner, Kumar et al. 
1994; Vigneron, Oudrhiri et al. 1996), a number of complications have been 
encountered during clinical trials, including low efficiency and toxicity 
(Bottega and Epand 2002; David, Marie-Laure et al. 2002; Kim, Park et al. 
2005; Lv, Zhang et al. 2006). 
In conclusion, although nonviral gene delivery techniques are more 
advantageous than viral techniques, the former also face several hurdles. The 
use of gene gun and electroporation are limited to superficial areas such as 
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the skin and skeletal muscle, while chemical techniques are characterised by 
low efficiencies. Therefore, ultrasound mediated gene delivery, either in the 
presence or absence of ultrasound contrast agents, is one of the most 
promising techniques since it can result in successful gene delivery into deep 
tissues with minimal invasion (Nelson, Perry et al. 1990; Bachor, Gottfried et 
al. 1995; Madersbacher, Kratzik et al. 1995; Larsen, Krasnik et al. 2002). 
Nevertheless, further investigation is required in order to establish the exact 
parameters necessary for regulated gene delivery both in vitro and in vivo 


























































2.1 Acoustic waves  
Sound is a form of mechanical wave energy that can travel from 
waves from a source to a receiver through a medium such as air, water or 
tissue (O'Brien 2007).  The sound wave can be defined by frequency, period, 
wave length, propagation speed, amplitude, intensity and attenuation (Kavic 
1996). The type of wave formed when a sound wave is propagating through 
a medium depends on the direction of motion of the particles of the medium 
in relation to the direction of the wave (O'Brien 2007). When sound is emitted 
from a source, the particles of a medium are displaced, thus transferring to 
adjacent particles (Laird and Walmsley 1991). When a sound wave is 
propagating though a medium, there are regions where the particles 
experience high pressure (compression) and regions where the particles 
experience low pressure (rarefaction) (figure 2.1) (Hangiandreou 2003).  
When the particles within a medium move in the direction of the sound 
wave, then the sound wave is termed longitudinal (O'Brien 2007). When the 
particles of the medium are moving at right angles in relation to the direction 
of the sound wave, the latter is termed a transverse or shear wave (O'Brien 
2007). While longitudinal waves can be found in all types of materials (solid, 
liquid, gas), shear waves can only be found in solid materials (O'Brien 2007).  
Therefore, in soft tissues, only longitudinal waves are of importance, 
whereas both longitudinal and shear waves can propagate through tissues 
such as bone (Humphrey 2007).  
The high points (crests) and lowest points (troughs) of the wave 
constitute the  pressure amplitude (P) of the wave and are designated as the  
peak compressional and rarefractional values respectively (figure 2.1) 
(O'Brien 2007). The pressure amplitude of a wave is measured in Pascals. The 
























Figure 2.1 Sound wave. Adapted from (Hangiandreou 2003; Fischetti and Scott 2007). Acoustical energy emitted from a 
source travels through a medium (air, solid, liquid) in order to arrive to a receiver. The acoustical energy released is 
transferred through the medium by displacing adjacent particles. This creates an acoustic wave that exhibits high pressure 
(compression) and low pressure (rarefaction) regions. The highest points (peak compression) and lowest points (peak 
rarefaction) of the wave constitute the pressure amplitude (P) of the wave. The distance between repeating points of a 
propagating waveform is defined as the wavelength (λ) of an acoustic wave. The number of complete wave cycles per second 
is referred to as frequency (ʄ). The relationship between the wavelength and the frequency of an acoustic wave is inversely 
proportional. An acoustic wave can be emitted in short bursts (pulses). The time interval of these pulses is defined as pulse 
duration. Pulse repetition frequency (PRF) is the rate of sound pulses per unit of time. 
Pulse duration 
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magnitude of change between a crest and a trough. The time taken for the 
wave to complete one cycle is defined as the period (T).  The speed (v) of a 
sound wave through a medium is dependent on density (ρ) and 
compressibility of the material, also known as bulk modulus (B). Thus, speed 
can be expressed by the following equation:    
                                        
ρ
B
v =                 (1)   
 The velocity of sound in fat, liver, kidney, blood and muscle are 
approximately 1,460, 1,555, 1,565, 1,560 and 1,600 ms-1, respectively 
(Zagzebski 1996). Since the velocity of sound in human soft tissues exhibits 
such small alterations from one tissue to another that, it is generally accepted 
to be around 1540 ms-1 (Herbener 1996; Zagzebski 1996; O'Brien 2007). The 
intensity (I) of an acoustic plane wave is given by: 






=                     (2) 
 
2.1.1 Frequency 
 The number of wave cycles per second is referred to as frequency (ʄ) 
and is measured in Hertz (1 Hertz = 1 cycle per second). Frequency is 
inversely proportional to the period (ʄ=1/T). Pulse repetition frequency (PRF) 
is the rate of sound pulses per unit of time (Fischetti and Scott 2007). The 
acoustic spectrum range can be classified into infrasound, audible sound and 
ultrasound depending on the range of frequency used (O'Brien 2007). 
Infrasound has a frequency range of less than 20 Hertz (Hz), while 
frequencies ranging between 20 and 20,000 Hertz (Hz) are within the human 
audible sound range (Kavic 1996; O'Brien 2007). The term ultrasound is 
employed for frequencies exceeding 20 kHz (Kavic 1996). Although 
ultrasound is inaudible to the human ear, a range of animals, including bats, 
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dolphins, tortoises and whales, use it in order to detect objects in the absence 
of light (Wade 2000). Nowadays, most ultrasound equipment serve for 
therapeutic and diagnostic purposes in the medical field with the former 
operating around 1-3 MHz and the latter operating between 2 and 15 MHz 
(Herbener 1996; O'Brien 2007). The selected frequency is a compromise 
between the depth of penetration and the spatial resolution (Herbener 1996) .  
 
2.1.2 Wavelength 
The wavelength (λ) of an acoustic wave is defined as the distance 
between repeating points of a propagating waveform. Wavelength depends 
on the velocity of sound in the medium and the frequency of the sound wave 
and is given by the following relationship: 
                                      
f
v=λ                (3) 
Where λ is wavelength, v is velocity of sound and f is frequency of sound. 
Therefore, the higher the frequency, the smaller the wavelength will be. 
 
2.1.3 Acoustic power 
Acoustic power is defined as the rate of flow of acoustic energy per 
unit time and is measured in Watt (W). The acoustic intensity of a sound 
wave can be defined as the rate of flow of acoustic energy within a unit area 
and is measured in W / m2.  
 
2.1.4 Absorption 
When an acoustic wave travels through a medium, a fraction of its 
energy is lost due to absorption, reflection and scattering, and it becomes 
attenuated (Herbener 1996).  
Absorption is the conversion of acoustic energy into heat energy while 
passing through a medium. The absorption coefficient of many media 
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depends on the frequency of the acoustic wave and the composition of the 
medium, thus the higher the frequency, the greater the absorption (Herbener 
1996).   
 
2.1.5 Reflection and scattering  
Acoustic waves act in a similar manner to light waves in that when an 
acoustic wave encounters an interface between two different materials, such 
as soft tissue and bone, at a perpendicular angle, a fraction of the wave will 
be reflected back to the first material, and the rest will be transmitted to the 
second material (Laird and Walmsley 1991; Herbener 1996). The acoustic 
impedance (Z) of a medium characterises how mechanical energy propagates 
through the medium. For a plane wave, characteristic acoustic impedance is 
defined by the product of the density (ρ) of the medium and the propagation 
speed of the acoustic wave ( cZ ρ= ). In ultrasonics, the unit of acoustic 
impedance is the rayl. The greater the impedance difference between two 
materials, the more energy is reflected back into the original material and the 
smaller the impedance difference between two materials, the more energy 
will be transmitted into the second material (Laird and Walmsley 1991).  The 
amplitude reflection coefficient (R) is given by the ratio of the pressure 
amplitude reflected (Pr) to the incident pressure amplitude (Pi). So  












==                      (4) 
where Z1 is the acoustic impedance of the first material and Z2 the acoustic 
impedance of the second material (Zagzebski 1996). Since the amplitude 
reflection coefficient at air interfaces has been calculated to be nearing 1, 
practically most of the acoustic wave would be reflected at air / soft tissue 
interface (Zagzebski 1996). Agents that reduce the amplitude reflection 
coefficient between two interfaces (such as gel), thus enabling the 
 41 
transmittance of most of the ultrasound waves are known as acoustic 
coupling agents (Herbener 1996; Zagzebski 1996).  It should be noted at this 
point that if the projected beam is at a non-perpendicular angle, the reflection 
wave will not return to the transducer, rather it will be reflected at an angle 
equivalent to the angle of incidence (Hangiandreou 2003). In addition, 
acoustic waves that are emitted at a non-perpendicular angle will also 
experience refraction at the interface between two surfaces. Refraction is the 
change of direction of an acoustic wave that occurs when the acoustic wave 
strikes an interface between two media at an angle and the speed of sound of 
the two media on either side of the interface is different (Zagzebski 1996).  
The extent of refraction can be calculated by Snell’s law, which is as follows:  











                   (5) 
 Where iθ  is the incidence wave angle, tθ  is the transmitted wave angle, iν  is 
the incident velocity of sound and tν  is the transmitted velocity of sound 
(figure 2.2). 
If however the projected beam strikes an object of the same size as its 
wavelength or smaller, at a non-perpendicular angle, then the beam will be 
scattered (Zagzebski 1996). Scattering occurs in all directions, thus scattered 
echoes are not as dependent on the angle of incidence of the wave as are 
reflected echoes (Zagzebski 1996). In addition, scattered echoes tend to be 
weaker than reflected echoes (Zagzebski 1996). 
 
2.1.6. Attenuation 
 Attenuation is the depletion of intensity of an acoustic wave due to 
absorption, reflection and scattering and can be expressed in decibels per 
centimetre (dB / cm). Since absorption is frequency dependent and it 
promotes attenuation, acoustic waves of a high frequency also 
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Figure 2.2 Reflection and transmission of a beam. When an incident beam 
travelling at a iθ  angle, hits an interface between two tissues, a fraction of the 
incident beam will be reflected at a rθ  angle, which is equal to iθ  but is travelling at 
an opposite direction. The rest of the beam will be transmitted through the second 
tissue. A difference in the acoustic impedance between the two tissues will lead to 
refraction of the transmitted beam, which will travel at a tθ  angle, where it θθ > . 
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exhibit greater attenuation (Herbener 1996). Therefore, when applying 
ultrasound at a higher frequency, the depth of penetration will be reduced 
compared to a lower frequency of insonation (Herbener 1996).   
    
2.2 Ultrasound  
The field of ultrasound was discovered by the Currie brothers, the 
pioneers of the piezoelectric effect in the late 19th century (O'Brien 2007).  The 
Currie brothers observed that application of an electric field through certain 
materials resulted in the vibration of these materials and subsequently the 
development of a sound wave. Amongst the several piezoelectric materials 
that have been discovered, ceramics, such as lead zirconate titanate (PZT) are 
most commonly employed for diagnostic ultrasound (Zagzebski 1996).  
Ultrasound machines send ultrasound waves through a medium and 
detect any echoes that return to them. Ultrasound waves are produced by an 
ultrasound transducer. The latter is composed of a piezoelectric crystal 
arranged in such as way that the overall electrical charges of the domains are 
evenly distributed. Application of an electrical field causes a disturbance on 
the electrical charges thus causing them to vibrate and produce a sound 
wave (Kavic 1996). The emitted ultrasound waves propagate through a 
medium. Upon striking a second medium, a fraction of the wave is reflected 
or scattered back to the transducer (due to differences in acoustic impedance), 
whereas the remaining wave is transmitted through the object. Since the 
speed of sound in soft tissue is assumed to be constant, the time it takes for 
the scattered / reflected echo to travel back to the transducer is proportional 
to the distance of the structure from the transducer.  Once the ultrasound 
probe has emitted an ultrasound wave, it enters receive mode and any 
scattered or reflected waves incident on the transducer crystal generate a 
voltage due to the converse piezoelectric effect (Kavic 1996). This voltage is 
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then detected, amplified and displayed as an image on the ultrasound 
apparatus screen (Kavic 1996). One of the first applications for 
piezoelectricity unfolded during the First World War in order to produce 
submarine detecting sonar (Wade 2000). Following the end of the war, 
scientists from the medical field envisioned the use of ultrasound for 
diagnostic and later for therapeutic medical purposes. 
 
2.2.1 Transducers 
The simplest form of transducer is a single unfocused transducer 
element (figure 2.3). The piezoelectric element is placed in a plastic casing 
and is isolated with rubber or cork in order to avert transmission of 
ultrasonic energy to the plastic case (Zagzebski 1996). In addition, the casing 
is contained in a metal electrical shield so as to prevent interference from 
external electrical signals (Zagzebski 1996). The frequency at which a 
transducer performs optimally is termed its resonance frequency and is 
effected by the thickness of the piezoelectric element (Zagzebski 1996). For 
greater precision the thickness of the piezoelectric element is designed so as 
to equal half the wavelength of the desired pulse centre frequency 
(Whittingham 2007). Furthermore, broad bandwidth transducers have been 
developed, that can transmit a range of frequencies. Modern array 
transducers allow the user to alter the focal depth without having to 
interchange between transducers (Fischetti and Scott 2007).  
 Due to the high acoustic impedance of PZT in relation to tissue, 
impedance-matching layers are inserted in front of the transducer so as to 
achieve maximum transmission (Whittingham 2007). Ultrasound waves can 
be produced in two modes: continuous and pulsed. Continuous waves (CW) 
are formed by exciting the ultrasound transducer at a constant amplitude, 
whereas pulsed waves (PW) are formed by exciting the ultrasound 
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Figure 2.3 Single element transducer. A typical ultrasound transducer is 
composed of a piezoelectric element that is encapsulated in a plastic case and is 
isolated from electrical interference with the use of rubber or cork. The encapsulated 
element is then contained in a metal electrical shield so as to further prevent 
interference from any external electrical signals. A backing material is placed behind 
the piezoelectric element in order to reduce vibrations of the element immediately 
after emission of a wave, thus allowing for formation of short pulses. Positioning a 
lens in front of the piezoelectric element allows focusing of the ultrasound beam to 















transducer repeatedly for short periods of time (O'Brien 2007). In pulsed 
wave transducers, a backing material is placed behind the piezoelectric 
element in order to diminish the vibrations of the elements as soon as 
possible, thus forming pulses of short duration (Zagzebski 1996).        
  
2.2.1.1 Ultrasound resolution 
Spatial resolution alludes to the minimal distance that two reflectors 
can have before they are no longer detected as two separate media but as one 
(Zagzebski 1996). Spatial resolution is proportional to frequency, thus as 
frequency increases, spatial resolution is enhanced (Zagzebski 1996). Spatial 
resolution can be divided into axial and lateral resolution, signifying the 
resolution along the length and width of the ultrasound beam respectively 
(Fischetti and Scott 2007). Axial resolution depends on pulse duration and 
frequency of the wave whereas lateral resolution depends on the ultrasound 
beam width (Zagzebski 1996; Fischetti and Scott 2007). Resolution can be 
enhanced by focusing the beam (Fischetti and Scott 2007). Focusing can be 
achieved by mechanical or electronic means. Mechanical focusing involves 
the use of a lens or a curved piezoelectric element in order to focus the 
ultrasound beam to the required distance (Zagzebski 1996). The focal 
distance is the plane at which the ultrasound beam is at its most confined 
span (Zagzebski 1996). More advanced transducers achieve electronic 
focusing by using of an array up to 196 elements (Hangiandreou 2003). Phase 
array transducers function by activating all elements of the transducer with a 
time delay, thus allowing steering of the direction of the beam (Fischetti and 






Following an ultrasound beam being transmitted through a medium, 
the receiver of the ultrasound scanner detects the reflected waves and 
processes them, before displaying them on the monitor (figure 2.4). 
Processing involves various stages, including amplification, time gain 
compensation (TGC), compression, demodulation and rejection (Zagzebski 
1996). Since ultrasound waves are attenuated when travelling through a 
medium, the reflected waves that arrive at the receiver are weak. Initially, the 
reflected signal is amplified. The degree of amplification is termed the gain of 
the receiver and is the ratio of the signal amplitude produced to the signal 
amplitude that is acquired (Zagzebski 1996). An additional component is also 
used in order to amplify the reflected waves. This component is called a 
preamplifier and as its name indicates, it amplifies the reflected signals 
before they are further amplified by the receiver. A prevalent complication 
with amplifiers is that apart from amplifying the reflected signal they also 
create artificial electrical signals, termed noise (Zagzebski 1996). Reflection 
waves arriving at the receiver from greater distances are more attenuated, 
thus give weaker signals than reflection waves arriving from shorter 
distances. TGC is the process which compensates for such attenuation 
(Zagzebski 1996). Distinct components of the ultrasound scanner have 
different dynamic ranges, i.e. the range of signal amplitude they can detect 
varies (Zagzebski 1996). A reflected signal of a large dynamic range needs to 
be compressed before the components with lower dynamic ranges are able to 
display it (Zagzebski 1996). Demodulation entails the modification of a 
reflected signal into a single pulse (Zagzebski 1996). Finally, rejection is a 
function that excludes any electronic noise, such as that generated by the 
amplifiers (Zagzebski 1996).  
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Figure 2.4 Schematic representation of the principal components of an 
ultrasound imager. Upon expulsion of an ultrasound wave from the ultrasound 
transducer, the latter is converter into a receiver, thus collecting the reflecting waves 
for further processing. Reflected signals tend to be attenuated due to their travelling 
through a medium, thus Initial processing necessitates amplification of the reflected 
signal firstly by the preamplifier and then by the amplifier. The signal then undergoes 
time gain compensation (TGC), compression, demodulation and rejection of any 
artificial electrical signal (noise) that has been created during the amplification 
process.  The processed signal is presented at the monitor of the ultrasound imager 
















2.2.3 Display modes 
There are three main display modes used in pulsed echo 
ultrasonography, these are: A-mode, B-mode and M-mode (figure 2.5). A-
mode (amplitude) displays the amplitude of the reflected wave versus the 
time it took for the reflected wave to arrive to the transducer (Zagzebski 
1996). Since this time corresponds to the distance of the reflector, therefore A-
mode is a display of amplitude of reflection versus distance of reflector. In 
addition, the PRF in A-mode is restricted so as to provide enough time for 
the reflected wave to decline before transmitting the next ultrasonic wave 
(Whittingham 2007). Factors such as propagation speed of ultrasound and 
distance of concern, determine the values of PRF (Whittingham 2007). A-
mode is advantageous when accuracy of depth is desired (Whittingham 
2007). B-mode (brightness) displays the reflected waves in pixels, which have 
different levels of brightness, whose position represents the amplitude of the 
scattered / reflected signal received at the transducer.  The position of the 
pixel is related to the distance of the reflector from the source (Zagzebski 
1996).  While both A-mode and M-mode transmit the ultrasonic beam in a 
fixed direction, B-mode is concerned with scanning the ultrasonic beam 
(Whittingham 2007). M-mode (motion) displays reflector distance versus 
time (Zagzebski 1996). M-mode is mainly used in echocardiography and 
obstetrics in order to observe movement of the heart valves, heart chamber 
wall and embryonic heart movements respectively (Whittingham 2007). 
 
2.2.4 Ultrasound equipment  
The capacity of ultrasound to serve both for therapeutic and 
diagnostic purposes makes it a very effective tool (ter Haar 2007). However, 
the requirements for each application differ. Therapeutic applications require 
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Figure 2.5 Schematic representation of the A-mode and B-mode displays. (a) 
A-mode display of a two pulse wave. This mode displays the amplitude of a 
reflected wave versus the time, which also corresponds to distance travelled by the 
reflected wave. (b) B-mode display of a two pulse wave. This mode displays the 
reflected wave in pixels of different brightness levels. The position of the pixel 
represents the amplitude of the wave, thus corresponds to the distance reflector 
from the source. (c) M-mode display of a two pulse wave. This mode displays the 
distance of the reflector versus time, thus it is useful for observing moving parts of 














induction of reversible or irreversible bioeffects, subject to the aim of the 
treatment, while diagnostic applications necessitate production of images 
with good spatial and temporal resolution (ter Haar 2007). Therapeutic 
applications of ultrasound include physiotherapy, transdermal drug delivery, 
thrombolysis, cancer treatment and bone healing (ter Haar 2002; Paliwal and 
Mitragotri 2009). The equipment used for each application are therefore 
different. 
 Ultrasound apparatus used for therapeutic applications, do not need 
to produce an image. The ultrasound beam is expelled by a non steered 
single disk shaped PZT element. The transducers used can transmit 
relatively high powers up to 10-12 Watts and emit waves of frequencies 
between 1-3.5 MHz. As frequency increases, penetration decreases and 
heating increases due to absorption (ter Haar 2007). Therefore the preference 
of frequency is a compromise between the maximum depth and absorption 
required (ter Haar 2007). The ultrasound waves delivered are of low 
pressures amplitudes (100-200 kPa) and can be either continuous or long 
pulsed waves (ter Haar 2007). Near field of transducer has complex 
interference pattern, i.e. local intensity varies rapidly with distance close to 
the transducer. 
The objective of diagnostic apparatus is to provide an image with axial 
resolution, i.e. the ability to distinguish between adjacent tissues (Paliwal 
and Mitragotri 2009). In addition it is important that no adverse effects are 
generated (ter Haar 2007). The transducers employed in diagnostic scanners 
are composed of an array of many small PZT elements so as to be able to 
steer the ultrasound beam through the tissue in order to form a 2D or 3D 
image. The ultrasound beam transmitted is of low power (few mWatt to 100-
200 mWatt) while frequencies used normally range between 0.2-20 MHz 
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depending on the depth of the tissue being imaged (ter Haar 2007). 
Diagnostic ultrasound scanners operate at higher frequencies than those 
used in therapeutic ultrasound (Miller 2007b). Typical frequencies used in 
diagnostic ultrasound are 3-5 MHz for abdominal and cardiac imaging, 10 
MHz for superficial areas such as the neck or breast, 30 MHz for the anterior 
chamber of the eye and 100 MHz for the cornea of the eye (Paliwal and 
Mitragotri 2009). The ultrasound scanners use relatively high pressures, with 
peak pressure ranging between 0.5-33 MPa and relatively short pulses. 
 
2.2.5 Bioeffects of ultrasound  
As ultrasound passes through a medium, such as a biological tissue, 
the particles of this medium experience forces and stresses that might lead to 
damage of the tissue (Zagzebski 1996). Although no tissue damage has been 
reported so far from clinical diagnostic ultrasound application, some effects 
of ultrasound on biological tissue have been described and are continuously 
been investigated in order to obtain a clear idea of any risk factors associated 
with the use of ultrasound (Miller, Pislaru et al. 2002). The bioeffects seen, are 
predominantly caused during application of high intensities and long 
exposure periods (Zagzebski 1996). Ultrasound bioeffects can be separated 
into two categories, mechanical and thermal (BMUS 2007; ECMUS 2008). 
Mechanical bioeffects include acoustic cavitation, acoustic microstreaming 
and radiation pressure, while thermal bioeffects involves heating of the 
tissues (Cheng-Huang, Yeh et al. 2008). 
 
2.2.5.1 Mechanical bioeffects of ultrasound  
2.2.5.1.1 Cavitation  
Ultrasonic cavitation refers to the production of microscopic gas 
bubbles during passage of an ultrasound beam through a medium (Patil and 
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Pandit 2007). The gas bubbles expand and contract with the fluctuations of 
the ultrasound wave (Zagzebski 1996). The occurrence of cavitation 
presupposes the presence of  stabilized nuclei (Dalecki 2004). If the negative 
pressure applied to the medium compels the particles within the medium to 
diverge further than their critical molecular distance (Rc), then gas bubbles 
will be formed (Mason 1987). Gas bubbles then grow by rectified diffusion, 
where gas diffuses into the bubble during rarefaction and escapes during 
compression (Crum 1982). Since the rate of diffusion depends on the surface 
area of the bubble, more gas enters  the gas bubble during rarefaction than 
escapes during compression, bringing about the growth of the bubble (Crum 
1982). In theory, in order for cavitation to take place in water, a negative 
pressure of  100 MPa (1000 atmospheres) would be necessary (Mason 1987). 
However, in reality, cavitation occurs at much lower negative pressures, due 
to the presence of weak spots in the medium (Mason 1987).  According to the 
crevice model, weak spots are areas of hydrophobic impurities, where gas 
nuclei are stabilized (Dalecki 2004). During negative pressures, the gas nuclei 
expand and disassociate from the impurities, thus forming gas bubbles 
(Dalecki 2004). In biological tissues gas nuclei are mainly present in the lungs 
and intestines (Dalecki 2004). The collapsed bubbles can either act as nuclei 
for new gas bubbles or if very small, can dissolve in the solution because of 
the “Laplace pressure” due to surface tension (Mason 1987; Wu and Nyborg 
2008). The physical properties of the medium and the initial radius of the gas 
bubbles are amongst the various parameters that determine the extent of 
cavitation (Dalecki 2004; Patil and Pandit 2007). In addition, frequency has 
been shown to be inversely proportional to production of cavitation (Mason 
1987). The basis for this observation can be explained in several ways. For 
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example, at high frequencies the time of rarefaction is so short that there is 
not sufficient time for the gas bubbles to grow (Mason 1987). 
 
2.2.5.1.2 Non-inertial cavitation  
  Non-inertial or stable cavitation entails the oscillation of gas bubbles 
below the inertial cavitation threshold (Miller 2007b). Gas body behaviour 
models locate the inertial cavitation threshold at ultrasonic conditions of a 
mechanical index (MI) of about 0.4 (Miller, Averkiou et al. 2008). Non-inertial 
cavitation can persist for several cycles and can expand the radius of the gas 
bubbles to around twice their initial radius (Mason 1987; Dalecki 2004). 
During non-inertial cavitation, extensive oscillatory and steady fluid shear 
stresses develop adjacent solid surfaces (Miller, Averkiou et al. 2008). Fluid 
shear stresses have been shown to exert mechanical injury on cell membranes 
(Miller, Averkiou et al. 2008). However, non-inertial cavitation is seldom 
studied since the microbubbles relevant to medical ultrasound undergo 
transient cavitation (Miller 2007b). 
 
2.2.5.1.3 Inertial cavitation  
Above the inertial cavitation threshold, gas bubbles grow to such 
dimensions that they collapse violently. Inertial or transient cavitations 
prevail for only a few acoustic cycles and can amplify the radius of the gas 
bubbles to many times the initial radius before collapsing (Mason 1987). This 
produces severe localized effects such as the formation of free radicals, fluid 
jets, temperatures of up to 14,000 K, pressures of up to 10,000 Atm and 
sonoluminescence (Patil and Pandit 2007; Cheng-Huang, Yeh et al. 2008; 
Miller, Averkiou et al. 2008). The latter refers to the production of light 




2.2.5.2 Thermal bioeffects of ultrasound  
During transmission of an ultrasonic beam through a medium, part of 
the beam is absorbed and converted into heat. The degree of temperature 
increase is dependent on both the properties of the medium and the 
ultrasonic beam (Dalecki 2004).  
 
2.2.5.3 Measuring bioeffects of ultrasound  
One can appreciate the importance of monitoring the factors that 
cause all the bioeffects discussed above. Therefore, a number of indicators 
have been assigned that relate to the potential bioeffects that arise from 
application of ultrasound. Such indicators include the mechanical index (MI) 
and thermal index (TI). The mechanical index is used to describe the 
likelihood of occurrence of cavitation and is directly proportional to the peak 
rarefractional pressure in the medium and inversely proportional to the 
square root of the ultrasound frequency (Zagzebski 1996). The higher the 
value of the MI, the higher the probability of cavitation (Wu and Nyborg 
2008). The thermal index is used to describe the potential increase in 
temperature that can happen as a result of ultrasound exposure and is 
defined as the ratio of the acoustical power over the power required to raise 
the temperature by 1 degree C (Zagzebski 1996).  
 
2.2.6 Measurement of ultrasound probes  
As the performance of ultrasound probes tends to decline over time, it 
is necessary to conduct frequent measurements in order to be able to employ 





2.2.6.1 Measurement of acoustic power 
 Ultrasonic power is routinely measured with the aid of a radiation 
force balance (Zeqiri 2007). Radiation force (F) is a force that is produced by 
an acoustic field and affects any object intercepting the field (Zeqiri 2007).The 
probe under investigation is placed in a water bath and held directly above a 
balance. The plate of the balance is composed of an acoustic absorber so as to 
collect the ultrasound wave generated by the probe (Zagzebski 1996). One 
can calculate the acoustic power that is exerted from the probe by applying 
the following equation: 
                                         
v
WF =                (6) 
 where W is the acoustic power and v is the propagation speed in water 
(Zagzebski 1996). 
 
2.2.6.2 Measurement of acoustic pressure  
Measurement of pressure is achieved with a hydrophone (Zagzebski 
1996). A hydrophone is made from thin membranes of the piezoelectric 
polymer polyvinylidene fluoride (PVDF) and functions as a receiver of the 
ultrasonic beam generated by the probe under investigation (Zagzebski 1996; 
Zeqiri 2007). As it contains a piezoelectric element, it is able to transform the 
vibrations received from the probe into an electrical signal of comparable 























Figure 2.6 Image of a type of hydrophone. A membrane hydrophone is composed 
of thin membranes of piezoelectric polymer polynivylidene fluoride (PVDF). It 
operates by transforming received vibrations into electrical pulses of comparable 
amplitude. Such a hydrophone can be used in order to measure the acoustical 










































Gramiak and Shah (1968) were the first to publish the enhanced 
reflectivity of blood observed by Joyner (Joyner, Reid et al. 1963), while 
carrying out a heart ultrasound during a catheter examination (Winkelmann, 
Kenner et al. 1994; Dawson 1999; Nico de Jong 2002; Miller and Nanda 2004). 
The use of a fluorescent dye (indocyanin green) during Joyner’s study was 
thought to be responsible for the increase in reflectivity observed (Dawson 
1999). However, it was later discovered that other dyes also produced a 
comparable outcome and that the presence of small air filled microbubbles 
were responsible for these effects (Winkelmann, Kenner et al. 1994; Dawson 
1999). These microbubbles were created as a result of cavitation when liquids 
were administered via a catheter or a small needle (Winkelmann, Kenner et 
al. 1994). This discovery instigated the development of a multitude of 
molecules with the same characteristics, including liquid-core 
microemulsions and nanoemulsions, colloidal suspensions, liposomes and 
microbubbles (de Jong, Frinking et al. 2000; Klibanov 2005). These are 
nowadays collectively known as ultrasound contrast agents. It should be 
noted at this point that the use of the term microbubble is somewhat generic. 
Microbubbles can be defined as spherical structures that are filled with air or 
gas. Liposomes can be defined as self-assembled lipid shelled microbubbles 
filled with an aqueous solution (Alkan-Onyuksel, Demos et al. 1996; Huang 
2008). However, it has been stated that liposomes can also be filled with gas 
(Alkan-Onyuksel, Demos et al. 1996; Dawson 1999; Wu, Chen et al. 2006). For 
example, the ultrasound contrast agent Definity® can be classified either as a 
liposome or as it encapsulates gas, a microbubble. Further research has lead 
to the development of efficient microbubbles that are employed for diverse 
ultrasound applications. First-generation ultrasound contrast agents were air 
filled microspheres, such as Albunex®, Levovist® and Echovist®. Second-
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generation ultrasound contrast agents, such as Optison® encompass inert 
high molecular gases in their cores. Finally third generation ultrasound 
contrast agents, such as Definity® and Sonovue®, are even more advanced 
with shells that are composed of several chemical components (figure 3.1) 
(Rubin 2004). Several of the ultrasound contrast agents developed and their 
relevant characteristics are listed in table 3.1. 
 
3.1 Interaction of microbubbles with ultrasound waves 
 The contrast enhancing powers of the microbubbles are determined by 
variables  such as their compressibility, their resonance frequency and their 
contents (Dawson 1999). Microbubbles oscillate in distinct modes depending 
on the frequency of the ultrasound wave applied (figure 3.2) (Dawson 1999). 
At a specific frequency, also known as the fundamental or resonance 
frequency, microbubbles demonstrate maximal oscillation (Dawson 1999). 
Since the scattered wave that is produced when an ultrasound beam strikes a 
microbubble is proportional to the sixth power of the microbubble’s diameter, 
such large increases in its diameter account for the exceptional enhancement 
in reflection observed (Winkelmann, Kenner et al. 1994). The resonance 
frequency of microbubbles of sizes equivalent to those used for clinical 
purposes, lies within the range of frequencies utilised for diagnostic 
ultrasound, thus allowing the employment of their reflectivity for diagnostic 
purposes (Dawson 1999). At frequencies higher than the fundamental 
frequency, microbubbles contract and expand in a non-linear manner, thus 
producing scattered waves of both fundamental and harmonic frequencies 
(Dawson 1999). Although harmonic frequencies tend to decline in intensity, 







Figure 3.1 Representation of typical microbubble. Microbubbles are spherical 
structures composed of lipid shells and an air / gas core. First-generation ultrasound 
contrast agents were air filled microbubbles (Albunex®, Levovist® and Echovist®). 
Second-generation ultrasound contrast agents, encompass inert high molecular 
gases in their cores (Optison®). Third generation microbubbles are composed of 
more advanced shells, such as phospholipids (Definity® and Sonovue®). 
Incorporation of molecules, such as ligands, peptides, hormones or antibodies, in 
the microbubble shell can assist attachment of the microbubbles to target cells. 
Therapeutic agents, such as genes or drugs, can be incorporated in the microbubble 
core in order to serve as delivery systems by ultrasound induced microbubble 
destruction. This is an electron microscopy image of an in-house microbubble, 
composed of two layers of lipid shell and filled with aqueous solution. The 
phospholipid layers have been stained with FM-143, a molecule that emits green 
fluorescence once attached to phospholipids.   
0.4 µm 
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Table 3.1 Ultrasound contrast agents. First, second and third generation microbubbles have several different characteristics. As 
microbubble production evolved, certain physical parameters were changed, such as shell composition, gas content, size, polarity and 
concentration, in order to produce microbubbles that had a longer life in the blood stream and achieved higher sonoporation efficiencies.   
A list of some of the commercially available ultrasound contrast agents and their characteristics is listed in this table in order of generation. 
I.e. first generation microbubbles are shown at the top of the table while third generation microbubbles are shown at the bottom of the 






















Figure 3.2 Reflection modes of microbubbles. Microbubbles oscillate in distinct 
modes depending on the frequency of the ultrasound wave applied. Upon 
application of an ultrasound wave, microbubbles begin to oscillate, thus producing 
reflective waves (reflection). At a specific frequency (resonance) microbubbles 
demonstrate maximal oscillation. At frequencies higher than the resonance 
frequency, microbubbles contract and expand in a non-linear manner, thus 
producing scattered waves of both resonance and harmonic frequencies (harmonic 
signals). At even higher frequencies, microbubbles can be destroyed, releasing their 


































































(Goldberg, Liu et al. 1994; Calliada, Campani et al. 1998; Dawson 1999). The 
harmonic response of the microbubbles is determined by the compressibility 
of the shell and the contents of the core (Dawson 1999). The more rigid the 
shell of a microbubble is, the smaller the scattered wave will be (Dawson 
1999). Hence, most microbubbles are composed of either a lipid or an 
albumin shell in order to reduce the shell rigidity. While small free air 
microbubbles exposed to an ultrasound beam disintegrate  and are dissolved 
rapidly, microbubbles filled with high molecular weight gases show 
prolonged persistence within the circulation due to the slower diffusion rate 
of such gases (Mason 1987; Dawson 1999; Klibanov 2005; Wu and Nyborg 
2008). At higher acoustic powers tissues also generate harmonics (Cosgrove 
2006). However, current microbubbles, composed of a phospholipid shell, 
generate harmonics at much lower acoustic powers than those necessary for 
tissues harmonics (Cosgrove 2006). One can therefore attempt to isolate the 
microbubble harmonics from tissue signals by separating the fundamental 
from the harmonic frequencies (de Jong, Frinking et al. 2000; Cosgrove 2006). 
Finally, at higher pressures, microbubbles can be destroyed, releasing their 
contents to the surrounding environment (Dawson 1999). This effect can be 
used clinically to study perfusion defects and has the potential to be tailored 
to be utilized for delivering a range of molecules, such as drugs and genes, to 
specific tissues (Nico de Jong 2002). 
 
3.2 Microbubble characteristics  
3.2.1 Size 
Microbubbles are administered intravenously and diffuse by means of 
in the bloodstream to all parts of the body. It is therefore vital to attribute an 
upper size limit in order for the microbubbles to be able to cross the lung 
capillary bed (Dawson 1999; Palma and Bertolotto 1999). This denotes that 
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microbubbles must have comparable size to that of red blood cells, not 
exceeding 7 µm diameter (Palma and Bertolotto 1999; Miller and Nanda 
2004). However, size limitations turn into a complex issue once echogenicity 
is taken into consideration. Since the echogenicity of a microbubble is 
proportional to the sixth power of its diameter, the bigger the size of a 
microbubble the greater its echogenicity. Therefore, the ideal size of a 
microbubble if one that takes into consideration both echogenicity and size 
limitations parameters. Most microbubbles nowadays have a diameter of 2-6 
µm (Quaia 2007). 
  
3.2.2 Longevity 
Both the shelf life and life span of microbubbles upon administration 
to the patient are important. Examination of certain areas of the body, such 
as renal and leg arteries can take considerable amount of time, thus 
microbubbles need to be able to persist in the bloodstream throughout the 
entire length of the examination (Dawson 1999). Persistence of a microbubble 
is dependent on both the nature of its shell and its contents. It can be 
described by the equation:   





             (7) 
where R=bubble radius, P=gas density, D=gas diffusivity and Cs= saturation 
constant (Raisinghani and DeMaria 2002). First generation microbubbles did 
not employ a shell and thus dissolved rapidly after administration to patients 
(Klibanov 2005). Second and third generation microbubbles employ a shell 
which delays diffusion of their contents (Klibanov 2005; Marcel, Alexander et 
al. 2009). Use of surfactants, such as palmitic acid, serum albumin, polymer, 
and phospholipids for shell manufacture, also extend the life span of 
microbubbles, as they act by reducing their surface tension (Dawson 1999; 
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Huang 2008). In addition, incorporation of electrostatically charged 
molecules, such as polyethylene glycol (PEG), hinders merging of the 
microbubbles (Klibanov 2005). Microbubbles containing PEG have been 
shown to survive many years without manifesting any decline in their 
echogenicity and can persist in the circulation for up to one hour after 
administration (Klibanov 2005). Furthermore, microbubbles can be classified 
as thin- or hard-shelled depending of the number of layers present (Marcel, 
Alexander et al. 2009). Thin-shelled microbubbles are 2-3 nm thick whereas 
hard-shelled microbubbles fall within the range of 20-200 nm (Dayton, 
Klibanov et al. 1999; Marcel, Alexander et al. 2009).  The thickness of the shell 
affects  the degree of oscillation which in turn affects the echogenicity of the 
microbubble (Marcel, Alexander et al. 2009).  
The contents of the microbubbles also play an important role in their 
persistence in the circulation. First generation microbubbles, such as Albunex 
and Levovist, were filled with air and exhibited short persistence once 
injected (Miller and Nanda 2004). Gases such as perfluorocarbons (PFC)  and 
sulphur hexafluoride (SF6) were perceived as ideal for within the 
microbubbles since they have a low saturation constant, high density and 
they diffuse slowly (Schneider 1999; Miller and Nanda 2004). In addition, the 
large discrepancy in acoustic impedance between gas (4.30 x 102) and blood 
(1.67 x 106), contributes to the echogenicity of the microbubbles (Calliada, 
Campani et al. 1998; Palma and Bertolotto 1999; Pomper and Gelovani 2008). 
Microbubbles containing such gases include Optison® (Amersham Health), 
Definity® (Bristol-Myers Squibb Medical Imaging Inc.), Imagent® 
(Pharmaceuticals Inc.) and Sonovue® (Bracco Diagnostics Inc.) (Miller and 
Nanda 2004). The presence of high molecular weight gases improves the 
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longevity of the microbubbles, since they have a slower diffusion rate than 
air.  
In addition to their capacity as ultrasound contrast agents, research 
into the potential use of microbubbles as delivery vehicles to target tissues is 
ongoing. In such cases, an equilibrium needs to be reached between adequate 
microbubble longevity and obliteration of microbubbles upon application of 
ultrasound waves of a specific frequency (Miller and Nanda 2004).   
Finally, a number of precautions can be taken that can extend the shelf 
life of microbubbles. These include avoiding extreme temperatures and 
administering microbubbles at a steady rate so as to avoid high 
pressurization and shear stress in the needle, which can lead to microbubble 
destruction (Dawson 1999; Barrack and Stride 2009).  
 
3.2.3 Safety  
As an ultrasound beam strikes microbubbles, the latter encounter a 
force that propels them away from the source of the beam. This force is 
known as acoustic radiation force. The latter can project microbubbles 
through distances of a fraction of a micron with each acoustic cycle, at a 
speed of 5-10 cms-1 (Dawson 1999; Ferrara, Pollard et al. 2007). In addition to 
this primary radiation force, microbubbles also endure a secondary radiation 
force, which can result in their coalescence (Dawson 1999; Ferrara, Pollard et 
al. 2007). When a microbubble is positioned adjacent to another echogenic 
surface, the radiation force of the microbubble is echoed back to itself. Thus 
the microbubble effectively receives its own radiation force, which leads to it 
being attracted to the echogenic surface in the same manner that two 
microbubbles are attracted to each other by secondary radiation forces 
(Dawson 1999). This can explain the attraction of microbubbles to cells in 
suspension during ultrasound application (Dawson 1999). Microbubbles 
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experiencing primary radiation forces, collide with cells at such high speeds 
and can cause severe impairment to cells, so much as to induce cell death 
(Dawson 1999). However, it is believed that this is not true for high cell 
concentrations where microbubbles are attracted to the cells and do not have 
enough distance to accelerate to such high speeds (Dawson 1999). 
As with any clinical application, safety is of utmost importance. 
Extensive investigations have been implemented in order to examine the 
possible bioeffects that can arise from the use of ultrasound in the presence of 
microbubbles, leading to the establishment of guidelines and good clinical 
practise recommendations for contrast enhanced ultrasound (Claudon, 
Cosgrove et al. 2008). Although bioeffects in animals have been observed, 
including haemolysis, platelet aggregation and endothelial damage, they are 
deemed negligible (Cosgrove 2006; Quaia 2007). Furthermore, bioeffects in 
humans are sparse, moderate and mainly temporary (Raisinghani and 
DeMaria 2002; Cosgrove 2006; Quaia 2007). These include dyspnea, chest 
pain, hypo-hypertension, nausea and vomiting, taste alterations, headaches, 
vertigo, warm facial sensation, and rashes (Cosgrove 2006; Quaia 2007). 
While, in vitro bioeffects include haemolysis, sonoporation and cell death 
(Claudon, Cosgrove et al. 2008). However, in response to a small number of 
reported cardiopulmonary events in high risk patients, the U.S. Food and 
Drug Administration (FDA) issued an alert to healthcare professionals, 
recommending monitoring of high risk patients for at least 30 min post 
administration of Definity® and Optison® contrast agents (FDA 2008). 
Ultrasound contrast agents are now treated as pharmaceuticals and require 
more stringent clinical trials than previously. In the same report, the FDA 
included a balancing comment, claiming that the clinical benefits of 
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ultrasound contrast agent use can outweigh the risk of severe reactions, even 
in high risk patients (FDA 2008).    
  
3.3 Clinical applications 
Microbubbles were initially discovered and developed for their 
capability to enhance echoes, thus serving as contrast agents for ultrasound 
diagnostic applications. Since then it has become evident, through several 
studies, that microbubbles can also be exploited for therapeutic purposes 
(figure 3.3) (Everbach and Francis 2000; Miller 2000; Unger, Matsunaga et al. 
2002; Dijkmans, Juffermans et al. 2004; Mitragotri 2005; Hernot and Klibanov 
2008; Marcel, Alexander et al. 2009). 
 
3.3.1 Diagnostic applications 
Two of the most prominent diagnostic applications of ultrasound 
contrast agents are liver and heart imaging. Although the reasons behind this 
effect continue to be ambiguous, it has been well established that 
microbubbles are taken up by the liver and spleen (Blomley, Cooke et al. 
2001). Ultrasound contrast agents can assist with visualisation of small 
(under 1 cm in diameter) liver lesions such as metastases and hepatocellular 
carcinomas (figure 3.4) (Blomley, Cooke et al. 2001).  
Microbubbles are widely used in echocardiography. Enhancement of 
the left ventricular cavity and the endocardial border of the heart are 
amongst the areas employing ultrasound contrast agents (Blomley, Cooke et 
al. 2001). Microbubbles are also employed for evaluating microvascular 









Figure 3.3 Ultrasound applications. A number of medical applications of 
ultrasound amongst many are shown in this figure. The optimal frequencies at which 
they are applied are also shown. A considerable amount of these applications are 









Figure 3.4 Ultrasound contrast agents. Ultrasound liver scans in the absence (a) 
and in the presence (b) of ultrasound contrast agent, depicting metastasis. 
Ultrasound contrast agents increase the contrast from reflected images, thus making 
it possible to detect previously undetectable lesions. White arrow is pointing towards 
the lesion that can only be detected in the presence of ultrasound contrast agents. 
Printed by permission Elsevier® (Blomley, Cooke et al. 2001).  
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3.3.2 Therapeutic applications 
 The utilization of ultrasound contrast agents as a therapeutic tool has 
been increasing rapidly and may ultimately develop into a more prominent 
role than as a diagnostic tool (Miller 2000). Therapeutic uses of microbubbles 
amongst others include thrombolysis, vascular permeability, tissue healing, 
soft tissue stimulation, bone regeneration tumour suppression, arteriogenesis, 
lithotripsy and haemostasis (Everbach and Francis 2000; Miller 2000; Unger, 
Matsunaga et al. 2002; Dijkmans, Juffermans et al. 2004; Mitragotri 2005; 
Hernot and Klibanov 2008; Marcel, Alexander et al. 2009). A particularly 
significant use of microbubbles involves the delivery of a therapeutic agent 
(gene or drug) by ultrasound targeted microbubble destruction (Bekeredjian, 


















































4.0 Ultrasound contrast agent mediated delivery 
4.1 Sonoporation 
 Successful drug / gene delivery and targeting to specific organs or 
tissues is still one of the main impediments of gene therapy (Shohet, Chen et 
al. 2000). Delivery of a therapeutic agent can be achieved by loading 
microbubbles with the desired agents or  by co-administration of drugs and 
microbubbles (figure 4.1) (Hernot and Klibanov 2008). This notion consists of 
two parts. Firstly, as mentioned earlier, the application of ultrasound of a 
sufficiently high pressure can bring about the destruction of microbubbles, 
thus causing outward dispersion of their contents. Microbubbles can act as 
carriers of genes or drugs that are incorporated into their cores and releasing 
them at the target area upon their destruction. This would result in a build 
up of their local concentration, which in turn would allow administration of 
lower drug doses (Bekeredjian, Grayburn et al. 2005). On the other hand, the 
amount of drugs that can be incorporated into microbubbles is limited due to 
the size and the thickness of their shell (Marcel, Alexander et al. 2009). 
Alternatively, one can attach the drugs on the outer surface of the 
microbubble shell (Marcel, Alexander et al. 2009). 
Cell membranes are arranged in a phospholipid bilayer, embedded 
with integral proteins (Singer and Nicolson 1971). They form a barrier 
between the cell and the outside environment. Cell membranes thus present 
an obstruction to large molecules such as drugs and particularly genes 
(Huang 2008). Application of ultrasound in the presence of microbubbles has 
been shown to lead to the formation of transient non-lethal perforations, a 
phenomenon termed sonoporation (Blomley, Cooke et al. 2001). During 
sonoporation, perforations up to 75 nanometers are formed permitting 
diffusion of small molecules across the cell membrane (Mehier-Humbert, 
Bettinger et al. 2005a). Formation of these pores has been reported to last 
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Figure 4.1 Methods of drug / gene delivery. (a) Therapeutic agent is co-
administered with microbubbles. Microbubbles destruction occurring upon 
insonification results in the formation of pores on the cell membrane. Therapeutic 
agents located in the vicinity can diffuse into the cell due to disparities in local 
concentration. (b) Therapeutic agent is incorporated into microbubbles. Upon 
microbubble destruction, the agent is released in the region of interest. (c) 
Microbubbles are attached to target tissues via cell surface receptors. Destruction of 
the microbubbles will release the therapeutic agent in the area of interest thus 
















milliseconds, sealing almost instantaneously after sonication, thus halting 
movement of drug / gene molecules across the plasma membrane (figure 4.2) 
(Mehier-Humbert, Bettinger et al. 2005a). However, certain ultrasonic 
conditions such as high pressures and prolonged exposure can induce 
irreparable damage to the cell membrane and therefore lead to cell death 
(Miyake and McNeil 1995; Ferrara, Pollard et al. 2007).  
A reduction in cell size is also observed after sonoporation, on account 
of the leakage of the cytosolic fluid through the pores formed (Mehier-
Humbert, Bettinger et al. 2005a). Morphological changes on the cell 
membrane have also been reported, whereby cell surface receptors such as 
CD19 (a Glycosylphosphatidylinositol (GPI) anchored cell surface receptor) 
are dislodged due to insonification (Brayman, Coppage et al. 1999; Mehier-
Humbert, Bettinger et al. 2005a). Moreover, nuclear membrane permeability 
seems to be impervious to insonification (Duvshani-Eshet, Baruch et al. 2005; 
Mehier-Humbert, Bettinger et al. 2005a).  
Although sonoporation has also been shown to occur in the absence of 
microbubbles, the level of acoustic power required is substantially higher 
than that used in clinical imaging (Lawrie, Brisken et al. 1999; Blomley, 
Cooke et al. 2001; Bekeredjian, Grayburn et al. 2005). The presence of 
microbubbles significantly reduces the energy threshold for sonoporation 
within the authorised ranges (Blomley, Cooke et al. 2001; Duvshani-Eshet, 
Baruch et al. 2005; Hernot and Klibanov 2008; Huang 2008).   
 
4.1.1 Mechanisms of sonoporation  
 Several means have been proposed for the increase of cell 
permeability, yet the precise mechanism is poorly understood. One of the 
most accepted mechanisms is inertial cavitation, which is associated with 
severe localized effects such as formation of free radical, high temperatures 
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and pressures, sonoluminescence, microjets and microstreaming (Gerard and 
Junru 1998; Ward, Wu et al. 2000; Patil and Pandit 2007; Cheng-Huang, Yeh 
et al. 2008). Microstreaming occurs as a result of cavitation and can be 
described as the high shear currents in the liquid that originate around 
oscillating gas bubbles in an acoustic field (Nyborg and Miller 1982; Wu, 
Ross et al. 2002; Dijkmans, Juffermans et al. 2004). There have been reports 
demonstrating that the shear stress created by microstreaming is correlated 
with sonoporation (Wu, Ross et al. 2002; Marcel, Alexander et al. 2009). Other 
reports suggest that the formation of free radicals, in particular H2O2, can 
cause sonoporation without impinging on cell viability (Juffermans, 
Dijkmans et al. 2006). The high temperatures produced during insonification, 
may modify the fluidity of the cell membrane, thus changing its permeability 
(Dijkmans, Juffermans et al. 2004). While it has been suggested that high 
temperatures may be a parameter of sonoporation, other reports detected 
changes in cell permeability in the absence of an increase in temperature 
(Miller, Pislaru et al. 2002; Duvshani-Eshet, Baruch et al. 2005). Mechanisms 
such as endocytosis and fusion of microbubble shell with the cell membrane 
have also been suggested (Dijkmans, Juffermans et al. 2004). Finally, an 
investigation using a high frame camera proposed that sonoporation occurs 
due to the mechanical force applied by oscillating microbubbles on the 
surface of the cells, thus putting forward stable cavitation as the basis for 
sonoporation (figure 4.3) (Van Wamel, Kooiman et al. 2006b).  
 
4. 2 Targeting 
 Efficient delivery of the contents of a microbubble can be reinforced 
with the persistence of the microbubbles in the bloodstream and more 
specifically at the target area (Lindner and Sanjiv Kaul 2001).                                         
Radiation forces acting upon the microbubbles are able to displace them 
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towards the target area, thus increasing their concentration and in effect their 
contents’ local concentration (Dayton, Klibanov et al. 1999; Ferrara, Pollard et 
al. 2007). Further direction can be achieved by targeting the microbubbles to 
the areas of interest. One of the tactics developed, is making use of the 
intrinsic electrostatic attributes of microbubbles (Lindner and Sanjiv Kaul 
2001). However, as electrostatic bonds are not highly specific, other 
mechanisms have been developed, which are based on stronger chemical 
interactions (Ferrara, Pollard et al. 2007).  These include adhering particular 
ligands or antibodies to the surface of the microbubble, which would then 
aim at specific surface markers embodied in the target cells (Lindner and 
Sanjiv Kaul 2001; Marcel, Alexander et al. 2009). While small molecules such 
as peptides and hormones can be incorporated within the microbubble shell 
during its preparation, larger and more unstable molecules such as 
antibodies are attached to a preassembled microbubble shell (Klibanov 2005; 
Ferrara, Pollard et al. 2007). The latter can be attained by attaching a 
biotinylated ligand with a biotinylated microbubble via an avidin link (figure 
4.4) (Lindner and Sanjiv Kaul 2001; Klibanov 2005; Ferrara, Pollard et al. 
2007). The avidin link is used in order to prevent binding between 

































Figure 4.2 Scanning electron microscopy micrographs. SEM images of Rat 
mammary carcinoma cells (MAT B III). (a) Cell morphology before insonification 
(scale bar represent 1 µm). (b) Perforations formed during insonification are shown 
with arrows (scale bar represent 200 mm). (c) Cell morphology after insonification, 
were perforations have been sealed (scale bar represent 1 µm). Printed by 







Figure 4.3 Schematic diagram showing the proposed model for sonoporation. During insonification, microbubbles experience 
cavitation, a cycle of expansion and contraction phases in response to the ultrasound waves present. During its expansion phase, the 
microbubble applies a mechanical force on the cell membrane which can lead to formation of pores on the cells membrane. Adapted from 
(Van Wamel, Kooiman et al. 2006b). 
 










Figure 4.4 Mechanisms for attaching microbubbles to targets cells. (a) 
Microbubbles can be attached to target cells via electrostatic interactions. (b) 
Microbubbles containing a ligand on the outer surface of their shell can attach to 
target cells via antibody-antigen interactions with the aid of polyethylene glycol 
(PEG). (c) For unstable molecules, such binding can also take place with the aid of 
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Conventional microscopy is a useful tool for visualising biological 
samples. However, a few obstacles emerge with the use of conventional 
fluorescence microscopy that limit the quality of the images acquired. 
Fluorescence microscopy images are often accompanied by an out of focal 
flare. This phenomenon is due to the presence of scattered light from objects 
not in the focal plane (McNally, Karpova et al. 1999; Piston 1999; Cahalan, 
Parker et al. 2002). Furthermore, the high numerical aperture objective lenses 
employed for conventional fluorescence microscopy limit the depth of image 
field. Finally, the prolonged use of excitation light when examining living 
specimens, can cause photodamage to the cells and bleach the fluorescent 
dye (McNally, Karpova et al. 1999; Cahalan, Parker et al. 2002). Confocal 
microscopy provided a partial solution to this problem. It has an advantage 
over conventional fluorescent microscopy in that a pinhole is placed in front 
of the detector. This pinhole allows the collection of excitation light from the 
focal plane while concurrently rejecting any out of focus light coming from 
below or above the focal plane (McNally, Karpova et al. 1999; Piston 1999; 
Cahalan, Parker et al. 2002). Confocal microscopy can, therefore, be used for 
3 dimensional (3D) reconstruction of a sample by acquiring a series of optical 
slices along the z axis (Cahalan, Parker et al. 2002), while precluding any 
bleaching of the fluorescent dyes.  
 
5.1 Deconvolution 
 Any image obtained by microscopy is distorted compared to the 
original object. Deconvolution, is an image data restoration technique that 
has been developed in order to characterise the distortion and restore an 
image to its original object (McNally, Karpova et al. 1999). Deconvolution can 
be applied to any microscope data, although a wide field or bright 
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microscope would produce an image with greater distortion than that of a 
confocal microscope. Deconvolution methods attempt to establish the 
amount of light that is expected to be acquired from out of focus plane and 
then attempt to reallocate this light back to its points of origin in the sample 
(McNally, Karpova et al. 1999). The out of focus light calculation is based on 
the 2D image of a point of source of light, accordingly named point spread 
function (PSF). The PSF can be determined both theoretically and 
experimentally. For a PSF to be calculated theoretically specific information 
must be provided, such as the numerical aperture of the objective lens, 
working distance of the objective lens, wavelength of the emitted light, XYZ 
dimensions of the PSF, size of pixel, spacing between Z slices and refractive 
index of the immersion medium (McNally, Karpova et al. 1999). A number of 
commercially available software packages are then able to determine the 
theoretical PSF. The experimental PSF can be determined with the use of a 
fluorescent microsphere of known size, ideally of diameter one third of the 
resolution size limit expected (McNally, Karpova et al. 1999). A 3D image 
should be acquired using the same parameters as for the real sample. Once 
the experimental PSF has been obtained, 3D images of the sample can also be 
acquired and then undergo deconvolution in order to restore the original 
sample. The final product should be an object with sharper edges than that of 
the initial image.  
 
5.2 Two-photon microscopy 
 Although confocal microscopy rejects any excitation light derived 
from out of focus plane, laser light is still emitted both above and below the 
focal plane, consequently, even though large regions of the sample are not 
being visualised; they are still predisposed to photodamage (Piston 1999). 
Therefore, confocal microscopy is still limited for long-term imaging of living 
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specimens. Maria Goppert-Mayer was first to introduce the concept of two 
photon excitation in her doctoral presentation in 1931 (Goppert-Mayer 1931, 
German). Two photon microscopy offers similar 3D resolution as confocal 
microscopy, in addition to providing an even deeper image field, as much as 
two to three times deeper, and negligible photodamage and photobleaching 
(Piston 1999; Cahalan, Parker et al. 2002). Two-photon microscopy is based 
on the physical principle that the energy of a photon is inversely 
proportional to its wavelength (λ) (Piston 1999). Therefore, a single photon, 
of a specific wavelength should result in the same fluorescent emission as 
two photons of twice the wavelength. For example, a fluorophore that 
normally absorbs light at 350 nm can also be excited by two photons at 700 
nm. Since this principle is valid only if two photons are absorbed 
simultaneously, that is within 10-18 seconds from each other, fluorescent 
emission is enhanced in proportion to the square of the excitation intensity 
(Cahalan, Parker et al. 2002). In other words, the probability to obtain two 
absorption events at any one time is equal to the product of individual 
probabilities of obtaining a single photon absorption event (figure 5.1). Thus 
for very improbable events, the probabilities improve as the number of single 
events increases. Such an approach can be achieved by sending the photons 
in batches, i.e. using pulsed beams (White and Errington 2005). Pulse lasers 
send a high peak power beam for every 80 femtoseconds wide, with a 
repetition rate of 80 MHz, thus increasing the photon density for a limited 
amount of time while keeping the average laser power lower than that of the 
conventional laser. The probability of generating considerable amount of two 
photon absorption events is very high only at the focal point, whereas it 
drops to nearly zero at distances less than 1 µm above or below the focal 
point (Piston 1999; Cahalan, Parker et al. 2002). Since excitation in two-
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photon microscopy is confined exclusively to the focal point, the presence of 
a pinhole is no longer required. The Titanium Sapphire femtosecond laser is 
the most commonly used pulse laser system, providing pulses of 




























Figure 5.1 Two photon microscopy. The probability of generating a two photon 
event falls to nearly zero outside the focal point (a) & (c). However, it is feasible at 
the focal point due to the high photo density (b). Thus, exciting the fluorophores 
(blue hexagon) only at the focal point prevents prolonged exposure of sample to 
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6.0 Cellular responses 
6.1 Stress response 
Ritossa (1962) was the first to observe that an elevation in temperature 
above physiological levels leads to upregulation of certain genes, which in 
turn results in expression of a number of proteins. It was later comprehended 
that in addition to elevated temperatures, a number of other environmental 
stresses, such as UV radiation, hypoxia, heavy metals, radiation, glucose 
deprivation, environmental pollutants, inflammation and virus infection 
could also provoke production of these proteins (Santoro 2000; Robert 2003; 
Horvath, Multhoff et al. 2008). Although these proteins have vital functions 
during non stressful settings, they have been termed heat shock proteins due 
to the circumstances in which they were first discovered (Benjamin and 
McMillan 1998).  Heat shock proteins serve as a protective mechanism 
against stimuli that attempt to shift cell homeostasis (Santoro 2000). The term 
stress response was thus conceived in order to describe cell reaction to 
stressful stimuli. Stress  response is universal and the proteins produced are 
highly conserved (Lindquist 1986). 
 
6.1.1 Heat shock proteins 
 Although heat shock proteins are also referred to as stress proteins, 
the later term also includes glucose regulated proteins and ubiquitin 
(Moseley 2000). Heat shock proteins are classified in six groups in accordance 
to their molecular weights (Sontag and Kruglikov 2009). The most abundant 
heat shock proteins are Hsp40, Hsp60, Hsp70, and Hsp90. Heat shock 
proteins are also termed molecular chaperones, since they play an important 
role in assisting in protein folding and in preventing aggregation of 
denatured proteins (Benjamin and McMillan 1998; Walther and Stein 2009). 
A large number of diseases have been associated with misfolding or 
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aggregation of proteins due to malfunction of heat shock proteins, including, 
Alzheimer’s, Parkinson’s and Huntington’s disease diseases (Broadley and 
Hartl 2009). Heat shock proteins also have several other  functions, including 
regulating apoptotic events and engaging in antigen formation (Horvath, 
Multhoff et al. 2008). Heat shock proteins are found in all intracellular 
compartments of a cell, while some are constitutively expressed whereas 
others are stressed inducible (Robert 2003). However, expression of heat 
shock proteins is upregulated, even those that are constitutively expressed 
(Robert 2003). Heat shock proteins have also been found in the extracellular 
environment, were they are believed to regulate  immunity (Multhoff 2007). 
Under normal physiological conditions, heat shock proteins are expressed in 
low levels in the cytoplasm and are attached to a set of proteins termed heat 
shock factors (Kiang and Tsokos 1998). When cells experience a stressful 
stimulus, heat shock proteins release heat shock factors, which are then 
phosphorylated, trimerised and translocated into the nucleus, where they 
promote heat shock protein expression by binding on promoter regions of 
the heat shock factor genes (Kiang and Tsokos 1998). Newly manufactured 
heat shock proteins act as a self inhibitory mechanism by binding to heat 
shock factors, thus repressing further production of heat shock proteins 
(figure 6.1) (Kiang and Tsokos 1998). 
 
6.1.2 Heat shock protein 70 
Heat shock protein 70 (Hsp70) is one if the best characterized families 
of heat shock proteins. Its structure is found to be highly conserved 
throughout evolution, thus signifying its vital role for cell survival (Santoro 
2000). Hsp70 proteins perform a range of chaperone functions, including 
stabilizing unfolded proteins, transferring proteins between intracellular 
departments, assisting in protein folding and preventing formation of 
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protein aggregates (Becker and Craig 1994). The Hsp70 family encodes for 
heat shock proteins that are both constitutively expressed (Hsc70) or are 
induced upon stressful environmental conditions (Hsp70, Hsp72) (Santoro 
2000). All proteins belonging to the Hsp70 family are composed of two 
conserved domains, an N-terminal and a C-terminal domain, that bind to 
ATP and to target proteins respectively (Benjamin and McMillan 1998; 
Robert 2003).   
 
6.1.3 Heme oxygenase-1 
 Heme oxygenase-1 (HO-1) also known as heat shock protein 32 
(Hsp32) is a stress protein. Its expression is induced in the presence of 
environmental stresses such as hypoxia, UV light, heavy metals and 
hydrogen peroxide (Benjamin and McMillan 1998; Otterbein and Choi 2000). 
Although termed a heat shock protein, its expression is not linked with 
hyperthermia, yet its name was attributed due to its expression during 
elevated temperatures in the rat (Morse and Choi 2005). HO-1 has been 
shown to be involved with degradation of heme, thus releasing carbon 
monoxide, free iron and biliverdin (Morse and Choi 2005). The latter is then 
converted to bilirubin (figure 6.2). All the products of this reaction fulfil 
essential cellular functions, for example carbon monoxide is a effective 
second messenger, biliverdin and bilirubin are antioxidants, while iron 
regulates oxidative stress levels (Morse and Choi 2005; Sontag and Kruglikov 
2009). Over-expression of HO-1 has been associated with several human 
disorders including hypertension, arteriosclerosis and acute renal failure 
(Sontag and Kruglikov 2009). Although there are three isoforms of heme 
oxygenase, only HO-1 is inducible by stressful stimuli, while HO-2 and HO-3 
are constitutively expressed (Otterbein and Choi 2000). In addition, the high 
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conservation of HO-1 molecules amongst distinct species, serves as an 






























Figure 6.1 Mechanism of heat shock protein induction in humans.  Heat shock 
protein factor (HSF) is found in the cytosol, bound by a heat shock protein (HSP). 
Upon application of a stress stimulus, HSPs disassociate from the HSFs, who are 
then phosphorylated and trimerized, prior to entering the nuclear compartment. In 
the nucleus, HSFs bind to the promoter region of the HSPs, thus initiating their 
transcription. Newly synthesized HSPs translocate to the cytosol where they inhibit 
further production of HSP molecules by binding to HSFs. Printed by permission 





Figure 6.2 Heme oxygenase reaction. Heme degradation into Biliverdin, carbon 
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7.0 Materials and methods 
 
7.1 Microbubble techniques 
7.1.1 Preparation of in-house microbubbles 
The constituent materials (Table 7.1) were placed in a glass flask and 4 
ml of 0.9 % (v/v) saline were added into the flask for every 100 mg of lipid 
mixture made. The lipid mixture was then allowed to hydrate at room 
temperature for 2 hours while stirring continuously. The flask was then 
placed in a heating bath and heated at 70-80 °C for 1 hour while stirring 
continuously. A condenser was fitted to prevent evaporation.  The mixture 
was then removed from the heating bath and allowed to return to room 
temperature with continuous stirring for 16-24 hours.  
 
 
Constituents  PC CHOL PE PG 
Amount  56 mg 30mg 11 mg 3 mg 
 
Table 7.1 Constituent materials of in-house microbubbles. Quantities of 
constituents are per 4 ml of saline. PC= Phosphatidyl Choline (Sigma Aldrich 
Company Ltd), CHOL= Cholesterol (Sigma Aldrich Company Ltd), PE= 
Phosphatidylethanolamine (Sigma Aldrich Company Ltd), PG= Phosphatidyl 
Glycerol (Sigma Aldrich Company Ltd). 
 
 
7.1.2 Commercial microbubbles 
The commercial microbubbles used for the purposes of some 




7.1.3 Sizing of microbubbles 
Both commercial and in-house microbubbles were fed through a 
LS230 coulter counter (Beckman) in order to obtain a size distribution 
graph. Two latex beads differing in diameter were used in order to 
confirm the minimum and maximum ranges of the coulter counter. The 
latex beads used were P.V.T. latex (Coulter electronics Ltd) and 
Nanosphere™ size standards (Duke scientific corporation) with a 
diameter of 2 µm and 300 nm respectively. 
 
7.1.4 In-house microbubble counting  
The concentration of in-house microbubbles was determined with a 
haemocytometer. An aliquot of a 1 in 100 dilution of in-house microbubble 
solution was mixed with 4 % (w/v) Trypan blue providing a 1 in 2 dilution. 
The solution was placed in a counting chamber of a haemocytometer and 
viewed under the microscope. The number of microbubbles within all 4 
squares present in the haemocytometer is counted. This is then divided by 4 
in order to provide an average count. In order to calculate the concentration 
of microbubbles within the sample, an equation is applied that takes into 
consideration the dilution factor, the area of each square on the 
haemocytometer and total volume of the microbubble suspension. The 
equation is as follows: Number of in-house microbubbles per ml = (total 
count of in-house microbubbles / 4) * dilution factor * 104 * volume of 
suspension.  
 
7.1.5 Density Gradient Centrifugation 
 1 ml of in-house microbubbles was placed at the bottom of a 
centrifuge tube. Different densities of 2 ml Nycoprep (Axis-Shield) were 
stacked on top of each other, ranging from 50 %, 30 %, 20 %, 10 % and 5 % 
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(figure 7.1). Samples were then centrifuged at a Beckman L8-55 
ultracentrifuge using a SW42 swing rotor, at 30,000 rpm for 30 min. Each 
fraction was collected at the end of the centrifugation with the use of a 
pipette and visualised using CLSM.  
 
7.1.6 Microbubble sorting 
Crude and fractionated in-house microbubble samples were taken for 
cell sorting. Crude samples correspond to the original in-house microbubble 
samples produced without any further manipulations. Cell sorting was 
performed by a FACS Vantage SE cell sorter, equipped with a dual output 
351 nm / 488 nm laser and a 633 nm laser, using FACSDiva software (Becton 
Dickinson) at the Centre of Inflammation Research, Little France, Edinburgh, 
UK.   
 
7.2 Microscope techniques 
7.2.1 Immunofluorescence 
 The in-house microbubble preparation was diluted 1 in 1000. A 
drop of the diluted sample was placed on a 9 mm coverslip and then 
placed in the microscope chamber. 1 µl of 1 mM FM 1-43 (Invitrogen) dye 
was added to the drop of microbubbles. Fluorescence of FM 14-3 was 
measured at 488 nm, with a long pass (LP) at 505 nm on a Zeiss LSM 510 


























Figure 7.1 Nycoprep separation. Microbubble preparations were mixed with 
different densities of Nycoprep solution and placed on top of each other in a 
centrifuge tube. The densities of Nycoprep used were 50 %, 30 %, 20 %, 10 % and 
5 %. The top fraction of each tube was collected using a pipette and the 
















7.2.2 Confocal microscopy 
 Confocal microscopy images were obtained by using a Zeiss LSM 
510 inverted microscope, which equipped with four types of lasers, 488 
nm Argon, 543 nm and 633 nm He-Ne and a MIRA NIR pulsed Titanium 
Sapphire multiphoton laser. Parameters such as detector gain, laser 
power and scan zoom were adjusted so as to acquire data within the 
dynamic range of the instrument. All live cell imaging was conducted in 
the microscope at 37 °C, 5 % (v/v) CO2 and 95 % (v/v) air. 
 
7.2.3 Imaging processing and analysis 
The data collected from the microscope were deconvoluted using 
the Huygens II package (Scientific Volume Imaging, Netherlands) to 
remove the out-of-focus haze, which is characterized by the microscope’s 
point spread function (PSF). The PSF, optical aberration and threshold 
levels were determined in advance using 200 nm and 15 nm diameter 
fluorescent latex beads (490 nm excitation / 517 nm emission; Molecular 
Probes). Image data were analysed using the Volocity software package 
(Improvision, Coventry), which allows visualisation and manipulation of 
image data. Therefore, 3D data describing each microbubble underwent a 
series of algorithms in order to reconstruct a 3D image. Further 
manipulation of these images provided essential information such as 
diameter, volume and surface area of in-house microbubbles. 
 
7.2.4 Cell viability assay  
Cells were seeded in 60 mm Petri dishes containing sterile 9 mm 
coverslips. This permitted the transfer of cells adhered to the coverslip to the 
microscope chamber. Several densities were seeded ranging from 2 x 105 to 1 
x 106 cells / ml. 24 hours after seeding, the coverslips were transferred into 
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microscope chambers and covered with 1 ml of DMEM (Gibco BRL). 3 µl of 1 
mM Propidium Iodide (Molecular Probes) and 3 µl of 1 mM Calcein AM 
(Molecular Probes) were added into the chamber. Calcein AM is a molecule 
that transverses the plasma membrane, where it is hydrolysed by 
intracellular esterases in order to emit a green fluorescence. Propidium 
iodide is a red fluorescent molecule that cannot transverse the plasma 
membrane, unless it has been compromised, thus staining cells which are 
dead or whose membrane has been compromised. The fluorescence of 
Calcein AM and Propidium Iodide were measured at 488-543 nm. The 
number of live (Calcein positive) and dead (Propidium Iodide positive) cells 
within each image was measured with the aid of Imaris software package 
(Bitplane AG, Zurich). Imaris software allows visualisation of images and 
identification of objects within images, based on several parameters, such as 
morphology, intensity and size. The total number of live and dead cells 
within each image of interest was counted automatically according to size. 
The figures collected were then used to determine cell viability, which was 
calculated as the number of viable cells divided by the total number of cells 
present (live and dead) and expressed as a percentage.  
 
7.2.5 Cell / microbubble toxicity assay 
 Cells were seeded in 60 mm Petri dishes containing sterile 9 mm 
coverslips at a density of 2 x 105 cells / ml. After 24 hours, 300 µl of in-house 
microbubble preparations, either in PBS or saline, were added to the cells. 
Cells were then examined using a CLSM after 1-48 hours. 3 µl of 1 mM 
Propidium Iodide and 3 µl of 1 mM Calcein AM were added into 1 ml of 
DMEM in the microscope chamber. The fluorescence of Calcein AM and 
Propidium Iodide were measured at 488-543 nm. Data collected were 
analysed using Imaris software package (Bitplane AG, Zurich).  
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7.3 Mammalian cell culture 
7.3.1 Mammalian cells 
 All mammalian cells used in this study (European Collection of 
Animal Cell Cultures, Public Health Laboratory Service Centre for Applied 
Microbiology and Research, Porton Down, UK) were cultured in DMEM 
(Gibco BRL) supplemented with 10 % (v/v) foetal calf serum (Gibco BRL), 1 
% (v/v) penicillin / streptomycin (Gibco BRL) and 1 % (v/v) L-glutamate 
(Gibco BRL). Passage of cells was prepared by removing the media washing 
the cells with PBS. 1 ml/75 cm2 of trypsin-EDTA was added to the cells and 
was incubated was 1-3 min at 37 ºC. The cells were then collected from the 
dish with DMEM. Cells were cultured at 37 °C in 5 % (v/v) CO2, 95 % (v/v) 
air and used between passage numbers 1 and 20. 
 
7.3.2 Cell counting 
The concentration of cells of interest was determined with a 
haemocytometer. An aliquot of cell suspension was mixed with 4 % (w/v) 
Trypan blue providing a 1 in 2 dilution. The solution was placed in a 
counting chamber of a haemocytometer and viewed under the microscope. 
The number of cells within all 4 squares present in the haemocytometer is 
counted. This is then divided by 4 in order to provide an average count. In 
order to calculate the cell concentration within the sample, an equation is 
applied that takes into consideration the dilution factor, the area of each 
square on the haemocytometer and total volume of the cell suspension. The 
equation is as follows: cell concentration (cells / ml) = (total count of cells / 4) 





7.3.3 Transfection of mammalian cells  
SK Hep-1 cells were transfected with pCS2 plasmid (figure 7.2) using 
ExGen 500 (Fermentas Life Sciences) and the manufacturer’s protocol was 
followed.  Cells to be transfected were cultured in six well tissue culture 
dishes and examined with a FACSCalibur analytical flow cytometer (Bector 
Dickinson) 24 hours after transfection. 
 
7.4 Flow cytometry techniques 
7.4.1 Examining cell viability assay 
Cells were trypsinised immediately after ultrasound exposure in order 
to detect the effect of ultrasound waves on cell viability. Calcein AM and 
Propidium Iodide were used in order to detect live and dead cells 
respectively. A cell suspension containing SK Hep-1 (human 
hepatocarcinoma) cells exposed to ultrasound waves was passed through a 
FACSCalibur analytical flow cytometer (Bector Dickinson). The fluorescence 
of Calcein AM and Propidium Iodide was detected by the FACSCalibur and 











        
 
Figure 7.2 PCS2 plasmid map. Schematic representation of pCS2 plasmid used for 
acquiring DNA delivery in to cells during sonoporation and subsequent expression of 










7.4.2 Examining for sonoporation  
Cells were trypsinised immediately after ultrasound exposure in the 
presence or absence of microbubbles and / or enhanced green fluorescent 
protein (EGFP), in order to detect sonoporation. Cell impermeable Calcein or 
EGFP were used in order to detect transfer of these molecules into the cells 
through pores formed during ultrasound exposure (sonoporation). These 
specific molecules were used as they differ enormously in size and would 
perhaps provide an indication of pore size. Propidium Iodide was used in 
order to detect dead cells. A cell suspension of the cells exposed to 
ultrasound waves was passed through a FACSCalibur analytical flow 
cytometer (Bector Dickinson). The fluorescence of cell impermeable Calcein 
or EGFP and Propidium Iodide were detected by the FACSCalibur and cells.      
were assessed as positive / negative for cell impermeable Calcein or EGFP 
and Propidium Iodide respectively.  
 
7.4.3 Examining gene expression 
Cells were trypsinised 24 hrs and / or 48 hrs after ultrasound exposure 
in the presence or absence of microbubbles and plasmid DNA pCS2 (Centre 
of Cardiovascular Sciences, Little France, Edinburgh). The pCS2 plasmid 
contains the gene encoding EGFP. This experiment was performed in order 
to detect pCS2 delivery into the cells and subsequent expression of EGFP in 
the cells. The fluorescence of EGFP and Propidium Iodide were used in order 
to detect gene expression and dead cells respectively. A cell suspension of 
the cells exposed to ultrasound waves was passed through a FACSCalibur 
analytical flow cytometer. The fluorescence of EGFP and Propidium Iodide 
were detected by the FACSCalibur and cells were assessed as positive / 
negative for EGFP and / or Propidium Iodide.  
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7.5 Ultrasound techniques 
7.5.1 Ultrasound equipment 
7.5.1.1 “Physiotherapy machine”  
The aim of this experiment was to calibrate the waveforms emitted by 
the physiotherapy machine, using a right angled PZT needle hydrophone-
type NP10-390A (Dapco Inc). The signal emitted by the “physiotherapy 
machine” was captured by a Tektronix 2211 digital storage oscilloscope. In 
addition it was essential to calibrate the actual head size of the transducer, in 
order to be able to calculate the actual power emitted by the scanner 
accurately. Nominal measurements of the intensities and the head size values 
are provided by the manufacturer but do not always correspond to reality. 
We attempted to calculate the actual values and compare them to the 
nominal values so as to make sure that the scanner was providing adequate 
amounts of power for future use in our experiments. 
A balance was used in order to calculate the intensity of the 
ultrasound waves emitted by the “physiotherapy machine”. As the waves hit 
an absorbable object, the object becomes heavier. This change in weight 
could then be interpreted into power (Watts). It is also known that an 
increase in weight of 69 mg = 1 Watt of power. While measuring the change 
in weight the fact that the absorbable object became more buoyant as it 
absorbed the ultrasound waves, had to be taken into consideration. So the 
weight of the object was noted a few seconds after applying the ultrasound 
waves and just after turning the ultrasound scanner off. This provided a 
negative number that corresponded to the buoyancy of the object due to its 
absorbance of ultrasound waves. We then added the two figures in order to 
calculate the actual weight change. 
Several different intensities were examined on the “physiotherapy 
machine” ranging from 0.5, 1.0, 1.5, 2.0, 2.5 W / cm2 and at different 
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frequencies (1 MHz & 3 MHz). The nominal power was calculated in Watts 
by multiplying the nominal intensities with the nominal head size which is 
4.42 cm2 at 1 MHz and 3.67 cm2 at 3 MHz. Multiplying the nominal power 
with 69 mg provided the nominal weight change expected. Actual weight 
changes were recorded and transformed to actual power by dividing with 69 
mg. Actual intensity was calculated by dividing with the actual head size 
which is 3.68 for both 1 MHz and 3 MHz calculated in W / cm2 (table 7.2). The 
hydrophone was used in order to calculate the actual head size of the 
transducer. Several apertures of different diameters ranging from 6 mm to 30 
mm while keeping the intensity and frequency constant at 1.0 W / cm2 and 1 
MHz / 3 MHz. 
 
7.5.1.2 Ultrasound scanners 
Ultrasound experiments were conducted with a Therasonic 1032 
ultrasound scanner (Electro-Medical supplies), using a range of intensities 
from 0.01-2.54 W / cm2 at a frequency of 1 or 3 MHz. A number of 
experiments were also conducted with either a Sono 5500 (Hewlett Packard) 
or an ATL ultrasound B-mode scanner DHI3500 (Philips) operating at a 
frequency between 1 and 2 MHz and 2 to 4 MHz respectively. The transducer 
used with Sono 5500 was a phased array S3 (33 MHz) (Philips Medical 
Systems, Andover), while the transducer used with DHI3500 was P4-2 
phased transducer (2-4 MHz) (Philips Medical Systems, Andover). 
The waveforms emitted by the ultrasound scanners used in this study 
were examined with the aid of a membrane hydrophone with a 0.4 mm 
active element (Precision Acoustics). The signal emitted by the scanners was 
captured by a Tektronix 2211 digital storage oscilloscope, calibrated by the 
National Physics Laboratory in 2007. The peak to peak pressures of the 





















1MHz            
0.5 2.21 152.49 230.25 3.34 0.91 
1 4.42 304.98 452 6.55 1.78 
1.5 6.63 457.47 659 9.55 2.60 
2 8.84 609.96 867.5 12.57 3.42 
2.5 11.05 762.45 1028 14.90 4.05 
3 MHz      
0.5 1.83 126.61 166 2.41 0.65 
1 3.67 253.23 372 5.39 1.47 
1.5 5.50 379.84 590 8.55 2.32 
2 7.34 506.46 839.5 12.17 3.31 
2.5 9.17 633.07 1056.5 15.31 4.16 
 
Table 7.2 Calculation of power output of physiotherapy machine. Nominal 
power was calculated by multiplying the nominal intensities with the nominal head 
size which is 4.42 cm2 at 1 MHz and 3.67 cm2 at 3 MHz. Multiplying the nominal 
power with 69 mgs provided the nominal weight change expected in mgs. Actual 
weight changes recorded were transformed to actual power output by dividing with 
69 mgs. Actual intensity was calculated by dividing with the actual head size which 
is 3.68 for both 1 MHz and 3MHz. 
 
7.5.2 Ultrasound investigations 
7.5.2.1 Bench-Petri Dish set up 
Initial experiments involved the application of ultrasound on cells 
attached to a 60 mm Petri dish. The dish was then placed on the microscope 
stage and an image of the cells was acquired. The fluorescence of Calcein AM 
and Propidium Iodide were measured at 488-543 nm. The dish was then 
transferred onto the bench were ultrasound waves were applied. The probe 
of the scanner was submerged in the cell media and was held by hand at a 
90° angle for the required length of time. The dish was then returned on to 
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the microscope stage in order to re-examine the original field of view. Data 
collected were analyzed using Imaris software package (Bitplane AG). 
 
7.5.2.1.1 Investigations of cell viability in the absence of microbubbles  
Cells were seeded in 60 mm Petri dishes at a density of 2 x 105 cells / 
ml. 24 hours after seeding; 3 µl of 1 mM Calcein AM and 3µl of 1mM 
Propidium Iodide (Molecular probes) were added into the Petri dish. The 
dish was then transferred on to the bench for application of ultrasound. 
Images of the cells were taken before and after application of ultrasound 
waves using a Leica DMIRB inverted microscope. Furthermore, a cross was 
drawn with a marker pen at the bottom of the Petri dish in order to be able to 
return the dish to the same field of view following any movement (figure 
7.3). The fluorescence of Calcein AM and Propidium Iodide were measured 
at 488-543 nm. Data collected was analyzed using Imaris software package 
(Bitplane AG). 
 
7.5.2.1.2 Investigations of cell viability in the presence of microbubbles  
Cells were seeded in 60 mm Petri dishes at a density of 2 x 105 cells / 
ml. 24 hours after seeding, 5 different concentrations (12.5 µl, 25 µl, 50 µl, 75 
µl) of 1.2 x 1010 Definity® microbubbles / ml were added into the Petri dish in 
addition to 3 µl of 1 mM Calcein AM and 3 µl of 11 mM Propidium Iodide 
(Molecular probes). Furthermore, each area exposed to ultrasound waves 
was marked. Smaller areas within the marked area, corresponding to the 
field of view of the microscope were also marked at the bottom of the Petri 
dish in order to be able to return the dish to the same field of view following 
any movement (figure 7.3).  The dish was then transferred on to the bench for  
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 Figure 7.3 Marking of Petri Dishes. Petri dishes were placed on the microscope 
stage and an image was taken. The Petri dish was then transferred on the bench 
were ultrasound waves were applied. The Petri dishes were place back on the 
microscope stage and a second image was taken. The marking on the Petri dishes 
allowed for repositioning them on the microscope stage at the original field of view. 
Initial markings (a) involved just a cross, where one image was taken. Subsequent 






application of ultrasound of different intensities, ranging from 0.2-1 W / cm2. 
Images of the cells were taken before and after application of ultrasound 
waves using a Leica DMIRB inverted microscope. The fluorescence of 
Calcein AM and Propidium Iodide were measured at 488-543 nm. Data 
collected was analyzed using Imaris software package (Bitplane AG).  
  
7.5.2.2 Ultrasound tank 
Further experiments were carried out in an ultrasound tank 
constructed at the departmental workshop (figure 7.4). The tank was made 
out of Perspex and its bottom was covered with an acoustic absorber 
APTflexF28 (Precision Acoustics Ltd.). 
 
7.5.2.3 Mylar membrane set up 
A bi-axially oriented polyethylene terephthalate (boPET) polyester 
film (Mylar® membrane, Preservation Equipment) of 12 µm thickness was 
coated with 100 µl of rat tail collagen 1 mg / ml (Roche Applied Sciences) and 
left to dry. Two acetal homopolymer (Derlin) rings were constructed in the 
departmental workshop in such a way so that one could fit inside the other. 
A Mylar® membrane was placed between the two Derlin rings (figure 7.5). 
The membrane-ring-membrane (MRM) “sandwich” was partially submerged 
into the ultrasound tank and was held into position by a custom made holder 
(Departmental workshop). 
 The ring-membrane-ring (MRM) “sandwich” was then UV treated for 
30 min. Cells were seeded on the membrane at a density of 2 x 105 cells / ml. 
24 hours after seeding; 5 µl of 1 mM Calcein AM and 5 µl of 1 mM 
Propidium Iodide were added into the MRM “sandwich”. The MRM 
“sandwich” was then transferred into the ultrasound tank. Images of the 
cells were taken before and after application of ultrasound waves. The 
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fluorescence of Calcein AM and Propidium Iodide were measured at 488-543 
nm with a Leica DMIRB inverted microscope. Data collected were analyzed 
using Imaris software package (Bitplane AG). 
 
7.5.2.4 OptiCell™ set up 
OptiCell™ (Anachem) is a chamber enclosed between two optically-
clear gas-permeable membranes that permit diffusion of O2 and CO2 across 
the membrane for promoting cell growth. Cells were grown on one of the 
membranes. The OptiCell™ has two self-sealing outlets that provide access 
to the interior of the chambers. The chamber provides a growth surface area 
of 100 cm2. Cells were seeded in OptiCell™ chambers at a density of 2 x 105 
cells / ml. Which enable the cells to grow in a controlled and stable 
environment prior to insertion into the tank for insonation. If sonoporation 
occurred, cell impermeable Calcein would traverse the cell membrane and 
the cells would have cell impermeable Calcein within their cytoplasm. The 
OptiCell™ was placed in a custom-made ultrasound tank, which allowed 
easy and precise manipulation of the ultrasound field relative to the 
OptiCell™. 
 
7.5.2.4.1 Investigations of cell viability  
For each OptiCell™ chamber, two areas were used for applying 
ultrasound. Prior to ultrasound exposure, a range of volumes of Definity® 
(Bristol Myers Squib) were injected into the OptiCell™, which was 
subsequently inverted several times in order to achieve an even distribution.  
The volumes of Definity® added to the OptiCell™ were 5 µl, 300 µl, 600 µl 
and 900 µl corresponding to a cell to microbubble ratio of 1 in 30, 1 in 1800, 1 
in 3600 and 1 in 5400. The in-house microbubble volumes added to the 
OptiCell™ were 0.9 ml, 1.8 ml, 3 ml, 6 ml, corresponding to 1 in 300, 1 in 600, 
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1 in 1000 and 1 in 2000. In addition, 10 µl of 1 mM of Calcein AM and 10 µl of 
1 mM of Propidium Iodide were added into each OptiCell™. Furthermore, 
areas corresponding to the field of view were marked just as previously done 
on Petri dishes (figure 7.6). These markings provided information on the 
viability of cells and therefore the intensities of ultrasound waves across the 
whole area of the probe.  A custom made holder (Departmental workshop) 
allowed the OptiCell™ to float in the ultrasound tank at a distance of 2 cm 
above the acoustic absorber. This holder could also slide across the tank, thus 
allowing the movement of the OptiCell™ towards and away from the 
microscope. The fluorescence of Calcein AM and Propidium Iodide were 
measured at 488-543 nm and an image was taken with a Leica DMIRB 
inverted microscope. The OptiCell™ was then slided of the microscope stage 
across to the opposite side of the tank, where ultrasound waves were 
applied. The OptiCell™ chamber was then transferred back on to the 
microscope stage where another image of the cells was acquired. Data 












Figure 7.4 Ultrasound tank. The ultrasound tank was made out of Perspex and a 
piece of acoustic absorbing material was placed at the bottom of the tank to absorb 
and backscatter produced during insonation. 
 
 
Figure 7.5 Membrane-ring-membrane (MRM) “sandwich”. A thin, acoustically 
transparent membrane was placed between to Derlin rings so as to form a 




Figure 7.6 Markings on OptiCell™. The OptiCells™ used in viability assays were 
marked as shown.  The OptiCell™ was placed under the microscope stage and an 
image of each field was taken. The OptiCell™ was then slided across the other side 
of the tank so as to allow for application of ultrasound.  The OptiCell™ was finally 
slided back to its original position and images of the original fields of view were 
taken based on the markings. The markings on the OptiCell™ also provided 
information about the intensities of the ultrasound waves at different regions of the 










7.5.2.4.2 Investigation of sonoporation  
The OptiCell™ was placed in the ultrasound tank and was held in position 
by a custom made holder (Departmental workshop). Prior to ultrasound exposure, a 
range of volumes of Definity® (Bristol Myers Squib) or in-house microbubbles were 
added to the OptiCell™. The OptiCell™ was submerged into the ultrasound tank 
and held in place by a custom-made holder (departmental Workshop). The volumes 
of Definity® added to the OptiCell™ corresponded to a cell to microbubble ratio of 
1 in 30, 1 in 1800, 1 in 3600 and 1 in 5400. Whereas the volumes of in-house 
microbubbles added to the OptiCell™ corresponded to a cell to microbubble 
ratio of 1 in 300, 1 in 600 and 1 in 2000.  In addition, 100 µl of 10 µM of cell 
impermeable Calcein (Molecular Probes) and 3 µl of 1 mM of Propidium 
Iodide were added into each OptiCell™. The ultrasound probe was placed at 
a 37° angle while taking care not to trap any air bubbles between the probe 
and the OptiCell™ membrane. The probe was slided across and down the 
OptiCell™ until the whole surface area was exposed to ultrasound waves. 
The ultrasound probe was moved at a very slow rate; exposing the cells to 
ultrasound waves for 2-3 sec. Cells were trypsinised and washed with PBS 
three times. The fluorescence of cell impermeable Calcein and Propidium 
Iodide were detected within half an hour by flow cytometry.   
 
7.5.2.4.3 Investigation of gene expression  
Experiments investigating the expression of EGFP were conducted in 
a similar manner to the ones described in section 7.5.2.4.2; apart from 
emitting cell impermeable Calcein. However, in these experiments, 
OptiCells™ were placed in an incubator following exposure to ultrasound. 
The fluorescence of EGFP and Propidium iodide was detected 24 hours later 
by flow cytometry.  
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7.6 Molecular techniques 
7.6.1 Transformation of Escherichia coli 
Vectors were transformed using One Shot TOP10 competent cells 
(Invitrogen). 5 µl of the pCS2 vector was added to a 50 µl aliquot of 
competent cells in a pre chilled tube. Samples were chilled on ice for 20 min 
and then heat shocked at 42 °C for exactly 30 seconds, before returning them 
on ice for another 2 min.  450 µl of SOC medium (Invitrogen) was then added 
to the cells before they were incubated at 37 °C for 1 hour while shaking 
vigorously (350 rpm). 10 µl and 100 µl of the transformed cells were plated, 
at room temperature, on L Broth agar plates (Appendix 1) containing 0.1 mg 
/ ml of the appropriate antibiotic. The L Broth agar plates were incubated 
upside down at 37 °C overnight.    
 
7.6.2 Plasmid preparations 
 Following transformation, a number of colonies were picked from the 
L Broth agar plates. Each individual colony was placed in 3 ml of Terrific 
Broth (Appendix 1) containing the appropriate antibiotic and incubated at 37 
°C overnight. The next day, each sample was transferred into 500 ml of L 
Broth (Appendix 1) containing the appropriate antibiotic and incubated at 37 
°C overnight. Large scale plasmid preparations were performed using the 
PureLink™ HiPure Plasmid Filter Purification Kit according to 
manufacturer’s instructions (Invitrogen). 
 
7.6.3 Quantification of plasmid DNA 
The concentration of plasmid DNA and DNA deoxyoligonucleotides 
was established by the A260 / 280 ratio in a spectrophotometer (Ultrospec 
2000, Pharmacia Biotech).   
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7.6.4 Restriction endonuclease digests 
Purified DNA plasmids were digested with the appropriate restriction 
enzymes (Promega) in order to become linearised. The linearised vectors 
were used for acquiring DNA delivery in to cells during sonoporation and 
subsequent expression of genes of interest. 1 µl of restriction enzyme was 
added to 1 µg of DNA solution. Then 1 µl of 10 x enzyme buffer and 1 µl of 
10 mg / ml BSA (Appendix 1) were also added. The solution was then made 
to a final volume of 10 µl by addition of sterile distilled H2O. The samples 
were allowed to incubate for 1 hour at 37 °C. Following the completion of 
digestion, DNA sample was separated using agarose gel electrophoresis. 
 
7.6.5 Agarose gel electrophoresis 
 Digested DNA plasmids were run in an agarose gel so as to evaluate 
whether the DNA sample had been linearised during the digestions 
performed. A 1 % (w/v) agarose gel solution was prepared in 1 x TAE buffer 
(Appendix 1) by boiling. After allowing for the solution to cool down, 0.02 
µg / ml of ethidium promide (EtBr) (Invitrogen) was added and the solution 
was then poured into a gel rack with the appropriate gel comb. Loading dye 
of appropriate volume was dded to the DNA samples, prior to their loading 
on the agarose gel. A 1 Kb DNA marker (Invitrogen) was also added in one 
of the wells. The agarose gel was then covered with 1 x TAE buffer and run 
at 100 V until adequate separation was observed under a UV light source. 
 
7.6.6 DNA extraction 
 Following visualisation with agarose gel electrophoresis, the 
linearised DNA samples were purified using a QIAquick gel extraction kit 
(Qiagen, UK) and following the manufacturer’s instructions. 
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7.7 Protein biochemistry techniques 
7.7.1 Preparations of cell lysates  
Cell lysates were prepared from SK Hep-1 cells grown in OptiCells™. 
The media was removed and the cells were washed twice with phosphate 
buffered saline (PBS) (Appendix 1). 1 ml of RIPA buffer containing the 
appropriate protease inhibitors was inserted into the OptiCell™ through its 
outlets. The cells were incubated for a few minutes. The top membrane of the 
OptiCell™ was cut with a scalpel and the solution was aspirated into an 
eppendorf tube and placed on ice. The samples were centrifuged at 10,000 
rpm for 5 min at 4 °C and the supernatant was collected into a new 
eppendorf tube. Samples serving as positive controls were placed in a 
hypoxic incubator for 1 hour (hypoxia control) or in a heated incubator for 1 
hour (heat shock control) prior to collecting the cell lysates.  
 
7.7.2 Protein assay  
 A protein assay was used in order to measure the concentration of total 
protein present in cell extracts. The BioRad DC Protein Assay Kit was used 
according to manufacturer’s instructions. A standard curve was made from a 
known standard of bovine albumin (BioRad). The cell extracts were 
measured on a Dynatech plate reader (Dynex MRX II, Dynatech) and the 
protein concentrations were calculated by comparison to the standard curve. 
 
7.7.3 Electrophoretic separation of proteins 
SDS polyacrylamide gels (SDS-PAGE) were used for the separation of 
proteins, using the protocol of Laemmli (1970). The mini-protean® 3 cell apparatus 
(Bio Rad) was used for casting gels. A 10 % separating gel (Appendix 1) was poured 
between glass plates to the appropriate level and then was overlaid with 2-
methylpropan-1-ol (BDH) and left to polymerise.  Once polymerised the 2-
methylpropan-1-ol was removed and the gel was rinsed with water before the 4 % 
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stacking gel (Appendix 1) was poured, followed by insertion of a comb allowing 
wells to form before the gel polymerised.  The protein samples were prepared by 
addition of 5x sample loading buffer (Appendix 1) and denatured by heating to 95 
°C for 5 min. Once the stacking gel had polymerised the tank was filled with 
electrophoresis buffer (Appendix 1).  The comb was then carefully removed and the 
samples loaded.  A potential of 200 V was then applied until the dye front 
reached the bottom of the gel.  
 
7.7.4 Immunoblotting 
The transfer of proteins from a polyacrylamide gel to a membrane was 
achieved by electrophoretic elution (Towbin, Staehelin et al. 1979). The 
method used in this study was semi dry transfer. A gel sandwich was made 
using 3 pieces of blotting paper, gel, membrane and 3 pieces of blotting 
paper. The membrane was pre-soaked in transfer buffer (Appendix 1) for 10 
min. The gel sandwich placed in a Pharmacia Novablot semi dry transfer cell 
(Bio Rad) and a current of 80 mA / cm2 was applied for 1 hour.  The 
membrane used was pure nitrocellulose membrane (Bio Rad). 
 
7.7.5 Marking & Blocking 
Complete transfer of the proteins was established by fully immersing 
the membrane in Ponceau Red (Sigma). Once the protein bands were visible, 
the membrane was rinsed with 1x TBS. The membrane was then fully 
immersed in 5 % (w/v) Marvel in TBS containing 0.5 % (v/v) Tween-20 
(TBST) (Appendix 1) for 1 hour at room temperature, in order to prevent any 




7.7.6 Antibody incubations 
After the blocking solution was removed the membrane was washed 3 
times over 5 min in TBST (Appendix 1)followed by incubation in the primary 
antibody, diluted appropriately depending on the antibody (Appendix 1), for 
1 hour at room temperature or usually overnight at 4 °C.  The primary 
antibody was then removed and the membrane was washed three times over 
5 min in TBST. The membrane was then incubated with the secondary 
antibody for 30 min.  The membrane was then washed twice over 5 min in 
TBST and once over 5 min in TBS. 
 
7.7.7 Antibodies 
 Rabbit polyclonal antibodies were directed against Hsp70 (Bioquote 
Limited, cat no: SPA-812) and Anti-Heme-Oxygenase-1 (Bioquote Limited, 
cat no: SPA-896). Mouse monoclonal antibodies were directed against beta 
Actin (Abcam, cat no: ab6276) and GAPDH (Abcam, cat no: ab9385). 
 
 
7.7.8 Enhanced cheminoluminescence 
The detection of the protein of interest used enhanced 
chemiluminescent reagent (ECL) (Western blotting detection reagents, 
Amersham biosciences), which involved incubating the membrane for 1 min 
using 2 solutions in a 1:1 ratio, ECL solution 1 and ECL solution 2.  Following 
this the protein bands were visualised by exposing the membrane to Konica 
x-ray film for an appropriate length of time, depending on how much protein 
is on the membrane, typically 1-5 min.  The film was then developed 
(Optimax film developer). Analysis of immunoblotting was performed with 




7.8 Statistical analysis  
For each experiment, a minimum of three replicate samples was 
examined unless stated otherwise. The mean and standard error of mean 
(SEM) was calculated for each experiment. A student’s t test was used in 
order to compare two treatments. A one-way ANOVA test was used to 
compare several treatments while a two-way ANOVA test was used to 
compare combinations of treatments. A significant difference between 
samples was considered when p<0.05, unless otherwise stated. Trend lines 
were added to some figures to show trends of samples, with the R2 indicating 




















































Characterisation of in-house microbubbles was an important part of 
this study. Since cavitation is thought to be the main mechanism associated 
with sonoporation and it is dependent on microbubble size, it was speculated 
that the size of the microbubbles could become a limiting factor when 
attempting to achieve sonoporation (Lentacker, De Smedt et al. 2006). Thus, 
it was important to attain the size distribution of in-house microbubble 
preparations before attempting to perform sonoporation. In addition, the 
contents of the microbubbles used, are also known to affect their efficiency in 
instigating sonoporation (Wang, Liang et al. 2005). Initially, attempts to 
produce microbubbles resulted in lipid shelled microbubbles with an 
aqueous solution core (Huang 2008). As it was later established that the 
oscillation mode of microbubbles and thus their ability to cause sonoporation, 
are also affected by their contents, production of microbubbles was focused 
encompassing initially air and later high molecular gases (Li, Tachibana et al. 
2003).   
The aim of this investigation was to characterise the in-house 
microbubbles in order to obtain valuable information, such as microbubble 
size and contents. This information would assist in setting some of the 
parameters for designing sonoporation experiments in the presence of the in-
house microbubbles. The size distribution of the in-house microbubbles was 
established with the aid of several methods, including confocal and two-
photon microscopy, cell sorting and coulter counter acquisition. All three 
methods confirmed the size distribution of the in-house microbubbles. Direct 
comparison of the size distribution of in-house microbubbles to that of 
commercially available microbubbles, such as Definity® and Sonovue® was 
also performed. As commercial microbubbles have already been shown to be 
involved in the sonoporation process, this would further substantiate the 
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ability of the in-house microbubbles to instigate sonoporation.  In addition, 
cell sorting provided an indication as to the contents of the in-house 
microbubbles. Finally, the information obtained from this section will allow 
formation of accurate parameters for designing a delivery system with the 
aid of ultrasound in the presence of in-house microbubbles. 
 
8.1 Results  
8.1.1 Imaging  
Confocal and two-photon imaging provided information about the 
size and shape of the microbubbles. Microbubbles were stained with FM 14-3 
dye, which is fluorescent when intercalated into phospholipid membranes 
and emits fluorescence at 488 nm. A number of stacks in the z plane were 
acquired for each microbubble and were then put together with Volocity 
software package, to provide a three dimensional (3-D) image. It was 
essential to image a large sample of microbubbles in order to be certain that 
we had an accurate representation of the size distribution within the 
microbubble preparations. Over one hundred images of in-house 
microbubbles were acquired in total (figure 8.1). As can be seen from figure 
8.1, there is a high fluorescent background present. Volocity image analysis 
(Improvision, Coventry) and 3-D rendering software provided information 
such as the surface area of the microbubbles. With the aid of this software, 
we were able to plot a surface area distribution graph (figure 8.2). Further 
experiments were performed in order to investigate the cause of this high 
background fluorescence. Coverslips imaged in the absence of microbubbles 
confirmed that the glass of the coverslips was not responsible for the 
fluorescence seen. Next, it was decided to image commercially available 
microbubbles (Definity®, Bristol Mayer Squibb) in order to examine if high 
xx    
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Figure 8.1 3-D images of crude in-house microbubbles. In-house microbubbles 
were stained with FM 14-3 dye. A number of stacks in the z plane were acquired 
with two photon microscopy for each microbubble and were then put together with 
Volocity software package, to provide a three dimensional (3-D) image. Original 
images of crude in-house microbubbles can be seen on the left hand side. Images 
on the right hand side are after manually subtracting the background. The units for 




 Figure 8.2 Surface area plotted against frequency of in-house microbubbles. A 
number of stacks in the z plane were acquired for each in-house microbubble and 
were then put together with Volocity software package, to provide a three 
dimensional (3-D) image. Volocity image analysis (Improvision, Coventry) and 3-D 
rendering software provided information such as the surface area of the 




















































fluorescent background would be still an issue. A total of four hundred and 
eighty eight images of Definity® were acquired (figure 8.3) and the data 
were processed as before (figure 8.4). 
We then attempted to separate the apparent phospholipid residues 
from the microbubble preparations by density gradient centrifugation. 
Microbubbles were added to a gradient of different densities (50 %, 30 %, 
and 5 %) of Nycoprep solutions, layered on top of each other. Samples of the 
centrifuged microbubbles were imaged using confocal microscopy as before 
in order to calculate their size distribution. Again, a large number of 
microbubbles were imaged (one hundred and seventy three for 50 % fraction, 
one hundred and eighty five for the 30 % fraction and one hundred and 
ninety six for the 5 % fraction) so as to obtain a valid representation of the 
population (figure 8.5, 8.6 and 8.7 respectively). 
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Figure 8.3 3-D images of Definity® microbubbles. Definity® microbubbles were 
stained with FM 14-3 dye. A number of stacks in the z plane were acquired with two 
photon microscopy for each microbubble and were then put together with Volocity 
software package, to provide a three dimensional (3-D) image. The units for the 






 Figure 8.4 Surface area plotted against frequency of Definity® microbubbles. 
A number of stacks in the z plane were acquired for each Definity® microbubble and 
were then put together with Volocity software package, to provide a three 
dimensional (3-D) image. Volocity image analysis (Improvision, Coventry) and 3-D 
rendering software provided information such as the surface area of the 

























































































Figure 8.5 Surface area plotted against frequency of in-house (50% fraction) 
microbubbles. In-house microbubbles were separated according to size by placing 
them in different density Nycoprep solutions and centrifuging them. Fractionated 
microbubbles (50 % fraction) were then stained with FM 14-3 dye and a number of 
stacks in the z plane were acquired with two photon microscopy for each 
microbubble. The z stacks were put together with Volocity software package, to 
provide a three dimensional (3-D) image. Volocity image analysis (Improvision, 
Coventry) and 3-D rendering software provided information such as the surface 












































Figure 8.6 Surface area plotted against frequency of in-house (30% fraction) 
microbubbles. In-house microbubbles were separated according to size by placing 
them in different density Nycoprep solutions and centrifuging them. Fractionated 
microbubbles (30 % fraction) were then stained with FM 14-3 dye and a number of 
stacks in the z plane were acquired with two photon microscopy for each 
microbubble. The z stacks were put together with Volocity software package, to 
provide a three dimensional (3-D) image. Volocity image analysis (Improvision, 
Coventry) and 3-D rendering software provided information such as the surface 













































Figure 8.7 Surface area plotted against frequency of in-house (5% fraction) 
microbubbles. In-house microbubbles were separated according to size by placing 
them in different density Nycoprep solutions and centrifuging them. Fractionated 
microbubbles (5 % fraction) were then stained with FM 14-3 dye and a number of 
stacks in the z plane were acquired with two photon microscopy for each 
microbubble. The z stacks were put together with Volocity software package, to 
provide a three dimensional (3-D) image. Volocity image analysis (Improvision, 
Coventry) and 3-D rendering software provided information such as the surface 




























Figure 8.8 3-D images of fractionated in-house microbubbles. Microbubbles 
were separated according to size by placing them in different density Nycoprep 
solutions and centrifuging them. Fractionated microbubbles were then stained with 
FM 14-3 dye and a number of stacks in the z plane were acquired with two photon 
microscopy for each microbubble. The z stacks were put together with Volocity 
software package, to provide a three dimensional (3-D) image. Images of 
fractionated in-house microbubbles can be seen. The units for the images are from 





8.1.2 Size sorting  
Crude in-house and fractionated samples were passed through a cell 
sorter in order to validate the size distribution results, obtained by imaging 
and density gradient separation, with a different method. Scatter plots from 
the in-house microbubbles showed that around 73 % of the crude samples 
were within 2-3 µm in diameter (figure 8.9). We then calculated the surface 
area of crude in-house microbubble samples by using Volocity (figure 8.10) 
and chose 40 images that fell within the two standard deviation of the mean. 
The diameter of these 40 representative microbubbles was measured 
manually. The calculated (nominal) and measured (actual) diameters of the 
selected microbubbles were plotted against surface area provided by 
Volocity. Furthermore, when the size distribution histograms from the crude 
and 5 % fractionated samples were overlaid on top of each other (figure 8.11) 
a very small shift towards the smaller sizes was observed.  
In-house microbubbles were fed through a coulter counter to examine 
their size distribution (figures 8.12-8.14). Two latex beads with a diameter of 
22 µm and 300 nm were also used in order to verify the detection range of 
the Coulter counter. Figure 8.12 demonstrates that most of the in-house 
microbubbles fall within a small range of 4-10 µm, with a small fraction 





Figure 8.9 Scatter plot of crude in-house microbubbles. Crude in-house 
microbubbles were passed through a cell sorter in order to validate their size 
distribution. (a) Scatter plot from the microbubble sample showing population 
distribution. FSC-A is the forward scatter emitted, representing microbubble size, 
while SSC-A is the side scatter emitted, representing microbubble morphology. (b) 
Statistical analysis of data. A total of 30,000 events were recorder, while the 
population falling within two standard deviations from the mean was gated (P4) and 
calculated to be 73 % of total population. (c)  Population distribution graph, showing 



































Figure 8.10 Nominal versus actual diameter of in-house microbubbles. 40 
microscope images of crude microbubbles were chosen, that fell within the two 
standard deviation of the mean microbubble surface area distribution according to 
Volocity (figure 8.2). The nominal and actual diameters of these microbubbles were 














Figure 8.11 Histogram of crude and 5% fractionated microbubbles. Size 
distribution histograms for crude (red) and 5 % fractionate microbubble (blue) 
samples were overlaid on top of each other to show the shift in size distribution 
between the two samples. The small shift towards the smaller microbubbles 












Figure 8.12 Coulter counter histogram of in-house microbubbles. As the size of 
microbubbles plays a crucial role in achieving sonoporation, it was necessary to 
define the size of the in-house microbubbles used. The microbubbles were therefore 
passed through a coulter counter in order to obtain a size distribution graph. The 
results show three distribution curves. The main curve contains microbubbles of an 












Figure 8.13 Coulter counter histogram of Definity® microbubbles. Obtaining the 
size distribution of other commercially available microbubbles such as Definity® was 
equally important as they have been shown to be capable of achieving sonoporation 
Definity® microbubbles were therefore passed through a coulter counter in order to 
obtain a size distribution graph. The results show two distribution curves. The first 
one has an average microbubble of 0.4 µm, while the second one has an average 












Figure 8.14 Coulter counter histogram of Sonovue® microbubbles. Obtaining 
the size distribution of other commercially available microbubbles such as 
Sonovue® was also important as they have been shown to be capable of achieving 
sonoporation Sonovue® microbubbles were therefore passed through a coulter 
counter in order to obtain a size distribution graph. The results show a normal 












 As previously mentioned the size of the microbubbles plays an 
important role in achieving sonoporation. Thus, confirming that the size 
distribution of in-house microbubbles falls within a similar range to that of 
microbubbles used for sonoporation in other studies was a significant part of 
this study. Characterization of in-house microbubbles was achieved, from the 
experiments described in this section. Three separate methods were used in 
order to evaluate the size distribution of the in-house microbubbles (a) two 
photon microscopy (b) cell sorting and (c) coulter counting.  
Confocal and two-photon imaging provided information about the 
size and shape of the microbubbles (figure 8.1). Volocity image analysis 
(Improvision, Coventry) and 3-D rendering software provided information 
such as the surface area of the microbubbles. With the aid of this software, 
we were able to plot a surface area distribution graph (figure 8.2). Volocity 
software was informed for the sake of the calculation that the microbubbles 
were spherical and applied the mathematical equation for calculating surface 
area of a sphere (4πr2, where r is the radius of the sphere). However, from the 
images obtained, it can be seen that the microbubbles were apparently not 
spherical (figure 8.1), since Volocity software analysis was unable, 
understandably, to distinguish between the high fluorescent background 
present and the microbubbles. 
Further experiments were performed in order to investigate the cause 
of this high background fluorescence. Images taken in the absence of 
microbubbles on coverslips, confirmed that the glass of the coverslips was 
not the cause of the fluorescence observed. As the FM 14-3 dye used for 
staining the microbubbles is only fluorescent inserted in phospholipid 
bilayers found in the sample, another possible explanation could be that 
some of the phospholipids used for microbubble production did not 
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incorporate themselves into the microbubbles, thus residues of these 
phospholipids would be accumulated on the coverslip surface and could 
explain the fluorescence seen.  
Examination of commercially available microbubbles (Definity®, 
Bristol Mayer Squibb) could assist to establish as to whether the high 
fluorescent background seen was present with all microbubbles or only in-
house microbubbles. As seen from figure 8.4, the population present was of 
much smaller size than that of the in-house microbubbles. In addition, the 
background fluorescence was much lower than that seen with in-house 
microbubbles, which suggested that the Definity® samples had fewer 
impurities (due to unincorporated lipids) than the in-house microbubbles.   
Two approaches were taken in order to eliminate the fluorescent 
lipidic “background” seen to be able to measure accurately the diameter of 
the in-house microbubbles. First, we attempted to “cut off” the fluorescent 
background of the in-house microbubbles manually using tools available in 
Imaris software. While there was now no fluorescence remaining in the 
sample data on the coverslip surface, the microbubbles were still not 
spherical since the cutting tools only allowed us to cut a straight line , so the 
bottom surface of the microbubbles was flat. However, this may reflect 
reality, since the phospholipid membrane of the microbubbles is most likely 
deformable, thus their own weight could actually result in a flat surface were 
they touch the coverslip surface. Nevertheless, once again the mathematical 
equation applied for calculating the surface area of the microbubbles by 
Volocity is assumed to be invalid, since the microbubble shape is not 
spherical. Secondly, we attempted to separate the apparent phospholipid 
residues from the microbubble preparations by density gradient 
centrifugation. Nycoprep consists of Nycodenz, a high density solution. 
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When microbubbles within the different density Nycoprep solutions were 
centrifuged, they separated according to size into the different density 
solutions. Therefore, any phospholipid residues present in the solution 
should be separated from the fully formed microbubbles. This experiment 
would also provide information about the contents of the microbubbles i.e. if 
the microbubbles were filled with air, then the smaller ones should sink to 
the bottom of the tube, however if the microbubbles were filled with saline, 
then the smaller ones should float to the top of the tube. Separation of 
microbubbles by density would also be useful for future experiments, if 
certain sizes of microbubbles prove to be toxic or more or less efficient in 
sonoporation, when introduced into cell cultures. 
Samples of the centrifuged microbubbles were imaged using confocal 
microscopy as before in order to calculate their size distribution. The images 
produced three types of information. First, as can be seen from figures 8.5-8.7 
the fractionated microbubbles were separated according to size and smaller 
microbubbles seem to accumulate at the top 5 % layer. If microbubbles were 
filled with saline, then smaller microbubbles would move towards the lower 
density fraction while larger microbubbles would move towards higher 
density fraction. The opposite would be true if microbubbles were filled with 
air, since larger microbubbles would be more buoyant than smaller ones, due 
to the density of air. Accumulation of smaller microbubbles at the top 5 % 
layer was an indication that in-house microbubbles were most probably 
filled with saline. Secondly, the fluorescent “background” had now been 
largely removed, presumably because of its difference density to the 
microbubbles (figure 8.8). Although this is not a direct proof that the 
background fluorescence was due to non-incorporated phospholipids, this 
speculation is plausible from the outcome of these results. Thirdly, a 
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comparison between the fractionated in-house and Definity® microbubbles 
(figure 8.4-8.7) confirmed that their surface area distribution was similar. 
Crude in-house and fractionated samples were passed through a cell 
sorter in order to validate the size distribution results obtained by imaging 
and density gradient separation, with a different method. Scatter plots from 
the in-house microbubbles showed that 73 % of the crude samples were 
within the 2-3 µm in diameter. It was decided to cross examine these results 
with those obtained from microscope imaging and Volocity measurements. 
40 microscope images of crude microbubbles were chosen. Selected images 
fell within the two standard deviation of the mean microbubble surface area 
distribution according to Volocity (figure 8.2). The diameter of these 40 
microbubbles was then manually calculated. The nominal diameter of these 
microbubbles that were calculated by Volocity, were plotted against the 
actual diameters that were calculated manually (figure 8.10). Data from 
figure 8.10 provide two pieces of information. Firstly it can be deduced that 
actual microbubble diameters fall within the range of 2-3 µm. Secondly, the 
actual diameters of microbubbles do not agree with the nominal diameter 
calculations according to Volocity. Thus it can be postulated that the method 
for calculating microbubble surface area with Volocity was not valid.   
Size distribution histograms from the crude and 5 % fractionated 
samples were overlaid on top of each other in order to verify whether 
fractionation had indeed separated microbubbles into fraction of different 
sizes (figure 8.11). The results indicate that fractionated sample has been 
slightly shifted towards smaller sizes. This suggests that only a small number 
of large microbubbles were extracted from the 5 % fraction. If however we 
take into consideration that most of the crude samples fall within the 2-3 µm 
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range (figure 8.10), then we can assume that there were not many large 
microbubbles in the original sample. 
Finally, in-house microbubbles were fed through a coulter counter to 
further validate their size distribution with a different method. Figure 8.12 
demonstrates that most of the microbubbles fall within a small range of 4-10 
µm, with a small fraction containing larger microbubbles. Although the 
results from the coulter counter show a microbubble population of a larger 
size than that observed with confocal imaging or cell sorting,  data from 
commercially available Definity® and Sonovue® microbubbles demonstrate 
that in-house microbubbles have similar size distribution to that of 
microbubbles used for attaining sonoporation (figure 8.13 and 8.14). 
 
8.3 Conclusion  
From the methods used in this section, it can be concluded that the 
size distribution of in-house microbubbles ranges from 2-10 µm with 73 % of 
the population falling within the 2-3 µm range and a smaller fraction 
containing larger microbubbles. These values are of comparable to 
microbubbles such as Definity® (mean 1.1-3.3 µm), (Miller and Dou 2009), 
Sonovue® (median 2 µm) (Rahim, Taylor et al. 2006a) and Optison® (mean 
2-5 µm) (Kinoshita and Hynynen 2007), that are used in sonoporation studies.  
Furthermore, cell sorting provided a possible indication that the in-
house microbubble core is filled with aqueous solution rather than air. 
Subsequent research was focused on establishing the parameters necessary 
for achieving sonoporation in the presence of in-house microbubbles. 
Induction of sonoporation would allow development of a system for 
ultrasound mediated gene delivery in the presence of in-house microbubbles 



































Cavitation is thought to be one of the main mechanisms for obtaining 
sonoporation (Van Wamel, Kooiman et al. 2006b). Several reports suggest 
that inertial cavitation and the phenomena associated with it, such as free 
radical formation, microstreaming, generation of high temperatures and 
pressures can be accountable for sonoporation (Gerard and Junru 1998; Ward, 
Wu et al. 2000; Dijkmans, Juffermans et al. 2004; Juffermans, Dijkmans et al. 
2006; Patil and Pandit 2007; Cheng-Huang, Yeh et al. 2008). On the other 
hand, other studies have demonstrated that sonoporation takes place as a 
consequence of stable cavitation (Van Wamel, Kooiman et al. 2006b). 
Regardless of the type of cavitation that leads to sonoporation, its 
manifestation is strongly associated with the presence of microbubbles 
(Greenleaf, Bolander et al. 1998; Wu, Ross et al. 2002; Zhou, Cui et al. 2008). It 
has also been demonstrated that cell viability and molecular uptake are 
proportional to cell density and inversely proportional to bubble 
concentration (Ward, Wu et al. 2000; Guzmán, McNamara et al. 2003). It is 
therefore safe to assume that sonoporation entails a cell-bubble synergy. 
Thus, the cell-to-bubble ratio could function as a useful non-acoustic 
parameter (Guzmán, McNamara et al. 2003). The cell-to-bubble ratio reflects 
the distance between cells and microbubbles. However, previous studies 
reporting sonoporation use a wide range of cell to bubble ratio from 1:1 to 
1:1000 (Brayman, Coppage et al. 1999; Ward, Wu et al. 1999; Kirosoglou, 
Hardt et al. 2006; Wu, Pepe et al. 2006; Van Wamel, Kooiman et al. 2006a). 
The use of such a broad range of cell to bubble ratio, and a large variation in 
published  acoustic and non-acoustic parameters, has resulted in the 
publication of a vast spectrum of sonoporation efficiencies (Appendix 2) 
(Guzmán, McNamara et al. 2003).  
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 The aim of this section was to establish both the acoustic and non 
acoustic parameters necessary for achieving ultrasound mediated 
sonoporation in the presence of microbubbles. Deciding on the initial 
parameters of this study was difficult due to the vast number of acoustic and 
non acoustic parameters involved in such an investigation. In order to 
decrease the number of initial parameters investigated, ultrasound induced 
sonoporation was examined in the presence of Definity® microbubbles, since 
they have been shown to induce sonoporation under certain ultrasonic 
conditions (Han, Ikegami et al. 2007; Zhou, Cui et al. 2008; Zhou, Shi et al. 
2008). Once the acoustic parameters for achieving sonoporation were 
established, experiments were repeated in the presence of in-house 
microbubbles. This course of action allowed for investigation initially of 
acoustic parameters, followed by investigation of non acoustic parameters. In 
addition, the use of three different ultrasound pieces of equipment 
necessitated the establishment of the acoustic parameters for each separate 
apparatus. Therefore, experiments in this section can be divided into three 
sections: 
(a) Acoustical measurements 
 When an ultrasound beam strikes upon an interface, a fraction of the 
wave will be reflected, leading to the generation of backscattered waves. 
Backscattered waves tend to move in the opposite direction of the original 
ultrasound wave, thus creating a standing wave (Wu and Nyborg 2008). 
Standing waves are characterized by areas called nodes, where no 
displacement takes place, and antinodes, where maximum displacement 
takes place (Wu and Nyborg 2008). Thus, the acoustic pressure along the 
length of a standing wave changes dramatically from one area to another. It 
is therefore important to eliminate the production of any backscatter and 
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hence any standing waves during insonation of cells. Although all studies 
provide information about the parameters of the ultrasound wave applied to 
their samples, such as intensity, only a handful of them take into 
consideration standing waves that might be present, thus failing to calculate 
the actual power delivered to the cells (Rahim, Taylor et al. 2006a; Kinoshita 
and Hynynen 2007). In addition, although ultrasound machines are 
calibrated by manufacturers, a discrepancy arises with time, between 
nominal and actual values obtained. Moreover, several studies perform their 
experiments in polystyrene or glass culture tubes without taking into 
consideration any backscatter waves produced at the medium / polystyrene 
or glass interface, due to the large discrepancy in their acoustic impedances 
(Rahim, Taylor et al. 2006a). Furthermore, acoustic pressure is critical to 
microbubble behaviour and thus for achieving sonoporation. The scarcity of 
precise recording of acoustic pressures during sonoporation studies, has 
made it difficult to reproduce experiments or to compare observations 
among studies (Rahim, Taylor et al. 2006a).  
 Although all precautions were taken in this study to eliminate the 
presence of any backscatter and standing waves, it was necessary to confirm 
this by measuring the exact acoustic field arriving at the cells of interest 
during each experimental set up. Therefore, measurement of the power 
outputs and pressure amplitudes of all the ultrasound equipment used was 
performed in order to accurately express the acoustic parameters used in 
sonoporation experiments.  
(b) “Physiotherapy machine” 
  Although ultrasound imaging does not utilize ionizing radiation, a 
number of studies have reported some adverse bioeffects. For example, cell 
surface molecules have been shown to detach from cells after ultrasound 
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exposure (Mehier-Humbert, Bettinger et al. 2005a). Microvascular leakage 
was also observed after exposure to ultrasound in the presence of ultrasound 
contrast agents (Li, Cao et al. 2003; Miller 2007a). On the other hand several 
studies have examined the possible harmful effects resulting from 
ultrasound application and have not found any detrimental effects 
(Bekeredjian, Chen et al. 2005). It was therefore important to investigate 
whether both the acoustic (acoustic pressure & intensity) and non acoustic 
parameters (optimal cell concentration & potential microbubble toxicity) 
used in this study had any adverse effects that could compromise cell 
viability.  
(c) Ultrasound scanner 
 Physiotherapy machines, as their name suggests are used for 
therapeutic purposes while ultrasound scanners are used for clinical imaging 
and diagnostic purposes. Therefore, the waveforms that are produced by 
each type of machine differ in a number of parameters. Since sonoporation 
was established with the aid of a physiotherapy machine, it was decided that 
further investigation of sonoporation should be carried out with the aid of an 
ultrasound scanner since that would be clinically relevant.  
 Furthermore, throughout the investigation of ultrasound induced 
sonoporation the following issues were examined: 
• Transport of different size molecules across plasma membrane 
• Transport and expression of DNA molecule across plasma membrane 
• Effect in sonoporation efficiencies amongst three different cell lines 
• Effect in sonoporation efficiencies between different culture methods 
• Sonoporation in the presence of in-house and Definity® microbubbles 
with the aid of a “physiotherapy machine” and an ultrasound scanner 
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 Finally, a number of experiments have been conducted in this study 
with the use of either a “physiotherapy machine “or an ultrasound scanner, 
in order to investigate sonoporation. Each experiment is normally an 
adaptation of the previous experiment with only one or two parameters 
changing. In order to make this chapter easier to follow, each experiment has 
been assigned a number and a schematic representation of the parameters 
used in each one is shown in Appendix 3.  
 
9.1 Experimental set up 
9.1.1 Petri dish 
During initial ultrasound experiments cells were seeded in a Petri dish 
and were placed on a bench, since similar studies investigating sonoporation 
had used Petri dishes or other culture dishes of similar material (Greenleaf, 
Bolander et al. 1998; Brayman, Coppage et al. 1999; Wu, Ross et al. 2002; 
Duvshani-Eshet, Baruch et al. 2005; Feril, Ogawa et al. 2005). Some studies 
took into consideration the acoustic pressure transmission coefficient 
(acoustic pressure measured outside the tube divided by the acoustic 
pressure measured inside the culture tube), which was found to be 0.77 (Wu, 
Ross et al. 2002) while other studies reported that over 95 % of the ultrasound 
waves  passed through the bottom of a Petri dish (Zhou, Shi et al. 2008). 
 
9.1.2 Mylar membrane 
 While placing the cells in the ultrasound tank would significantly 
diminish the backscatter arising from the passing of ultrasound waves from 
the Petri dish to the air, the polystyrene, which the Petri dishes are made of, 
would still reflect a fraction of the ultrasound wave.  The use of a Mylar 
membrane, which is acoustically transparent, would lessen the reflections 
produced, thus allowing for more accurate measurements of the acoustic 
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field. The Mylar membrane was wedged between two Derlin rings in order 
to eliminate any creases (ring-membrane-ring (MRM) “sandwich”). 
 
9.1.3 OptiCell™ 
 A small number of studies investigating sonoporation have used 
OptiCells™ as the sample chamber for applying ultrasound (Rahim, Taylor 
et al. 2006b; Van Wamel, Kooiman et al. 2006b). Subsequent experiments 
were performed with the use of OptiCells™, which are chambers enclosed 
between two acoustically transparent gas-permeable membranes. Such 
chambers provided a stable environment for the cells in order to survive for 
the length of time necessary to perform the ultrasound experiments 
(maximum 60 min). In addition, due to the closed environment provided 
with the use of OptiCells™, no bacterial contaminations were observed. 
Furthermore, since the membranes of the OptiCell™ were permeable only to 
gas, the OptiCell™ could be submerged into the tank, thus allowing for a 
greater distance between the transducer and the cells, which would decrease 
the likelihood of reflections generated from the base of the tank. 
 
9.1.4 Development of experimental rig 
In order to be able to measure accurately the acoustic field incident on 
the cells, it is essential to diminish the possibility of any backscattered 
ultrasound. An ultrasound tank was designed so as to minimize generation 
of any backscatter. This was mainly achieved by increasing the distance 
between the cells and the bottom of the tank to 2 cm compared to almost 
none when the experiment was performed on the bench. Hence, ultrasound 
waves were allowed to travel further before reaching the Petri dish 
(polystyrene / air interface) thus reducing any backscatter waves. However, 
the distance between the transducer and the cells, was kept constant (~0.5 
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cm). Since the ultrasound tank set up minimized the possibility of 
backscatter, there was no reason to change the distance between the 
transducer and the cells. Increasing the transducer-cell distance would alter 
the power of ultrasound wave received by the cells, thus making comparison 
with previous experiment not possible. Some studies attempted to minimise 
the likelihood of reflection waves by placing a rubber absorber below the 
culture dish (Brayman, Coppage et al. 1999; Duvshani-Eshet, Baruch et al. 
2005). However, it should also be taken into account that once the ultrasound 
waves have passed through the bottom of the culture dish they would first 
encounter air, which would result in generation of reflection waves, before 
arriving at the rubber absorber. In another study, cells were seeded in a 6 
well dish and insonated from below (Feril, Ogawa et al. 2005).  Although a 
transmitting gel was used between the transducer and dish interface in order 
to reduce the reflected waves, the reflection waves generated at the medium / 
air interface, were not taken into consideration. During subsequent 
experiments, an acoustic absorber was therefore placed at the bottom of the 
tank, prior to an air interface, in order to further minimise the possibility of 
any backscatter. Furthermore, turning the transducer at a 37° angle ensured 
that any backscatter still present would be guided away from the cells. The 
ultrasound tank set up also allowed for the cells to be placed on the 
microscope stage and then to be moved away from the stage so that 
ultrasound could be applied and returned back to the identical  position on 
the microscope stage (figure 9.1-9.2). 
 The presence of air bubbles can act as potential cavitation nuclei, thus 
augmenting any effect the ultrasound might have on the cells (Dalecki 2004). 
However, Ward, Wu et al. (1999) did not detect any significant difference in 
the outcome of their experiments with the use of air-saturated or degassed 
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water at room temperature. In addition, a study investigating sonoporation 
with a range of temperatures reported maximum sonoporation efficiency at 
37 °C (Zarnitsyn and Prausnitz 2004). Therefore it was decided to fill the 
ultrasound tank with boiled water and leave it to settle for 30 min, so as to 
minimise the presence of air bubbles and at the same time keep the 



















Figure 9.1 Ultrasound tank setup. The tank was placed on a base so as to be the same level as the microscope. Cells grown in an 
OptiCell™ were submerged in the tank and held into position with the aid of a custom made holder. The holder also allowed for the cells 
to slide on to the microscope stage after insonation which enabled images at the same field of view as that observed prior to insonation. 
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Figure 9.2 Schematic representation of ultrasound tank set up. Cells grown in an OptiCell™ were submerged in the tank and held into 
position with the aid of a custom made holder. The holder also allowed for the cells to slide on to the microscope stage after insonation 
which enabled images at the same field of view as that observed prior to insonation (image not drawn to scale). 
 









9.2 Results  
9.2.1 Ultrasound fields 
9.2.1.1 Measurements of the ultrasound field of the “physiotherapy 
machine” 
 The peak to peak pressure of the ultrasound wave of the 
“physiotherapy machine” used in this study was investigated with the aid of 
a hydrophone (figure 9.3). The electrical interference observed in both images 
(a) and (b) of figure 9.3 is due to the presence of harmonics generated by the 
transducer. As can be seen from figure 9.4 the nominal and actual intensity of 
the ultrasound wave emitted from the “physiotherapy machine”, measured 
with the aid of a radiation force balance, differ significantly. The acoustic 
pressure for ultrasound waves of 1 MHz and 3 MHz were measured for 
increasing intensities, with the aid of an oscilloscope (figure 9.5).  
 
9.2.1.2 Measurements of the ultrasound field of the ultrasound scanners 
9.2.1.2.1 Acoustic pressure in the presence of OptiCells™ 
 A Philips Sono 5500 ultrasound scanner was used for conducting 
initial experiments. The acoustic pressure of the ultrasound beam was 
measured in the presence and absence of an OptiCell™ in order to confirm 
that the membrane of the OptiCell™ is acoustically transparent (figure 9.6). 
The acoustic pressure was measured at three different frequencies (1.59, 1.62, 
2 MHz). Statistical analysis (student’s t test, p=0.005, n=3) of the data 
indicated that there is no significant difference in the acoustic pressure of an 
ultrasound wave in the presence and absence of OptiCell™ for a range of 
frequencies. This experiment confirmed that the OptiCell™ is acoustically 
transparent.  
Subsequent experiments were preformed with HDI3500 scanner as it 
became available for use. Peak to peak pressures were calculated at a 
frequency of 2-4 MHz with a centre frequency of 3 MHz, with the aid of a 
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hydrophone and the negative peak pressure were found to be 2.19 µPa while 































Figure 9.3 Peak to peak pressure measurements of “physiotherapy machine” 
for 1MHz (a) and 3 MHz (b). (a) X- axis is 100ns per division and Y-axis is 10 mV 
per division, (b) X- axis is 250ns per division and Y-axis is 10 mV per division. Peak 
to peak pressure for 1 MHz is 0.3 MPa and for 3 MHz is 0.79 MPa. The electrical 
interference observed in both images (a) and (b), is due to the presence of harmonics 









Figure 9.4 Intensity of “physiotherapy machine”. The nominal and actual 
intensities of ultrasound wave of the “physiotherapy machine” used in this study 
were investigated with the aid of a hydrophone. The differences between the 
nominal acoustic intensity outputs for 1 MHz (■) and 3 MHz (▲) and the actual 
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Figure 9.5 Acoustic pressure of “physiotherapy machine”. As actual and 
nominal values for acoustic intensity of the “physiotherapy machine” were shown to 
differ significantly, it was necessary to calculate the actual acoustic pressure for 
ultrasound waves of 1 MHz (▲) and 3 MHz (■) for a range of intensities. These 














   
ACOUSTIC PRESSURE OF PHYSIOTHERAPY MACHINE
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Figure 9.6 Peak to peak pressure from the Sono 5500 scanner. A Philips Sono 
5500 ultrasound scanner was used for conducting initial sonoporation experiments. 
The acoustic pressure of the ultrasound beam was measured in the presence (□) 
and absence of an (■) OptiCell™ in order to confirm that the membrane of the 













































Figure 9.7 Peak to peak pressure from the HDI3500 scanner. Peak to peak 
pressure measurements of the HDI3500 scanner were performed with the aid of a 
hydrophone, in order to establish the actual pressure output exerted by this scanner. 
The figure depicts the graphical representation of the amplitude of the acoustic wave 
plotted against time. X- axis is 500ns per division and Y-axis is 0.1 mV per division. 
The negative peak pressure was found to be 2.19 µPa and the positive peal 


















9.2.1.2.2 Mechanical index in the presence of OptiCells™ 
Since the use of an ultrasound scanner provides an ultrasound beam 
with parameters that differ significantly from those applied with 
physiotherapy machines, it was essential to investigate cell viability in 
OptiCell™ during insonation with the ultrasound scanner HI3500. The 
mechanical index (MI) value is equal to the peak rarefractional pressure 
divided by the square root of the centre frequency of the beam (Church 2005). 
Therefore, any potential mechanical bioeffects are related to the peak 
negative pressure that has been measured. The mechanical and thermal (TI) 
indexes were recorded as they provide valuable information about the 
likelihood of cavitation or maximum temperature occurring, respectively. In 
addition, the lower the frequency the higher the likelihood of mechanical 
effects, hence the reason as low a frequency as possible was used with the 
system (3 MHz). 
Cell viability assays were performed using ultrasound waves of 
increasing MI (0.2, 0.5, and 1.1). While in previous experiments, the 
transducer was placed in close proximity to the OptiCell™, during 
experiments with the use of the ultrasound scanner the OptiCell™ was 
placed 2.5-3 cm below the probe so that the cells were situated at the focal 
point of the ultrasound beam (figure 9.8). In order to minimise the amount of 
OptiCells™ used, the transducer was placed in three areas within each 
OptiCell™. Each of these areas was applied with ultrasound of the same MI. 
In addition, a fourth area was also examined within each OptiCell™, which 
served as an internal control. Control OptiCells™ were also used, where no 
ultrasound was applied. The OptiCells ™ were placed under the microscope 
and 10 images were taken for each of these areas before and after insonation 
(figure 9.9). Furthermore, the transducer was placed at a 90° angle. As can be 
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seen from figure 9.10, cell viability is not affected significantly for the MIs 
examined. This was also confirmed with statistical analysis (one-way 



























Figure 9.8 Representation of monitor from ultrasound scanner HDI3500. During 
sonoporation experiments with the ultrasound scanner, OptiCells™ were placed at 
the focal point of the beam, shown by the small arrow on the right hand side of the 
image. Distance from probe to bottom of the tank is 6.8 cm, while the focal point is 
around 2.5-3 cm below the probe. A range of mechanical and thermal indexes were 
used in order to establish sonoporation of cells. Top image MI=0.2, TI=0.1 and 









Figure 9.9 Representation of application of ultrasound via transducer P4-2 to 
OptiCell™. During investigation of the effect of mechanical index on cell viability, 
three areas within each OptiCell™ were exposed to ultrasound of the same MI value. 
A fourth area was also used as an internal control. Each circle within the areas, 
represents a field of view under the microscope, thus 10 images were taken before 













Sample 3 Internal control 
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Figure 9.10 Effects of ultrasound scanner on cell viability. Experiments were 
conducted in order to determine the likelihood of any adverse bioeffects with the 
acoustic pressure and intensity emitted from the ultrasound scanner HDI 3500. As 
the peak rarefractional pressure is directly proportional to the mechanical index, the 
latter can provide an indication of bioeffects. Cells were thus insonated with a range 
of mechanical indexes in order to determine the likelihood of any adverse bioeffects 
occurring on cells during sonication. The mechanical indexes examined (0.2, 0.5, 
1.1) correspond to acoustic pressures of 0.35 MPa, 0.87 MPa and 1.91 MPa 
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9.2.2 “Physiotherapy machine” experiments 
9.2.2.1 Investigation of non acoustic parameters 
 One of the essential factors necessary to examine was the viability of 
the cells used in this study at different concentrations. Cells viability assays 
were performed on SK Hep-1 cells in order to find the optimum seeding 
densities. Five different seeding densities were examined, ranging from 2 x 
105 to 1 x 106 cells / ml. Cell were stained with Calcein AM and Propidium 
Iodide 24h hours after seeding in order to measure the ratio of live to dead 
cells in the culture. For each seeding density, fifteen images from three 
separate Petri dishes were taken. The percentage of viabilities of each density 
along with the standard error of the mean (SEM) are plotted in figure 9.11. 
Cell viability was calculated as the number of viable cells after insonation 
divided by the number of viable cells before insonation and expressed as 
percentage. Statistical analysis of the data (one-way ANOVA, p=0.03, n=3) 
showed no significant difference between the different densities. Thus, it was 
decided to use the lower density of 2 x 105 cells / ml, as cells had to survive a 
further 2-3 days post seeding, so as to allow the cells to reach a concentration 
of approximately 4 x 105 cell / ml when used for sonoporation experiments.  
 As the microbubbles intended to be used in sonoporation experiments 
with in-house microbubbles, it was also essential to assess any potential 
toxicity. Therefore, crude in-house microbubbles were added to SK Hep-1 
cells. Cells were then incubated for 1-48 hours, before carrying out a cell 
viability assay as described earlier. Such a prolonged period of incubation 
was necessary in order to evaluate cell survival during gene expression 
experiments. While planning these experiments, it was hypothesised that the 
0.9 % (v/v) saline in which microbubbles were made in could be toxic to the 
cells. To test this hypothesis, in-house microbubbles that were prepared with 
phosphate buffered saline (PBS) were also incubated with cells. Figure 9.12 
 170 
gives an indication of cell viability for different times of incubation with 
crude in-house microbubbles. Statistical analysis (one-way ANOVA, p=0.03 
(saline), p=0.01 (PBS) n=3) showed no significant difference between different 
incubation times in the presence of microbubbles prepared in saline or in PBS. 
In addition, there is no significant difference between PBS and saline 
prepared microbubbles. Therefore, the results indicate that in-house 






















Figure 9.11 SK Hep-1 viability assay. Cells were seeded in a Petri dish in different 
concentrations in order to determine optimal seeding concentration. Cell viability 
was determined with the use of Calcein AM and Propidium Iodide. Error bars 
represent standard error of means. Statistical analysis showed no significant 
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Figure 9.12 Cell / in-house microbubble viability assays. In-house microbubbles 
were incubated with SK Hep-1 cells in order to examine microbubble toxicity. 
Microbubbles were manufactured in the presence of saline (top graph) or in the 
presence of PBS (bottom graph). Microbubbles were added to the Petri dish 
containing SK Hep-1 cells and were left to incubate from 1 to 48 hours. Microbubble 
toxicity was assessed in terms of cell viability, which in turn was determined with the 
use of Calcein AM and Propidium Iodide.  
 
 










































9.2.2.2 Investigation of acoustic parameters 
9.2.2.2.1 Investigation of acoustic parameters in the presence of a Petri 
dish 
 As previously mentioned, the parameters used in each study in order 
to achieve sonoporation vary immensely; it was therefore believed that the 
use of an ultrasound contrast agent previously reported to cause 
sonoporation could assist in setting the initial parameters necessary for 
sonoporation. Once all the acoustic and non-acoustic parameters were 
established in the set up used in this study, sonoporation of in-house 
microbubbles could be then investigated. Initial experiments were thus 
performed with Definity® microbubbles, as they are commercially available 
ultrasound contrast agents and have been previously shown to bring about 
sonoporation (Han, Ikegami et al. 2007; Zhou, Cui et al. 2008; Zhou, Shi et al. 
2008).  
 Cells were seeded in a Petri dish and then insonified with the 
ultrasound waves of different intensities (0.1, 0.2, 0.3, 0.4, 0.6, 0.8 W / cm2) in 
the presence and absence of Definity® microbubbles (figure 9.13). A range of 
microbubble concentrations was used (12.5, 25, 50, 75 µl) in order to assure 
that increasing amounts of microbubbles did not have any adverse effects on 
cell viability (Exp. 1). As can be seen from figure 9.14, cell viability is 
inversely proportional to intensity of ultrasound. In addition, higher 
concentrations of in-house microbubbles lead to decreased cell viability. 
Statistical analysis (two-way ANOVA, p=0.0001, n=9) of the samples 
confirmed that there is a significant difference in cell viability between 
different amounts of in-house microbubbles at a specific ultrasound intensity 
and between different intensities investigated.  As can be seen from figure 
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9.14, maximum cell death (50.27 %) occurred at 0.8 W / cm2 in the presence of 
75 µl of Definity® microbubbles.  
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Figure 9.13 Experimental set up for cell viability assays. Cell viability was examined for a number of non acoustic parameters such as 
cell concentration and microbubble toxicity. Cells were seeded in a Petri dish 24 hours prior to insonation. The following day, cells were 
placed on a bench (a), where they were insonated with the “physiotherapy machine” (b). Cells were then transferred to the microscope 
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Figure 9.14 Kill curve in the presence of Petri dish. Cell toxicity was examined in 
relation to increasing ultrasound intensity and increase. Four different 
concentrations of Definity® microbubbles were added into the Petri dish, (◆) 75 µl, 
(-) 50 µl (▲) 25 µl, (x) 12.5 µl and (■) control (n=9). Cells were insonated with 
ultrasound waves of varying intensities (0.1, 0.2, 0.3, 0.4, 0.6 and 0.8 W / cm2). 
Following insonation, cells were transferred to the microscope were their viability 
was assessed with the aid of Calcein AM and Propidium Iodide. 
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9.2.2.2.2 Investigation of acoustic parameters in the presence of a Mylar 
membrane (MRM) “sandwich”  
During experiments with the MRM “sandwich”, cell fatality was 
considerable even in the absence of ultrasound application, mainly because 
cells were exposed to non-regulated environment. Exposure of the cells to 
the air in the room where the experiments were conducted, affected the pH 
of the cellular environment. This was confirmed by the change in colour of 
the medium (DMEM) used to culture the cells. The DMEM contains phenol 
red, which is pH sensitive and changes colour accordingly; high pH values 
turn the medium into a bright pink colour. In addition, because cells were 
exposed to a non-sterile environment for a period of time, bacterial 
contamination was frequent. Experiments with the MRM “sandwich” were 
therefore not continued, since increased cell death was present in all samples, 
including the controls.  
 
9.2.2.2.3 Investigation of acoustic parameters in the presence of an 
OptiCell™ 
 Initial experiments with the use of OptiCells™ involved investigation 
of cell viability in the presence of microbubbles during sonication (Exp. 2). 
The viability of cells was examined in the presence of Definity® 
microbubbles using a range of ultrasound intensities similarly to those 
previously described in section 9.2.2.2.1. The microbubbles were injected into 
the OptiCell™ that was inverted several times in order to achieve an even 
distribution. Preliminary data (n=3) showed no change in cell viability with 
the intensities previously used (0.1, 0.2, 0.4, 0.6, 0.8 W / cm2) (figure 9.15). It 
was believed that backscatter waves present in the initial (Petri dish) set up, 
were eliminated due to the use of OptiCells™, which are acoustically 
transparent unlike Petri dishes, which are highly reflective. This could 
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explain the absence of any effects on cells viability during insonation. Thus, 
subsequent experiments were performed with increased levels of intensity 
(2.54 W / cm2). Two different concentrations of Definity® microbubbles were 
examined, while cells where sonicated for either 1 min or 3 min (Exp. 3). 
Figure 9.16 demonstrates the effects of different periods of sonication in the 
presence of Definity® microbubbles. As can be seen, the optimal cell survival 
was observed during application of ultrasound wave of 2.54 W / cm2 
intensity, for 1 min, in the presence of 100 µl of Definity® microbubbles. 
These results suggest that the presence of higher concentrations of 
microbubbles during sonication has a detrimental effect on cell viability.  
  At that point, an acoustic absorber was placed at the bottom of the 
tank in order to further minimise the possibility of any backscatter. At the 
same time, the transducer was turned at a 37° angle so that any backscatter 
still present would be guided away from the cells (figure 9.17). Therefore, the 
previous experiment was repeated in the presence of the acoustic absorber 
and transducer at a 37° angle. In addition, the area of cells exposed to 
ultrasound was marked on one of the membranes of the OptiCell™. Smaller 
areas within the marked area, corresponding to the field of view of the 
microscope were also marked as previously described in section 7.5.2.4.1.  
Therefore it was possible to map out the effects of ultrasound on different 
areas of the OptiCell™, in the presence and absence of microbubbles. 
Ultrasound of 2.54 W / cm2 intensity was applied to cells for either 1 min or 3 
min in the absence of microbubbles (figure 9.18), followed by 100 µl or 300 µl 
of Definity® microbubbles for each time period (figure 9.19-9.20). In addition 
to the cells being examined immediately after sonication, cells were also 
examined 24 hours after sonication (figure 9.21) (Exp. 4). The observations of 
this experiment have been plotted as percentage of cell viability. A colour  
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Figure 9.15 Kill curve in the presence of OptiCell™.  During sonoporation 
experiments cells were seeded in acoustically transparent OptiCells™. Toxicity of 
the parameters established so far was examined prior to carrying out any 
sonoporation experiments. 100 µl of Definity® microbubbles were injected into the 
OptiCell™ and inverted several times in order to achieve even distribution. Cells 
were then insonicated with ultrasound waves of varying intensities (0.1, 0.2, 0.4, 0.6 
and 0.8 W / cm2). Following insonation, cell viability was assessed under the 




































Figure 9.16 Effect of ultrasound on SK Hep-1 cells cultured in an OptiCell™. 
Cells were sonicated with an ultrasound wave of 2.54 W / cm2 for different time 
periods (1min, 3 min) in the presence of 100 µl (◆) or 300 µl (■) of Definity® 
microbubbles. Following sonication, cells viability was examined under a microscope 
































Figure 9.17 OptiCell™ in ultrasound tank. The OptiCell is placed in the ultrasound 
tank and is held at approximately 2.5 cm above the bottom of the tank so as to 
minimise any backscatter waves. In addition, the ultrasound probe is held in a 37 ºC 
angle so any backscattering waves that have not been absorbed by the acoustic 
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scale has been was devised, with each colour representing a 10  % decrease in 
cell viability i.e. bright red areas represent cell viability of 90-100  %, whereas 
bright blue areas represent cell viability of 0-10 %. Although from the data 
shown in figures 9.19-9.21 it visually appears that cell viability was greater 
during 3 min of sonication in the presence of 100 µl of Definity® 
microbubbles compared to all other parameters examined (3 min sonication 
in the presence of 300 µl of Definity® microbubbles  and 1 min sonication in 
the presence of 100 µl and 300 µl of Definity® microbubbles), statistical 
analysis (two-way ANOVA, p=0.006, n=3) showed no significant difference 
between the different concentrations of microbubbles used or the amount of 
time ultrasound was applied (two-way ANOVA, p=0.006, n=3). As a result, it 
was decided to continue with the parameters that would minimise the 
probability of any bioeffects and / or cell death (minimum sonication in the 




Figure 9.18 Effects of ultrasound on SK Hep-1 cells in the absence of 
microbubbles. Cells were sonicated for 1 min (a) and 3 min (b) with an ultrasound 
wave of 2.54 W / cm2 intensity. Each large circle represents the area where 
ultrasound was applied. The circle on the left is before ultrasound and the circle on 
the right is after ultrasound application. Bright red areas represent cell viability of 90-

















Figure 9.19 Effects of ultrasound on SK Hep-1 cells in the presence of 
microbubbles. Cells were sonicated with an ultrasound wave of 2.54 W / cm2 
intensity, for 1 min with either 100 µl (a) or 300 µl (b) of microbubbles. Each large 
circle represents the area where ultrasound was applied. The circle on the left is 
before ultrasound and the circle on the right is after ultrasound application. Bright 
red areas represent cell viability of 90-100 %, whereas bright blue areas represent 
cell viability of 0-10%.   
 














Figure 9.20 Effects of ultrasound on SK Hep-1 cells in the presence of 
microbubbles. Cells were sonicated with an ultrasound wave of 2.54 W / cm2 
intensity, for 3 min with either 100 µl (a) or 300 µl (b) of microbubbles. Each large 
circle represents the area where ultrasound was applied. The circle on the left is 
before ultrasound and the circle on the right is after ultrasound application. Bright 
red areas represent cell viability of 90-100 %, whereas bright blue areas represent 
cell viability of 0-10%.   
 














Figure 9.21 Effects of ultrasound on SK Hep-1 cells in the presence of 
microbubbles 24 hours after insonation. Cells were sonicated with an ultrasound 
wave of 2.54 W / cm2 intensity, for 1 min with either 100 µl (a) or 300 µl (b) of 
microbubbles. Each large circle represents the area where ultrasound was applied. 
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9.2.2.3 Sonoporation in the presence of Definity® microbubbles 
9.2.2.3.1 Cell impermeable Calcein 
 Completion of initial experiments led to establishing a number of 
parameters necessary for achieving sonoporation. SK Hep-1 cells were 
therefore seeded in OptiCells™ and were sonicated for 2-3 sec with 
ultrasound waves of 2.54 W / cm2 intensity in the presence of 100 µl of 
Definity® microbubbles. Two different concentrations of pCS2 plasmid (0.1, 
0.3 µg / ml) were used in order to demonstrate occurrence of sonoporation. 
Successful sonoporation would allow the pCS2 plasmid to enter the 
cytoplasm and express EGFP, a green fluorescent protein. Expression of 
EGFP was examined 24 hours later, via electron fluorescence microscopy 
(Exp. 5). The results from this experiment suggested that sonoporation had 
not taken place. A possible explanation could be that sonoporation had taken 
place but the size of the pores formed, were too small for the plasmid to pass 
through. To determine if this was the case, cells were transfected with a 
transfection agent (ExGen 500) with the same amounts of pCS2. Although 
transfection uses a completely different pathway for attaining DNA entry in 
to the cells, the purpose of this experiment was to demonstrate that the 
quantities of DNA used for sonoporation experiments were capable of 
expressing EGFP once in the cell cytoplasm and could be detected. Increasing 
amounts of pCS2 plasmid during transfection showed to be correlated with 
increasing transfection rates. As can be seen from figure 9.22, the highest 
transfection rate (52.25 %) is achieved with the use of 1.5 µg / ml of pCS2. 
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Figure 9.22 Transfection efficiencies in the presence of ExGen 500. SK Hep-1 
cells were transfected with pCS2 plasmid in the presence of varying amounts of 
ExGen 500. Transfection efficiency was evaluated with EGFP fluorescence, which 
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However, since the total amount of media in an OptiCell™ is 10 ml, an 
immense quantity of pCS2 plasmid would be required for the sonoporation 
experiments. Since smaller amounts of pCS2 plasmid (0.3 µg / ml) also 
resulted in successful transfection, it was decided to carry out sonoporation 
experiments with the smallest amount of pCS2 possible (0.1 and 0.3 µg / ml). 
In addition, it was thought that low rates of sonoporation would be difficult 
to detect using a fluorescence microscope, therefore subsequent experiments 
were examined via flow cytometry.  
 Sonoporation has been shown to form transient pores with an upper 
size limit of 75 nm for nanospheres and 464 kDa for dextran (Mehier-
Humbert, Bettinger et al. 2005a). It was therefore hypothesised that the lack 
of EGFP expression during sonoporation experiments was due to the size of 
pores being smaller than the size of the pCS2 plasmid (149 kDa). In addition, 
it has been shown that there is an inverse correlation between the size of a 
molecule and its cellular uptake (Mehier-Humbert, Bettinger et al. 2005a).  
Thus, even if plasma membrane permeability was increased, only a small 
number of larger molecules would pass through the plasma membrane, 
which would be very hard to detect. In order to verify this hypothesis, 
sonoporation experiments were performed in the presence of cell 
impermeable Calcein, a much smaller molecule of 623 kDa (d=1.2 nm) (Exp. 
6).  Flow cytometry data, shown in figure 9.23, show that sonoporation was 
achieved during sonication of SK Hep-1 cells in the presence of several 
different concentrations of Definity® microbubbles. Statistical analysis (one-
way ANOVA, p=0.001, n=3) of the data revealed that there is a significant 
difference between all the samples. In addition, the samples with the highest 
amounts of microbubbles (300 µl, 600 µl & 900 µl) were significantly different 
from controls (student’s t-test, p=0.001 (300µl), p=0.007 (600µl), p=0.004 
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(900µl), n=3), whereas the lowest amount of microbubbles used (5 µl) was 
not significantly different from the controls (student’s test, p=0.5, n=3). As 
can be seen from figure 9.24, maximum sonoporation (8.37 % efficiency) was 
achieved in the presence of 900 µl of Definity® microbubbles, which 
corresponds to a cell to bubble ratio of 1 in 5400. Nevertheless, lower 













Figure 9.23 Sonoporation in the presence of cell impermeable Calcein.  
Representation of data collected via flow cytometry, during application of ultrasound 
(a) & (b). Cells were fed through a flow cytometer and emission of Calcein (green) 
and PI (red) fluorescence were detected. A 2D histogram was plotted with the x- axis 
(FL1-H) representing the Calcein fluorescence and the y-axis (FL2-H) representing 
the PI fluorescence. The histogram can thus be divided into 4 quadrants with 4 
distinct populations. The lower left (LL) quad is Calcein and PI negative, i.e. cells are 
alive but have not been sonoporated. The Upper left (UL) quad is Calcein negative 
and PI positive, i.e. cells are dead and were not sonoporated. The lower right (LR) 
quad is Calcein positive and PI negative, i.e. cells were sonoporated and are still alive. 
The upper right (UR) quad is Calcein and PI positive, i.e. cells were sonoporated but 
died. A total of 100,000 cells were examined per sample and the statistics for each 






Quad Events % Gated % Total
UL 3195 3.19 2.97
UR 95 0.10 0.09
LL 90171 90.17 83.76





Quad Events % Gated % Total
UL 2954 2.95 2.71
UR 58 0.06 0.05
LL 92934 92.93 85.26
LR 4054 4.05 3.72
(c) (d) 






Figure 9.24 Sonoporation in the presence of cell impermeable Calcein. (a) Ultrasound was applied at a nominal intensity of 2.54 W / 
cm2 for 2-3 secs, in the presence of 5 µl (sample1), 300 µl (sample 2), 600µl (sample3) & 900 µl (sample 4) of Definity® microbubbles (1.2 
x 1010 / ml), in order to detect attainment of sonoporation. After sonoporation cells underwent flow cytometry, where the presence of 
Calcein and viability of cells were assessed. Successful sonoporation should lead to transport of Calcein into the cytoplasm of a viable cell 
(yellow bars). Control 1= no treatment, control 2 = only Calcein, control 3 = 5 µl of Definity® microbubbles and Calcein, control 4= 










































































































9.2.2.3.2 EGFP expression in SK Hep-1 cells 
 Detection of cell impermeable Calcein in the cell cytoplasm 
confirmed the hypothesis that under the specific ultrasonic conditions used 
in this study, sonoporation had taken place. As mentioned previously a 
possible explanation for the absence of EGFP expression could be the large 
size of pCS2 plasmid. It was therefore hypothesised that linearization of 
pCS2 plasmid would decrease its 3D size enabling it to pass through the 
pores formed during insonation (Exp. 7). In the experiments in the previous 
section sufficient sonoporation was achieved with as low as 300 µl of 
Definity® microbubbles. It was decided to use only this amount of Definity® 
for subsequent experiments for two reasons. Firstly, the cell to bubble ratio 
with such an amount was 1 in 1800, which is closer to those reported in other 
studies. Secondly, each vial of Definity® contained 3 ml, thus it was 
important to use it economically. Samples were placed in an incubator 
following insonation and were examined 24 hours later. However, no 
expression of EGFP was detected during these experiments. During 
transfection experiments with transfection reagents, it is common practise to 
use serum free media. It has been reported that serum interferes with DNA-
cell interaction by binding to the transfection reagent-DNA complexes 
(Nchinda, Überla et al. 2002). It was therefore hypothesised that the serum 
present in the cell media could also inhibit uptake of pCS2 plasmid during 
sonoporation. The sonoporation experiments were repeated in the absence of 
serum, as described in section 9.2.2.3.1  and expression of EGFP was detected 
as shown in figure 9.25-9.26 (Exp. 8).  
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Figure 9.25 Sonoporation in the presence of linearised pCS2. Representation of 
data collected via flow cytometry, during application of ultrasound (a) & (b). Cells 
were fed through a flow cytometer and emission of Calcein (green) and PI (red) 
fluorescence were detected. A 2D histogram was plotted with the x- axis (FL1-H) 
representing the Calcein fluorescence and the y-axis (FL2-H) representing the PI 
fluorescence. The histogram can thus be divided into 4 quadrants with 4 distinct 
populations. The lower left (LL) quad is Calcein and PI negative, i.e. cells are alive 
but have not been sonoporated. The Upper left (UL) quad is Calcein negative and PI 
positive, i.e. cells are dead and were not sonoporated. The lower right (LR) quad is 
Calcein positive and PI negative, i.e. cells were sonoporated and are still alive. The 
upper right (UR) quad is Calcein and PI positive, i.e. cells were sonoporated but 
died. A total of 100,000 cells were examined per sample and the statistics for each 





Quad Events % Gated % Total
UL 10979 10.98 9.93
UR 49 0.05 0.04
LL 86731 86.73 78.44





Quad Events % Gated % Total
UL 7447 7.45 6.80
UR 41 0.04 0.04
LL 90651 90.65 82.81











Figure 9.26 Sonoporation in the presence of linearised pCS2. Ultrasound was applied at a nominal intensity of 2.54 W / cm2 for 2-3 
secs, in the presence of 300 µl of (1.2 x 1010 / ml) Definity® microbubbles, in order to detect attainment of sonoporation. After 
sonoporation cells underwent flow cytometry, where the presence of Calcein and viability of cells were assessed. Successful sonoporation 
should lead to transport and expression of DNA into the cytoplasm of a viable cell (yellow bars).  Control = no treatment. The last three 
samples have been magnified (b) so as to be able to see all 4 columns corresponding to each sample.  
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9.2.2.3.3 Pore size formation during sonoporation 
Previous studies have shown that the pores formed during 
sonoporation have an upper limit of 75 nm yet with the molecular size being 
inversely proportional to the rate of their uptake (Mehier-Humbert, Bettinger 
et al. 2005a). In order to confirm the upper size limit of the pores formed 
during the sonoporation experiments of this study, EGFP, which is 4.2 nm in 
length and 2.4 nm in diameter, was added into the culture medium (Exp. 9) 
(Pawley 2006). A range of EGFP concentrations (final concentration 70 µM, 
700 µM & 700 mM) were investigated in the presence of 300 µl of Definity® 
microbubbles. No EGFP was detected in the cells after insonation, suggesting 
that the pores formed during sonoporation were not large enough for the 
protein to pass through. 
 
9.2.2.3.4 Sonoporation of different cell lines  
Sonoporation experiments were repeated with two other cell lines 
(ACHN (human renal adenocarcinoma) & HUH7 (human hepatic carcinoma) 
in the presence of Definity® microbubbles, as previously described in section 
9.2.2.3.2. The purpose of these experiments was to establish whether 
sonoporation efficiency was affected by the use of different cell lines (Exp. 
10). As can be seen in figures 9.27-9.28 sonoporation was not achieved. 
However, a decrease in cell viability is observed after cell insonation. 
Statistical analysis (student’s t test, p=0.00004 (ACHN), p=0.0001 (HUH7), 
n=3) of the data confirmed that there is a significant difference between 
insonated and non-insonated samples for both ACHN and HUH7 cells lines. 
Figure 9.29 shows the effect of ultrasound on cell viability for all three cell 
lines examined in this study, under identical experimental conditions. 
Statistical analysis (one-way ANOVA, p=0.0002, n=3) confirmed that there is 
a significant difference in cell viability amongst the three cells lines used in 
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this study.  
 
9.2.2.4 Sonoporation in the presence of in-house microbubbles 
 Since the parameters necessary for sonoporation were established with 
the aid of Definity® microbubbles, sonoporation in the presence of in-house 
microbubbles was subsequently investigated. A range of in-house 
microbubble volumes were investigated leading to cell-bubble ratios of 1:300, 
1:600, 1:1000, and 1:2000 (Exp. 11). Cells were insonated with acoustic 
parameters identical to those used for achieving sonoporation in the presence 
of cell impermeable Calcein (section 9.2.2.3.1). The results shown in figure 














Figure 9.27 Effects of “physiotherapy machine “on ACHN & HUH7 cell lines in 
the presence of Definity® microbubbles and linearised pCS2. Representation of 
data collected via flow cytometry, during application of ultrasound (a) & (b). Cells 
were fed through a flow cytometer and emission of Calcein (green) and PI (red) 
fluorescence were detected. A 2D histogram was plotted with the x- axis (FL1-H) 
representing the Calcein fluorescence and the y-axis (FL2-H) representing the PI 
fluorescence. The histogram can thus be divided into 4 quadrants with 4 distinct 
populations. The lower left (LL) quad is Calcein and PI negative, i.e. cells are alive 
but have not been sonoporated. The Upper left (UL) quad is Calcein negative and PI 
positive, i.e. cells are dead and were not sonoporated. The lower right (LR) quad is 
Calcein positive and PI negative, i.e. cells were sonoporated and are still alive. The 
upper right (UR) quad is Calcein and PI positive, i.e. cells were sonoporated but 
died. A total of 100,000 cells were examined per sample and the statistics for each 







Quad Events % Gated % Total
UL 24750 48.83 27.49
UR 4 0.01 0.00
LL 25925 51.15 28.80





Quad Events % Gated % Total
UL 27026 67.26 50.70
UR 12 0.03 0.02
LL 13116 32.64 24.60
LR 28 0.07 0.05
(a) 
(c) 
UL UR UL UR 




Figure 9.28 Effects of “physiotherapy machine” on ACHN & HUH7 cell lines in 
the presence of Definity® microbubbles and linearised pCS2. An experiment 
was conducted with ACHN and HUH7 cells, using identical conditions as those used 
for achieving sonoporation in SK Hep-1 cells. Ultrasound was applied to ACHN and 
HUH7 cells, at a nominal intensity of 2.54 W / cm2 for 2-3 secs, in the presence of 
300 µl of (1.2 x 1010 / ml) Definity® microbubbles, control = no treatment (n=1). 
Although no sonoporation was detected, this graph shows the effect of sonication on 
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Figure 9.29 Effects of “physiotherapy machine” on ACHN, HUH7 & SK Hep-1 
cell lines in the presence of linearised pCS2. All three cells lines were treated 
under identical conditions in order to achieve sonoporation. Ultrasound was applied 
at a nominal intensity of 2.54 W / cm2 for 2-3 secs, in the presence of 300 µl of (1.2 
x 1010 / ml) Definity® microbubbles. The graph presents the effect of sonication on 

































Figure 9.30 Effects of “physiotherapy machine” in the presence of in-house 
microbubbles and cell impermeable Calcein. Cells were treated in the presence 
of in-house microbubbles with identical conditions to those used to achieve 
sonoporation in the presence of Definity® microbubbles. Ultrasound was applied at 
a nominal intensity of 2.54 W / cm2 for 2-3 secs, in the presence of 0.9 ml (sample 
1), 1.8 ml (sample 2), 8 ml (sample 3) & 5.97 ml (sample 4) of in-house 
microbubbles (6.7 x 108 / ml). Control 1= no treatment, control 2 = only Calcein, 
control 3 = ultrasound and Calcein. In the presence of in-house microbubbles no 
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9.2.3 Ultrasound scanner experiments  
9.2.3.1 EGFP expression in SK Hep-1 cells 
A set of experiments were performed in order to achieve sonoporation 
with the aid of the ultrasound scanner. Since the acoustic parameters used in 
these experiments in comparison with those performed with the 
“physiotherapy machine “were different, a range of Definity® microbubbles, 
MIs and DNA plasmid concentrations were investigated (Exp. 12). Therefore, 
cells were insonated with ultrasound wave of MI 0.2-0.5-1.1, in the presence 
of a range of concentrations of linearised pCS2 plasmid (0.1µg / ml, 1 µg / ml 
& 5 µg / ml) and two different amounts of Definity® microbubbles (100 µl 
and 300 µl). In addition, cells were insonated in the presence / absence of 
serum for the reasons described in section 9.2.2.3.2. Furthermore, since the 
ultrasound wave produced by the scanner is of a much lower pressure ( peak 
to peak pressure 0.3 MPa) than that produced by the “physiotherapy 
machine “(peak to peak pressure 3 MPa), the duration of insonation was 
increased to 10 secs. The probe was held at a 90° angle, while being moved 
0.5 cm across the OptiCell™ and then moved 0.5 cm downwards, thus 
swiping the entire surface of the OptiCell™ (figure 9.31). Following 
sonication, samples were placed in an incubator and examined 24 hours later 
by flow cytometry. Results from these experiments suggested that 
sonoporation had not taken place. It was therefore hypothesised that cells 
might require more time in order to express EGFP. Therefore, experiments 
were repeated and samples were examined 48 hours after insonation, 
however, no EGFP expression was detected (Exp. 13). A possible explanation 
for this could be that a higher concentration of DNA was necessary in order 
for sufficient amounts of EGFP to be detected. Therefore, subsequent 
experiments were performed with increased amounts of linearised pCS2 
plasmid (20, 30 µg / ml) (Exp. 14). Results from these experiments, collected 
 203 
24 and 48 hours after insonation, showed no EGFP expression. Even when 
the MI was further increased to 1.3, no EGFP expression was detected.  
 Microbubble concentration could be another possible factor limiting 
sonoporation. Therefore, experiments were repeated with increased amounts 
of Definity® microbubbles (1 ml) in the presence of 20 µg of pCS2 plasmid 
(Exp. 15). Cells were insonated with ultrasound of MI=1.3. During these 
experiments, it was observed that addition of such large amounts of 
microbubbles formed a white layer above the cells.  
 All the experiments in this study, up to this point, were performed 
with cells grown in a monolayer fashion, as this best reflects the way cells are 
organised in tissues within the human body. It was thus decided to 
investigate the possibility of sonoporation for both adherent and suspension 
in cells. Therefore, sonoporation experiments were repeated as described 
earlier in this section, while 24 hours after insonation both adherent and in 
suspension cells were collected for analysis (Exp. 16). Although no 
expression of EGFP was detected during these experiments, viability of cells 
in suspension following insonation was observed to be lower than that of 
adherent cells (figure 9.32). Statistical analysis (student’s t-test, p=0.0002, n=4) 
of the data confirmed a significant difference between adherent cells and 








Figure 9.31 Representation of movement of ultrasound transducer P4-2 during 
sonoporation experiments in the presence of pCS2 plasmid. Sonoporation 
experiments were conducted with the ultrasound scanner HDI 3500. The probe of 
the P4-2 transducer was held at a 37º angle, while being moved 0.5 cm across the 
OptiCell™ and then moved 0.5 cm downwards and again 0.5 cm across, thus 
swiping the entire surface of the OptiCell™. Cells were insonated for 10 secs at 
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Figure 9.32 Effects of different culture methods on cell viability. SK Hep-1 cells 
were grown both in a monolayer fashion and in suspension. Each culturing method 
was then insonated under identical acoustic conditions in order to determine any 
differences in cell viability. Ultrasound was applied at an MI=1.3 for 10 secs, in the 






































 9.2.3.2 Cell impermeable Calcein 
Although the experiments described in the previous section, did not 
reveal any EGFP expression that did not eliminate the possibility of 
sonoporation taking place. It was thus, hypothesised that if under the specific 
acoustic parameters used in the experiments with the ultrasound scanner 
sonoporation efficiency was very low, then EGFP expression, which depends 
largely on passage of the DNA plasmid through the plasma membrane, 
would also be compromised. In order to test this hypothesis, experiments 
investigating sonoporation in the presence of cell impermeable Calcein were 
carried out (Exp. 17). Cells were insonated with ultrasound wave of MI=1.3 
in the presence of a range of Definity® microbubble concentrations, identical 
to those used during similar experiments with the use of “physiotherapy 
machine “(section 9.2.2.3.1). Statistical analysis (student’s t test, p=0.07 (5 µl), 
p=0.0006 (300µl), p=0.06 (600µl), n=3) for the data collected revealed that 
there is no significant difference between control samples and samples 
containing 5 µl or 600 µl of Definity® microbubbles, yet there is a significant 
difference between control samples and 300 µl microbubble sample. Thus it 
can be deduced that with the experimental conditions used, sonoporation 
was achieved in the presence of Definity® microbubbles (figure 9.33).  As can 
be seen from figure 9.34 the maximum sonoporation efficiency obtained was 
1.13 %. This was much lower to that obtained with the use of the 
“physiotherapy machine “under similar conditions (8.37 %). 
    
 
 





Figure 9.33 Sonoporation of SK Hep-1 cells with the aid of an ultrasound 
scanner in the presence of Definity® microbubbles. Representation of data 
collected via flow cytometry, during application of ultrasound (a) & (b). Cells were 
fed through a flow cytometer and emission of Calcein (green) and PI (red) 
fluorescence were detected. A 2D histogram was plotted with the x- axis (FL1-H) 
representing the Calcein fluorescence and the y-axis (FL2-H) representing the PI 
fluorescence. The histogram can thus be divided into 4 quadrants with 4 distinct 
populations. The lower left (LL) quad is Calcein and PI negative, i.e. cells are alive 
but have not been sonoporated. The Upper left (UL) quad is Calcein negative and PI 
positive, i.e. cells are dead and were not sonoporated. The lower right (LR) quad is 
Calcein positive and PI negative, i.e. cells were sonoporated and are still alive. The 
upper right (UR) quad is Calcein and PI positive, i.e. cells were sonoporated but 
died. A total of 100,000 cells were examined per sample and the statistics for each 





Quad Events % Gated % Total
UL 3466 3.47 3.26
UR 5 0.01 0.00
LL 95399 95.40 89.83





Quad Events % Gated % Total
UL 8104 16.21 15.38
UR 18 0.04 0.03
LL 41337 82.67 78.44









Figure 9.34 Sonoporation of SK Hep-1 cells with the aid of an ultrasound scanner in the presence of Definity® microbubbles. 
Ultrasound was applied for 2-3 secs, in the presence of 5 µl (sample 1), 300 µl (sample 2), & 600 µl (sample 3) of (1.2 x 1010 / ml) 
Definity® microbubbles, in order to detect attainment of sonoporation. After sonoporation cells underwent flow cytometry, where the 
presence of Calcein and viability of cells were assessed. Successful sonoporation should lead to transport of Calcein into the cytoplasm of 
a viable cell (yellow bars).  Control 1= no treatment, control 2 = only Calcein, control 3 = ultrasound and Calcein. Samples 1-3 have been 
magnified (b) so as to be able to see all 4 columns corresponding to each sample. 


















































9.3.1 Measurements of the ultrasound field 
This section of the study focused on the investigation of ultrasound 
induced sonoporation. Initial experiments involved determining the exact 
acoustic field applied on the cells of interest. As mentioned previously, the 
nominal and actual values of an ultrasound apparatus can different 
significantly. In addition, it is vital to verify the elimination of any secondary 
acoustic forces, such as backscattering and standard waves, since they are not 
present in vivo (Kinoshita and Hynynen 2007). While examining the 
acoustical output of the “physiotherapy machine”, it was concluded that the 
nominal and actual values of this machine differ significantly (figure 9.4). 
Therefore, at 1 MHz for nominal intensity of 0.5 W / cm2, the actual intensity 
of the ultrasound wave is 0.97 W / cm2, while for nominal intensity of 2.5 W / 
cm2, the actual intensity is 4.20 W / cm2, which is almost double the nominal 
value.  It is therefore necessary to take into consideration the discrepancies 
between nominal and actual values when carrying out experiments with this 
machine, in order to be able to accurately define the ultrasound wave 
received by the samples. In addition, such measurements are valuable when 
required to replicate experiments performed with this machine, with other 
ultrasound apparatuses.  
The use of different sonoporation apparatuses necessitated the 
investigation of the acoustic field created by each apparatus. Thus, 
experiments were conducted to accurately calibrate the acoustic pressure and 
intensity of the ultrasound wave emitted towards the cells of interest. The 
results confirmed that (a) the experimental set up used (OptiCells™) are 
acoustically transparent, thus eliminating the possibility of any backscatter or 
standing waves (figure 9.6) and (b) the acoustic parameters used with the 
ultrasound scanner, which correspond to the mechanical index (MI), did not 
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affect cell viability (figure 9.10). These results, suggest that the likelihood of 
any adverse bioeffects on cells is minimal. 
 
9.3.2 “Physiotherapy machine” experiments 
9.3.2.1 Investigation of non acoustic parameters 
Investigation of ultrasound induced sonoporation was initially 
conducted with the aid of a “physiotherapy machine”. Non acoustic 
parameters such as optimal cell concentration and potential microbubble 
toxicity were investigated. The optimal cell concentration was established at 
2 x 105 cells / ml (figure 9.11). In addition, it was shown that the presence of 
in-house microbubbles, regardless of the solution used (saline or PBS), was 
not toxic to cells. 
 
9.3.2.2 Investigation of acoustic parameters 
Further experiments were geared towards designing a set up that 
would allow sonication of cells with negligible interference. Cell viability 
was examined upon sonication of cells seeded on Petri dishes. The results 
suggest that cell viability is inversely proportional to intensity of ultrasound 
(figure 9.14).  Although previous reports claim that the use of a Petri dish 
allows for most of the ultrasound wave to pass through  (Wu, Ross et al. 2002; 
Zhou, Shi et al. 2008), the large extent of cell death observed in this 
experiment was believed to be due to the presence of backscatter waves. 
When the transmitted ultrasound wave passed through the base of the Petri 
dish, a fraction of this wave would be reflected back towards the cells, due to 
the large discrepancy between the acoustic impedances of the Petri dish and 
the air. In addition, because of the proximity of the transducer to the cells 
(~0.5 cm), the ultrasound wave would not have travelled enough distance to 
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become attenuated, thus the possibility of the formation of strong backscatter 
was high. 
In order to minimise the formation of such strong backscatter, a new 
setup was devised, that involved seeding cells in OptiCells™ and placing 
them in a specially designed ultrasound tank. The setup was designed is 
such a way so as to eliminate any backscatter, by adding an acoustic absorber 
at the bottom of the tank. In addition, the ultrasound transducer was held at 
an angle so that any backscatter still present was redirected away from the 
cells (figure 9.17). Application of under these experimental conditions 
showed reduced bioeffects compared to those observed with the use of Petri 
dishes (figure 9.15). It was thus concluded that backscatter waves present at 
the Petri dish set up were eliminated with the use of OptiCells™ and the 
ultrasound tank. Since no bioeffects were observed under these conditions, 
further experiments were conducted with increased levels of ultrasound 
intensity. Ultrasound was applied for different time periods in the presence 
of different Definity® concentrations (figures 9.19-9.20). The results 
suggested that there was no significant difference between the difference 
concentrations of microbubbles or the amount of time ultrasound was 
applied. Although it is anticipated that longer periods of ultrasound 
application would lead to higher sonoporation efficiency rates, the possibility 
of adverse bioeffects would also be great (Pan, Zhou et al. 2005). The 
duration of ultrasound in studies that have reported sonoporation varies 
immensely as do so many other parameters. There are studies that have 
reported sonoporation with application of ultrasound as little as 0.5 sec 
(Deng, Sieling et al. 2004), while other studies have insonated their samples 
for up to 7 min (Wu, Ross et al. 2002). A study investigating the effect of 
increasing times of insonation on sonoporation efficiency, reported an initial 
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increase in transfection efficiency followed by a decrease for longer  exposure 
of up to 16 sec (Zarnitsyn and Prausnitz 2004). Since several studies have 
reported sonoporation with short insonation periods, and in order to 
minimise the likelihood of any bioeffects, ultrasound application in 
sonoporation experiments was kept to a minimum of 2-3 sec in the presence 
of 100 µl of Definity® microbubbles (Liang, Lu et al. 2004; Rahim, Taylor et al. 
2006a; Van Wamel, Kooiman et al. 2006b). 
 
9.3.2.3 Sonoporation in the presence of Definity® microbubbles 
Once the initial parameters for sonoporation were established, further 
experiments were conducted in order to achieve ultrasound induced 
sonoporation and the subsequent expression of EGFP fluorescent protein. 
Cells were sonicated in the presence of Definity® microbubbles and pCS2 
plasmid. Successful sonoporation would lead to diffusion of the DNA 
molecule into the cells, following expression of the EGFP. Initial results 
suggested that EGFP had not been expressed. However, this did not exclude 
the incidence of sonoporation. Two possibilities existed: (a) the pores formed 
during sonoporation were too small for the DNA molecule to pass through 
or (b) the amount of DNA used for not sufficient to exhibit detectable 
amounts of EGFP. 
 
9.3.2.3.1 Cell impermeable Calcein 
In order to eliminate the second possibility, similar quantities of DNA 
were used to transfect SK Hep-1 cells with a transfection agent (ExGen 500). 
Although the mechanism underlying such a transfection is different to that of 
sonoporation, this experiment was performed purely to demonstrate that the 
amounts of DNA used during sonoporation experiments could potentially 
express detectable levels of EGFP. Results from this experiment suggested 
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that the amounts used during sonoporation experiments were able to express 
detectable levels of EGFP (figure 9.22). Having eliminated one of the two 
possibilities, it was deduced that the lack of EGFP expression was due to the 
small size of perforations formed during sonoporation. This possibility was 
then examined by applying the same sonication parameters in the presence 
of a small fluorescent molecule (Calcein). Since Calcein is impermeable to 
plasma membranes, its transport into the cytoplasm would be a direct effect 
of sonoporation. Results suggested that sonoporation in the presence of cell 
impermeable Calcein was achieved with maximum sonoporation efficiency 
at 8.37 % (figure 9.24).  
Comparing sonoporation efficiencies between studies is complex, 
since acoustic parameters and contrast agents used vary significantly from 
one study to another (Kinoshita and Hynynen 2007). There are studies that 
claim sonoporation was achieved at an efficiency of 4 % (Rahim, Taylor et al. 
2006b) and others at an efficiency of 67 % (Van Wamel, Kooiman et al. 2006b). 
A large discrepancy in the cell viability documented, can also be identified 
(Kinoshita and Hynynen 2007). Such inconsistencies in the efficiency rates of 
sonoporation are anticipated, since sonoporation is dependent on several 
factors, both acoustic and non-acoustic. Non-acoustic parameters include the 
cell to bubble ratio, the culture method of cells (monolayer or suspension), 
whereas acoustic parameters include the power, frequency and duration of 
the ultrasound beam and the transmittance of the beam through the sample 
cells with minimum reflective effects (i.e. backscatter and standing waves).  
 A study investigating the importance of standing waves in 
sonoporation, reported that in the absence of standing waves, sonoporation 
efficiency rates were decreased in comparison to set ups where standing 
waves were present (Kinoshita and Hynynen 2007). The efficiency rates of 
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sonoporation in the absence of standing waves are similar to those achieved 
in this study. In the same study, cell viability was reported to be higher in the 
absence of standing waves. A possible explanation for the low sonoporation 
efficiency rate observed can be due to the elimination of standing waves. 
Although Kinoshita et al. (2007), suggest that standing waves are necessary 
for achieving “a satisfactory amount” of sonoporation, it can be argued that 
standing waves rarely occur in the human body, therefore experimental set 
ups that minimise the possibility of standing waves, such as in this study, are 
more realistic and valuable for clinical use.   
 
9.3.2.3.2 EGFP expression in SK Hep-1 cells 
As mentioned earlier, successful sonoporation in the presence of 
Calcein signified that EGFP had not been previously expressed due to the 
small size of the pores formed during sonoporation. It was thus linearisation 
of the DNA plasmid further validate this theory. In addition, serum free 
medium was used, as reports have suggested that serum can inhibit DNA-
cell interactions (Nchinda, Überla et al. 2002). Indeed, EGFP was detected 
upon sonication of SK Hep-1 cells in the presence of Definity® microbubbles 
and pCS2 plasmid (figure 9.26).  
Although sonoporation was achieved, the efficiency was lower (2 %) 
compared to that observed with the use of Calcein under the same conditions 
(4.97 %) (figures 9.24 & 9.26 respectively). Zarnitsyn et al. (2004) also 
reported similar findings, where under identical conditions; sonoporation 
efficiency was lower when measuring gene expression of DNA plasmid than 
when adding fluorescent molecules. A possible explanation could be the 
number of obstacles that DNA plasmid has to endure once it enters the cell 
cytoplasm until it reaches the nucleus, where it can initiate expression of the 
proteins it encodes. Once in the cytoplasm the plasmid would be taken up by 
 215 
lysosomes for degradation (Khalil, Kogure et al. 2006). The next hurdle it has 
to overcome is the nuclear membrane, which contains nuclear pores, which 
in turn allow for passive diffusion of molecules up to 70 kDa (Khalil, Kogure 
et al. 2006). It is believed that DNA plasmid, which would not normally be 
able to pass through the nuclear pores, passes through it during mitosis, 
when permeability of nuclear membrane is compromised (Khalil, Kogure et 
al. 2006). However, under normal conditions, the cycles of cells within a cell 
culture are not synchronized, thus not all cells would have compromised 
nuclear membranes that would allow the DNA plasmid to be expressed. 
Another possible explanation for the difference in sonoporation efficiencies 
observed could be the degradation of DNA during insonation (Zarnitsyn and 
Prausnitz 2004). Miller et al. (2009) demonstrated that sonoporation activates 
apoptotic pathways, thus altering gene expression levels. This could provide 
a third possible explanation for the observations seen in this study. Therefore, 
although EGFP expression is an established method of accessing 
sonoporation efficiency, there are additional factors which may affect its 
expression which are not directly related to sonoporation.   
 
9.3.2.3.3 Pore size formation during sonoporation 
 Although sonoporation and EGFP expression was achieved, the issue 
of pore size had come to the surface. The experiments conducted so far 
suggested that EGFP was too large to pass through the pores from during 
sonoporation, whereas Calcein and linearised DNA were small enough to 
passively diffuse through. An attempt was made to determine the upper size 
limit of the pores formed during sonoporation, by sonicating SK Hep-1 cells 
in the presence of EGFP. As EGFP was not detected in the cytoplasm of 
sonoporated cells, this suggests that the pores formed during sonoporation 
have an upper size limit of 2.4 nm. However this was much smaller than that 
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previously reported (Mehier-Humbert, Bettinger et al. 2005a). There are 
several possible explanations for such a finding. Firstly, since sonoporation 
has been shown to occur due to the mechanical stress applied by the 
microbubbles on to the cell membrane (Van Wamel, Kooiman et al. 2006b), 
then it can be hypothesised that microbubbles of different physical 
parameters, such as size and compressibility, would exert different amounts 
of mechanical pressure. The pore size in the presence of Definity® 
microbubbles has not been investigated until now. Secondly, cell viability 
during insonation is different for distinct cell lines, i.e. there is a discrepancy 
amongst levels of cell toxicity during sonoporation by ultrasound among cell 
types (Kinoshita and Hynynen 2007). Although not proven in this study, it 
can be postulated, that the cell line used in this study (SK Hep-1) can only 
repair small sized perforations, whereas larger ones lead to cell death. This 
would explain, the passage / transport of smaller but not larger molecules 
through the plasma membrane, during this study.  
 
9.3.2.3.4 Sonoporation of different cell lines 
An important part of this investigation was to construct a setup that 
would achieve ultrasound induced sonoporation. Ideally, one would be able 
to use this setup to achieve sonoporation across a range of different cell lines. 
An attempt was therefore made to demonstrate the usability of this setup 
across a range of cell lines, by performing sonoporation experiments with 
ACHN and HUH7 cell lines. The results from these experiments suggest that 
sonoporation did not take place (figure 9.27). Nevertheless, they provide 
useful information. Careful comparison between all three cell lines used in 
this study (SK Hep-1, ACHN and HUH7) illustrates a significant difference 
in cell viability during insonation between each cell line used (figure 9.29). A 
possible explanation for this outcome is the fact that each distinct cell type is 
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portrayed by different characteristics, such as cell size and cell membrane 
structure, thus increasing the possibility of different response to cavitational 
effects and hence sonoporation efficiencies (Wang, Liu et al. 2009). 
 
9.3.2.3.5 Sonoporation in the presence of in-house microbubbles 
Further experiments were directed towards establishing sonoporation 
in the presence of in-house microbubbles. Since sonoporation was 
established in the presence of Definity® microbubbles, it should be possible 
to achieve sonoporation in the presence of in-house microbubbles. However, 
the data collected suggest that sonoporation was not achieved under these 
experimental conditions (figure 9.30). The only difference between this 
experiment and previous ones where successful sonoporation was reported 
with the aid of the physiotherapy machine was the presence of different 
ultrasound contrast agent. As mentioned earlier in this chapter, sonoporation 
has been shown to be a result of cavitation and that in turn is dependent on a 
number of acoustical parameters, including the physical properties of the 
microbubbles. Since all acoustic parameters remained the same apart from 
the type of microbubbles employed, it can be deduced that the difference in 
the properties of the in-house microbubbles compared to those of the 
Definity® microbubbles are responsible for the lack of sonoporation. The 
mode of oscillation of microbubbles and thus their ability to cause 
sonoporation under specific ultrasonic conditions, is determined by a 
number of variables, including their size, contents and shell compressibility 
(Dawson 1999). Although it was shown earlier in this study that the size 
distribution of in-house microbubbles is comparable to that of commercially 
available ultrasound contrast agents, including Definity® (chapter 8), the 
contents of the in-house microbubbles differ to those of Definity®. While the 
former are most probably filled with aqueous solution (section 8.1.1), the 
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latter are filled with gas. In addition, only a limited amount of information is 
available on the characteristics of the Definity® microbubbles, while valuable 
information such as the composition of their shell are not been disclosed. 
Differences in the shell constituents of the microbubbles, could lead to 
differences in their compressibility, which could also explain the lack of 
sonoporation (Dawson 1999).   
In conclusion, several of the microbubble physical properties 
contribute to sonoporation. Although a number of possible explanations can 
be hypothesized, it was not possible to determine the basis for lack of 
sonoporation in the presence of in-house microbubbles. This was mainly 
because comparison between Definity® and in-house microbubble 
experiments was not feasible due to insufficient information of the 
commercial contrast agent used in this study. Further investigation of the 
parameters necessary to achieve sonoporation in the presence of in-house 
microbubbles would be required.  
 
9.3.3 Ultrasound scanner experiments 
9.3.3.1 EGFP expression in SK Hep-1 cells 
In contrast to physiotherapy machines that are used for therapeutic 
purposes, ultrasound scanners are used for diagnostic purposes. The latter 
operate at higher frequencies in order to provide an image with good axial 
resolution with minimal bioeffects (Miller 2007b). Thus ultrasound scanners 
are employed more frequently in clinics.  As a result, further experiments in 
this study were performed with an ultrasound scanner as this became 
available for use. Ultrasound induced sonoporation in the presence of 
Definity® microbubbles was investigated. However, since the acoustic 
parameters emitted from the ultrasound scanner differ immensely to those of 
the “physiotherapy machine”, further adjustments where necessary in order 
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to achieve sonoporation and subsequent EGFP expression. Several 
parameters were examined, including pCS2 and Definity® concentration. In 
retrospect, it was thought that increased amounts of microbubbles could 
attenuate the ultrasound beam, thus decreasing the likelihood of 
sonoporation. Indeed, it has been shown that high microbubble 
concentrations, reduce the microbubbles’ capacity to act upon adjacent cells, 
thus decreasing the likelihood of sonoporation (Guzmán, McNamara et al. 
2003). In addition, cells were allowed to recover for prolonged periods of 
time (24 & 48 hours), thus allowing sufficient time for expression of EGFP to 
take place. The data collected, however, suggested that sonoporation had not 
taken place. 
 
9.3.3.2 Effect of different culturing methods on sonoporation  
 Another parameter that differs between studies investigating 
sonoporation is the culture method of cells. Most studies use cells in 
suspension (Brayman, Coppage et al. 1999; Ward, Wu et al. 1999; Deng, 
Sieling et al. 2004; Mehier-Humbert, Bettinger et al. 2005a; Wu, Pepe et al. 
2006), while only a handful of studies, culture cells in a monolayer fashion 
(Duvshani-Eshet, Baruch et al. 2005; Rahim, Taylor et al. 2006b; Van Wamel, 
Kooiman et al. 2006b). In addition, it has been reported that sonoporation 
efficiency rates are the same, regardless of the cell culture method (Kinoshita 
and Hynynen 2007). Furthermore, cell viability was observed to be higher 
when cells were grown in a monolayer fashion (Kinoshita and Hynynen 
2007). Experiments conducted in this study with either culturing method 
(monolayer fashion or in suspension) did not result in sonoporation. These 
results agree with the findings of Kinoshita et al (2007), where under 
identical ultrasonic conditions, adherent cells have higher viability rates than 
cells in suspension (figure 9.32). 
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9.3.3.3 Cell impermeable Calcein 
Ultrasound contrast agents are known to oscillate in distinct modes 
depending on the frequency and the acoustic pressure applied (Dawson 1999; 
Chen, Zagzebski et al. 2002; Tang, Eckersley et al. 2005). In addition, a direct 
dependence between acoustic pressure and sonoporation has been 
demonstrated (Han, Ikegami et al. 2007). Such a large discrepancy among 
sonoporation efficiencies are therefore thought to be a consequence of the 
different parameters of the ultrasound beams generated by the ultrasound 
scanner and the “physiotherapy machine”. The acoustic parameters of the 
scanner differ significantly from those of the “physiotherapy machine”, 
leading to a different mode of oscillation of the Definity® microbubbles, thus 
effecting sonoporation efficiency rates. Due to this fact, it is possible that 
during insonation with the ultrasound scanner, EGFP expression is lower 
than that observed during insonation with the “physiotherapy machine”. 
Since experiments conducted with the “physiotherapy machine” in the 
presence of Calcein, resulted in sonoporation efficiency of 8.37 %, it was 
hypothesized that “under similar conditions”, employment of the ultrasound 
scanner might result in lower yet detectable sonoporation efficiencies.  
Indeed, the data collected show that during insonation from the ultrasound 
scanner, maximum sonoporation efficiency in the presence of Calcein was 
1.13 % (figure 9.34), which is much lower to that obtained with the use of the 
“physiotherapy machine “under similar conditions (8.37 %).  
 
9.4 Conclusion 
A vast number of experiments were conducted in this section in order 
to establish all the acoustic and non acoustic parameters necessary for 
achieving sonoporation. An experimental set up was developed where the 
acoustic field formed was accurately described by measuring all the acoustic 
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parameters involved. In addition, factors such as backscattering and standing 
waves were also taken into consideration. This is of particular importance as 
the majority of research performed in this area fails to accurately measure the 
acoustic field produced, thus providing inaccurate information and making 
it impossible to reproduce their results (Kinoshita and Hynynen 2007).  
Initial experiments in this study, were performed with a 
“physiotherapy machine”. A range of parameters were examined prior to 
achieving sonoporation, including cell and microbubble concentration, 
ultrasound time exposure and, acoustic pressure and intensity of ultrasound, 
different cell lines, different culturing methods, upper size limit of pores 
formed, transport of small molecules and DNA across plasma membrane 
and expression of the latter. Successful sonoporation was achieved in the 
presence of Definity® microbubbles under specific ultrasound conditions 
with the aid of the “physiotherapy machine”. Attempts were made to 
demonstrate sonoporation in the presence of in-house microbubbles under 
identical conditions, yet they were not successful. Although Definity® and 
in-house microbubbles are of similar composition and size; they also have 
other characteristics that can affect their ability to achieve sonoporation, such 
as their core contents. 
 Further experiments involved investigating sonoporation with the aid 
of an ultrasound scanner as this is more clinically relevant. Successful 
sonoporation was accomplished in the presence of Definity® microbubbles 
under specific ultrasound conditions with the aid of the ultrasound scanner 
HDI 3500. While the results obtained demonstrate the achievement of 
sonoporation, they do not provide an explanation as to why under identical 
experimental conditions, EGFP expression was no detected. It was, however, 
hypothesized that ultrasound application might act as a stressful stimulus 
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and thus affect gene expression in cells. Therefore, subsequent research 
focused on investigation of the cellular responses following ultrasound 
application. Upregulation of specific genes that reveal stressful conditions for 
the cells, were investigated, following insonation of identical parameters to 
those used for achieving sonoporation. Such information would assist in 
gaining a better understanding of the effects ultrasound has on cells and thus 













































10.1 Cell responses during insonation   
Heat shock proteins are involved in a multitude of vital cellular 
functions (Horvath, Multhoff et al. 2008). It is therefore not surprising that 
they contribute in the development of several human disorders. Heat shock 
proteins implement a protective role against stress stimuli that would 
otherwise lead to apoptosis (Santoro 2000).  
Application of ultrasound can result in a number of bioeffects, 
depending on the pressure and frequency of the ultrasound waves. 
Ultrasound bioeffects can be separated into two categories, mechanical and 
thermal (Cheng-Huang, Yeh et al. 2008). Insonation at low intensities exerts a 
mechanical stress on cells that brings about formation of perforations on the 
cell membrane (Blomley, Cooke et al. 2001; Sontag and Kruglikov 2009). 
However, certain ultrasonic conditions can induce irreparable damage to the 
cell membrane and therefore lead to instant cell death (Miyake and McNeil 
1995; Ferrara, Pollard et al. 2007). Miller et al. reported that in addition to 
initial cell death, sonoporated cells experience damages that eventually lead 
to apoptosis (Miller and Dou 2009). Once the apoptotic pathway has been 
activated, the capacity of cells to express genes is altered. This could provide 
a possible explanation for the observations seen both in this study and by 
Zarnitsyn (2004), where under identical conditions; sonoporation efficiency 
was lower when measuring gene expression of a DNA plasmid than when 
adding fluorescent molecules. 
The aim of this section was to validate this hypothesis by investigating 
expression of heat shock proteins, such as Hsp70 and HO-1. Variations in 
expression of these proteins, resulting from insonation, will provide vital 
information as to the degree of stress the cells are experiencing and whether 
the apoptotic pathway has been instigated. This in turn can assist in 
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adjusting the parameters involved in sonoporation so as to achieve 
maximum sonoporation with minimal bioeffects. 
 
10.2 Results 
10.2.1 Heat shock protein 70 
SK Hep-1 cells were insonated under identical conditions to those 
used for achieving sonoporation with the aid of the physiotherapy machine. 
Expression of Hsp70 was examined prior to and following insonation, in the 
presence (300 µl) and absence of Definity® microbubbles. Upregulation of 
Hsp70 protein during insonation would indicate that cells were experiencing 
stressful conditions.  
Subsequently samples insonated in the presence and absence of ultrasound 
contrast agents were probed against GAPDH and actin antibodies. Results 
shown in figure 10.2 revealed that expression of both GAPDH and actin was 
upregulated in the absence of ultrasound contrast agents. In addition, the 
total amount of protein loaded was examined for insonated samples in the 
absence of ultrasound contrast agents and for non-treated samples. Careful 
observation of figure 10.3 revealed that insonated samples have less high 








Figure 10.1 Effects of sonication on Hsp70. SK Hep-1 cells were sonicated in the 
presence and absence of Definity® microbubbles under identical ultrasound 
conditions as those used to achieve sonoporation. Following sonication, samples 
were collected and examined for increased stress levels. As heat shock protein 70 
(Hsp70) is upregulated during stressful conditions, this provided a direct 
measurement of the stress exerted on cells. Immunoblotting shows increased levels 
of actin and Hsp70 to a lesser extend for sonicated samples. In addition, both 
proteins examined show a lower level upregulation in the presence of Definity® 
microbubbles than in the absence of Definity® microbubbles. A negative (non 
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Figure 10.2 Effects of sonication on actin and GAPDH. Cells were sonicated in 
the absence of Definity® microbubbles under identical ultrasound conditions as 
those used to achieve sonoporation. Sonicated and non sonicated samples were 
collected and examined in order to detect any changes in levels of expression of 
actin and/or GAPDH. Immunoblot analysis reveals that both actin and GAPDH 
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Figure 10.3 Effects of sonication on all proteins. Since both actin and GAPDH 
which are normally used as loading controls were previously shown to be 
upregulated in sonicated samples, it was thought that examination of the total 
amount of protein within cells could also serve as a loading control. The same 
samples as those used in previous experiment (figure 10.2) were loaded on a gel 
and examined for total amount of protein. a) Although Immunoblot analysis shows 
that the total amount of protein loaded was similar across the samples, the level of 
expression of certain proteins changes between sonicated and non sonicated 
samples. Samples 1-6 = sonicated, samples 7-12 no treatment. (b) Intensity of total 
protein of each sample (pixels), measured by image J 1.41 software (National 
Institute of Health, USA), shows that the total amount of protein is similar between 
all samples (Numbers is brackets correspond to sample lanes from immunoblot).   
 
   1          2         3        4        5       6        7        8         9       10      11       12 
(a) 
(b) 
    Sonicated                    no treatment 
(1) 80357   (7) 85063 
(2) 81544   (8) 87803 
(3) 78177   (9) 89499 
(4) 74167   (10) 87835 
(5) 73979   (12) 73037 
(6) 78553   (12) 70525 
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10.2.2 Heme oxygenase-1 
  HO-1 expression is associated with oxidative stress (Morse and Choi 
2005; Sontag and Kruglikov 2009). Expression of HO-1 following insonation 
was also investigated in order to assess whether cells are experiencing 
stressful conditions. Furthermore, HO-1 expression was not detected in the 
presence of microbubbles. It can thus be proposed that the presence of 














Figure 10.4 Effects of sonication on HO-1. SK Hep-1 cells were sonicated in the 
presence and absence of Definity® microbubbles under identical ultrasound 
conditions as those used to achieve sonoporation. Following sonication, samples 
were collected and examined for increased stress levels. As heme oxygenase (HO-
1) is upregulated during stressful conditions, this provided a direct measurement of 
the stress exerted on cells. Immunoblotting shows increased levels of actin and HO-
1 to a lesser extend for sonicated samples. In addition, actin shows a lower level 
upregulation in the presence of Definity® microbubbles than in the absence of 
Definity® microbubbles, while HO-1 expression is undetectable in the presence of 
Definity® microbubbles. A negative (non sonicated) and a positive (hypoxia treated) 





















































































10.3.1 Heat Shock protein 70  
 The aim of this section was to examine whether insonation of cells in 
the presence of ultrasound contrast agents exerts a stress on cells. Indeed, 
stress responses were revealed to take place with upregulation of stress 
proteins, such as Hsp70 and HO-1 (figure 10.1 & 10.4). From the data shown 
in figure 10.1 three observations can be made. First, the amount of actin was 
much lower when cells were insonated in the presence of Definity® 
microbubbles that when cells were simply insonated. Actin is a cytoskeletal 
protein used regularly as a control, since its expression is thought to be 
unaffected by stressful stimuli. Therefore, addition of actin can provide an 
assurance that similar amounts of cellular proteins have been loaded during 
Western blotting. However Dittmer et al. (2006) demonstrated that actin is 
not a very reliable loading control as it cannot distinguish amongst different 
concentrations of protein. Furthermore, Dittmer et al. (2006) reported that a 
number of other proteins such as glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH), were more suitable for serving as loading controls. 
The unusual upregulation of both actin and GAPDH during 
insonation also strengthens the notion that cells are experiencing stressful 
conditions during insonation (figure 10.2). In addition, an increase in 
GAPDH expression during oxidative stress and apoptosis has been 
previously reported (Darstoor and Dreyer 2001; Hara, Cascio et al. 2006). It 
can therefore be suggested that application of ultrasound via a 
“physiotherapy machine” creates stressful conditions for cells, thus altering 
expression of a multitude of proteins, including actin and GAPDH. 
Coomassie assay staining reveals the amounts of all proteins present 
in a loaded sample, which are separated according to their molecular mass. 
Therefore, such an assay would further indicate whether equal amounts of 
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cellular proteins were loaded during Western blotting. Careful observation 
of figure 10.3 revealed that insonated samples have less high molecular mass 
bands and additional lower molecular mass bands. Since the possibility of 
protein degradation by proteases was eliminated with the addition of 
protease inhibitors in the samples during the assay preparation, it was not 
possible to explain such a difference between smaller and larger proteins. 
Nevertheless, measurement of the total amount of proteins in each sample 
revealed that all samples contained similar amounts of total protein (figure 
10.3). Although stressful conditions have not been previously associated with 
upregulation of actin, a recent study demonstrated upregulation of over 200 
genes during application of low intensity pulsed ultrasound (Tabuchi, 
Takasaki et al. 2008). 
Taking into account that the amount of total protein loaded was 
similar for all samples examined, as demonstrated by the Coomassie assay, 
then the second observation that can be made from figure 10.1 is that Hsp70 
expression is upregulated following insonation in the absence of ultrasound 
contrast agents. Application of pulsed wave ultrasound has been previously 
shown to increase expression of other heat shock proteins, such as Hsp32, 
Hsp40 and Hsp90 (Ando, Feril et al. 2006). It can therefore be concluded that 
ultrasound causes a stressful environment to the cells, upon which 
expression of several heat shock proteins, including Hsp70, is upregulated.  
A third observation that can be made from figure 10.1 is that although 
Hsp70 is also expressed following insonation in the presence of microbubbles, 
its levels of expression are lower than those observed in the absence of 
microbubbles. These results are in conflict with other studies, which have 
shown that the presence of ultrasound contrast agents lowers the ultrasound 
pressure required to induce apoptosis (Tran, Jongbum et al. 2002; Ando, Feril 
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et al. 2006). Thus under identical sonication conditions one would expect to 
observe higher levels of Hsp70 expression in the presence of microbubbles. A 
possible hypothesis could be that the presence of microbubbles attenuates 
the ultrasound affect to the cells, thus minimising their stress response 
compared to sonication in the absence of microbubbles. Finally, it can be 
concluded that application of ultrasound both in the presence and absence of 
microbubbles, acts as a stress stimuli to cells, which in turn respond by 
expressing Hsp70.  
 
10.3.2 Heme oxygenase 1 
Results from figure 10.4 suggest that HO-1 expression is upregulated 
following insonation in the absence of microbubbles. Previous reports have 
also demonstrated induction of HO-1 following application of continuous 
wave ultrasound (Kagiya, Ogawa et al. 2006). Furthermore, HO-1 expression 
was not detected in the presence of microbubbles. Similarly to the 
observations made for Hsp-70 expression, it can be proposed that the 
presence of microbubbles provides a protection for cells from the effects of 
ultrasound waves. HO-1 expression has been associated with several human 
disorders; therefore such findings could potentially serve as indicators of 
potential bioeffects of gene therapy. 
 
10.4 Conclusions 
It can therefore be hypothesized from the alterations observed in 
protein expression that ultrasound cannot only lead to sonoporation but it 
can potentially lead to several other bioeffects. Stress proteins are 
upregulated in an attempt to promote cell survival through stressful 
conditions. Upregulation of stress related genes could therefore also be 
coupled with downregulation of other non stress related genes, which could 
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serve as a possible explanation to the low efficiencies observed in EGFP 
expression during sonoporation experiments. Therefore, establishing the 
effects of ultrasound on cell survival is of great importance since it can 
facilitate in adjusting acoustic parameters so as to achieve maximum 
























































11.0 Conclusions and future aims 
11.1 Conclusions 
Several commercial microbubbles have been shown to induce 
sonoporation under specific ultrasonic conditions. The purpose of this study 
was to develop techniques for successful sonoporation and delivery of 
therapeutic agents. Therefore, it is necessary to quantify the composition and 
physical characteristics of microbubbles in order to be able to determine how 
these affect the sonoporation process as required. Since the components of 
the shell of the commercially available microbubbles have not been disclosed, 
experimental in-house microbubbles were used.  
Characterisation of the in-house microbubbles was necessary prior to 
any attempts to use them as delivery vehicles in vitro, or indeed, in vivo. 
Confocal imaging and 3-D reconstruction of in-house microbubbles indicated 
the structure, morphology and size-distribution of these membrane-bound 
microbodies. Microbubbles were later separated according to size using a 
density gradient. It was concluded that the size distribution of the in-house 
microbubbles was comparable to that of commercial microbubbles that have 
been previously shown to induce sonoporation.   
The majority of studies provide insufficient amount of information for 
the acoustic parameters used (transmit frequency, acoustic pressure, pulse 
period), making it difficult to obtain a specific protocol for achieving 
sonoporation (Sboros, Moran et al. 2004). Therefore, this study focused firstly 
on establishing the parameters necessary for achieving sonoporation. It was 
decided that the use of a commercial ultrasound contrast agent that have 
previously been shown to induce sonoporation, would be a good starting 
point.  Initial experiments were conducted with the aid of a “physiotherapy 
machine” and in the presence of Definity® microbubbles. Ultrasound 
parameters were optimised in order to increase delivery of target molecules 
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into the cells. Both acoustic and non-acoustic parameters necessary for 
achieving in vitro sonoporation were established. Greatest sonoporation 
efficiency (8 %) was observed with the aid of cell impermeable Calcein 
during insonation in the presence of Definity® microbubbles. In addition, the 
exact acoustic field applied was determined, thus providing information on 
the precise characteristics of the ultrasound field (pressure, frequency) 
experienced by the cells. This in turn provides useful information for 
investigating potential bioeffects under such acoustic conditions. 
Microbubble mediated gene delivery (EGFP) was also accomplished in SK 
Hep-1 cells with the aid of the physiotherapy machine. Although 
sonoporation efficiency was half of that observed in the presence of cell 
impermeable Calcein, the achievement in itself brings us a step closer to 
establishing the parameters for regulated and consistent gene therapy.  In 
addition, lack of delivery of EGFP protein into the cells during insonation 
revealed that the upper size limit of the perforations formed during 
sonoporation was 2.4 nm, thus providing essential information on the size 
limitations of molecules that can be delivered to the cells. Furthermore, 
examination of several distinct cell lines revealed that under identical 
sonication conditions, sonoporation efficiency was dependent on the cell 
type used. This finding is of particular importance as it suggests that acoustic 
parameters need to be adjusted in order to achieve sonoporation in different 
cell types.  
Subsequent experiments were performed with the aid of an 
ultrasound scanner as this is more clinically relevant. Sonoporation 
efficiencies were negligible in the presence of Calcein while no sonoporation 
was observed with the use of a DNA plasmid. Nevertheless, the conditions 
used in these experiments can serve as a starting point for future experiments, 
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in order to adjust the parameters so as to establish sonoporation with an 
ultrasound scanner. 
Since sufficient sonoporation was achieved with the aid of the 
physiotherapy machine, experiments were also conducted with the 
“physiotherapy machine” in order to investigate sonoporation in the 
presence of in-house microbubbles. Investigation of sonoporation in the 
presence of in-house microbubbles revealed that the acoustic parameters for 
achieving sonoporation are different to those in the presence of Definity® 
microbubbles. The mode of oscillation of an ultrasound contrast agent under 
specific ultrasonic conditions, is dependent on a number of variables such as 
its contents, size and constituents (Dawson 1999). The degree of oscillation of 
the ultrasound contrast agents will affect the degree of stress exerted on to 
the cell membranes, thus regulating the possibility of sonoporation. 
Although certain parameters of the in-house microbubbles were comparable 
to Definity® microbubbles (size distribution), other parameters were either 
most probably different (contents) or unknown (constituents). Thus further 
investigation is required in order to establish the parameters necessary for 
achieving sonoporation in the presence of in-house microbubbles.  
During insonation a fraction of the cells were instantly killed 
(necrosis), another fraction was filled with molecules from the extracellular 
environment (sonoporation), such as Calcein and plasmid DNA, and some 
were impervious (Zarnitsyn and Prausnitz 2004). Furthermore, it was 
observed that the sonoporated fraction was smaller in the presence of 
plasmid DNA than in the presence of marker molecules such as Calcein. 
Such discrepancies in sonoporation efficiencies can be challenging for 
attaining high gene expression via sonoporation. It was therefore important 
to examine the cause of this discrepancy. A possible explanation could be 
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that during insonation cells are experiencing stressful conditions and are 
initiating apoptotic pathways thus upregulating expression of selective genes 
that have a protective role. In order to validate this hypothesis, cells were 
insonated under identical conditions to those used for achieving 
sonoporation. Cellular stress response was detected by examining 
upregulation of stress proteins such as Hsp70 and HO-1. Both Hsp70 and 
HO-1 expression were found to be elevated. It can thus be concluded that 
sonication creates a stressful environment for cells and induces activation of 
apoptotic processes. These results can also explain the discrepancy between 
sonoporation efficiencies in the presence of a DNA plasmid and marker 
molecules. Identifying the cellular mechanisms in response to ultrasound, 
could assist in establishing the parameters for attaining maximal 
sonoporation and gene expression (Zarnitsyn and Prausnitz 2004).  
 
11.2 Future aims 
The principal aim for gene therapy is to develop a method where 
expression of a therapeutic gene is achieved in target cells (Gao 2007). The 
use of ultrasound in the presence of ultrasound contrast agents is one of the 
leading candidate methods for use in gene therapy. The mechanical stress 
exerted on cells by oscillating microbubbles during insonation, results in the 
formation of transient perforations on the cell membrane thus allowing 
delivery of therapeutic molecules into the intracellular compartment of the 
cells. Successful delivery of therapeutic molecules, such as drugs or genes, 
into cells will open the road for curing a broad range of human diseases 
(Verma and Weitzman 2005). However, obstacles such as innate immune 
response, non-specific uptake by cells, degradation of genes by enzymes in 
the blood, interaction with blood components and rapid clearance, are yet to 
be conquered (Sakurai, Kawabata et al. 2008; Shigeru Kawakami 2008). In 
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addition, efficiency levels of ultrasound mediated gene delivery are still 
much lower than those achieved by viral methods, especially for in vivo 
delivery (Gao 2007). Therefore, considerable amount of research has yet to be 
performed before ultrasound mediated gene delivery can be fit for clinical 
use (Shigeru Kawakami 2008).  
In this study the acoustic parameters were established for achieving 
sonoporation with the aid of a clinically relevant scanner in the presence of 
commercially available Definity® microbubbles. All the field parameters 
affecting cell responses, such as standing waves, reflective waves and 
pressure of the ultrasound beam applied, were taken into consideration, in 
order to be able to specify the precise acoustic parameters necessary for 
inducing sonoporation. Being able to induce sonoporation in the presence of 
in-house microbubbles would be of immense benefit for future work as  it 
would allow for modifications in the microbubble design in order to improve 
sonoporation efficiencies (Shigeru Kawakami 2008). In-house microbubbles 
could also be modified in order to interact efficiently with DNA load 
(Shigeru Kawakami 2008). Furthermore, in-house microbubbles could be 
targeted for delivery to specific cells / tissues thus eliminating non-specific 
uptake (Shigeru Kawakami 2008). A better understanding of the fate of DNA 
following delivery into the cell, would allow for improvement of the 
ultrasound mediated gene delivery system (Gao 2007).  Finally, patient safety 
is of utmost importance. Future work should therefore, involve further 
investigation into the cellular responses triggered during sonoporation, 
which would allow adjustment of the field parameters in order to achieve 





Appendix 1 Solutions  
 
RIPA buffer 
1 x PBS 
1 % NONIDET P-40 (v/v) 
0.5 %  Sodium deoxycholate (w/v) 
0.1 %  SDS (w/v) 
 
D-PBS (Ca and Mg free) 
1 g KCl   
1 g KH2PO4  
40 g NaCl  
5.75 g Na2HPO4 (anhydrous) 
Dissolve in 5 l of H2O  
 
50 x TAE 
242 g      Tris base 
57.1 ml   glacial acetic acid 
100 ml    0.5 M EDTA (pH 8.0) 
Dissolve in 1 l of H2O adjust to pH 8.5 
 
10 x TBS 
121 g     Tris   
438.5 g  NaCl   





0.5 %  Tween 20 (v/v) 
 
SDS-PAGE 10  % separating gel ( 2 gels) 
3.96 ml    distilled H2O    
2.5 ml       0.375 M Tris, pH 8.8  
100 µl       10 % SDS (w/v)    
3.33 ml      Acrylamide / Bis (30 % stock) (Biorad) 
100 µl       10 % AMPS Ammonium persulphate (v/v)    
 10 µl       TEMED  
 
SDS-PAGE 4  % Stacking gel (2 gels)  
3 ml         distilled H2O    
1.25 ml    0.5 M Tris-HCl, pH 6.8  
50 µl       10 % SDS (w/v)    
0.6 ml    Acrylamide / Bis (30 % stock) (Biorad) 
50 µl      10 % AMPS Ammonium persulphate (v/v)    
10 µl     TEMED    
 
Sample loading buffer (x5) 
0.5 ml     distilled H2O    
2.5 ml     1 M Tris-HCl, pH 6.8   
4 ml       glycerol     
0.8 g      10 % SDS (w/v)    
2 ml        2-β-mercaptoethanol    





Running buffer (5x) 
30 g     Tris  
144 g    Glycine 
10 g      SDS   
Dissolve in 1800 ml of H2O, adjust pH to 8.3 
Make up to 2 l with H2O 
 
Transfer buffer 
5.86 g     Glycine  
11.65 g   Tris   
0.75 g     SDS   
400 ml   Methanol  
Dissolve up to 2 l with H2O 
 
Molecular Marker  
Kaleidoscope Prestained standards (BioRad) 
 
L Broth 
5 g     Tryptone 
2.5 g   yeast extract 
5 g      NaCl 
Dissolve in 500 ml of H20, adjust to pH 7 with NaOH 
 
LB agar plates 




12 g   Tryptone 
24 g   Yeast extract 
4 ml   glycerol 
Dissolve in 900 ml of H20. Add 100 ml sterile 0.17 M KH2PO4 
 
Antibody dilutions 
Hsp70                                             1 in 5000 (diluted in TBST) 
Anti-Heme-oxygenase-1             1 in 5000 (diluted in TBST) 
Actin b                                           1 in 10,000 (diluted in TBST) 
GAPDH                                         1 in 10,000 (diluted in TBST) 
 
 0.1 % Coomassie blue R250 stain  
40 %   MeOH (v/v) 
10 %   acetic acid (v/v) 
50 %    H20 (v/v) 
 
Coomassie blue R250 destain 
5 %        MeOH (v/v) 
7.5 %     acetic acid (v/v) 

























0.6 MPa  1 min 
Definity® 
0.1 % (v/v) 
40 
µg/ml SR / PE (Miller and Dou 2009) 




4.5x107ml  SR / CT (Wu, Ross et al. 2002) 
      
In-house 
liposomes 
109/ml    
1.75 MHz PW  0.3 MPa   
Definity® 
0.1 % (v/v)  A / PS (Zhou, Shi et al. 2008) 
1.98 MHz PW  0.2 MPa  5 min 
Optison® 
120 µl/ml  SR / CT (Ward, Wu et al. 2000) 
100 kHz CW  
0.1 MPa- 
5 MPa  
10 sec- 
10 min  
0.66 
µg/ml S  
(Huber and Pfisterer 
2000) 
255 kHz CW   
0.4 
W/cm2 30 sec   S  
(Tachibana, Uchida et al. 
1999) 
 
*acoustic power, *peak to peak pressure, *** peak positive pressure, CW=continuous wave, PW=pulsed wave, S=cells 
cultured in suspension, SR= cells cultured in suspension and rotating, A=cells cultured in monolayer fashion, Pl=plastic, 
PE=polyethylene, PS=polystyrene, OC=OptiCell™, P=6, 12, 48 well plate, CT=culture tube, CF=copolymer foil, 


















1 MHz PW    60 sec 
Sonovue® 
2x108- 
5x108/ml 5 µg/ml A / OC 














25-30 / cell  
 
 
SR / PS 
 
(Mehier-Humbert, 
Bettinger et al. 2005a) 




25-30 / cell    
21.4 kHz CW  
0.4 MPa-
4.1 MPa  1-7 min   S / CT (Wu, Ross et al. 2002) 






5, 10 % (v/v)  AS / P 
(Kinoshita and Hynynen 
2007) 
24 kHz PW    2 sec   S  
(Schlicher, Radhakrishna 
et al. 2006) 
 
*acoustic power, *peak to peak pressure, *** peak positive pressure, CW=continuous wave, PW=pulsed wave, S=cells 
cultured in suspension, SR= cells cultured in suspension and rotating, A=cells cultured in monolayer fashion, Pl=plastic, 
PE=polyethylene, PS=polystyrene, OC=OptiCell™, P=6, 12, 48 well plate, CT=culture tube, CF=copolymer foil, 


















CW  0-570 kPa  60 sec 
Definity® 
3.3 % (v/v)  S 
(Karshafian, Bevan et al. 
2009) 
2.5 MHz   
0kPa- 
2320 kPa  2 min     
5 MHz   
0kPa- 
3500 kPa       





amounts  A / ATM (Miller 2000) 
0.98 MHz PW  0.4 MPa  10 sec 
Optison® 
10 % (v/v)  A / ATM (Pan, Zhou et al. 2005) 
1 MHz PW  
0.35 MPa- 
1.4 MPa **  10 sec 
Optison® 
2 × 108- 
5 × 108/ml  A / OC 
(Rahim, Taylor et al. 
2006b) 
1 MHz PW 0.159  2 W/cm2 30 min 
Optison® 
10 % (v/v) 
0.5-7.5 
mg/ml A / Pl 
(Duvshani-Eshet, Baruch 
et al. 2005) 
 
*acoustic power, *peak to peak pressure, *** peak positive pressure, CW=continuous wave, PW=pulsed wave, S=cells 
cultured in suspension, SR= cells cultured in suspension and rotating, A=cells cultured in monolayer fashion, Pl=plastic, 
PE=polyethylene, PS=polystyrene, OC=OptiCell™, P=6, 12, 48 well plate, CT=culture tube, CF=copolymer foil, 


















CW  0.1 MPa  1 min 
Albunex® 
10 % (v/v) 
20 
µg/ml SR / PE (Bao, Thrall et al. 1997) 
1.8 MHz CW 0.1-0.5   50 sec 
Sonovue® 
10 µl/ml  A / OC 
(Juffermans, Dijkmans et 
al. 2006) 
1 MHz PW 0.1-0.5        
1 MHz CW  0.5 MPa  30 sec   SR / PS 
(Brayman, Coppage et al. 
1999) 
1 MHz CW   
0.4 
W/cm2 60 sec  
7.5 
mg/ml A / P 
(Lawrie, Brisken et al. 
1999) 
1.7 MHz PW 1.15-1.8 
195kPa-
2350 kPa  50 sec 
Optison® 
2 x106/ml  A / CF 
(Kirosoglou, Hardt et al. 
2006) 
      
Sonovue® 
2x107/ml    
0.96 MHz PW  1 MPa  1 sec 
Optison® 
0.05- 5 % 
(v/v)  S / ATM (Deng, Sieling et al. 2004) 
 
*acoustic power, *peak to peak pressure, *** peak positive pressure, CW=continuous wave, PW=pulsed wave, S=cells 
cultured in suspension, SR= cells cultured in suspension and rotating, A=cells cultured in monolayer fashion, Pl=plastic, 
PE=polyethylene, PS=polystyrene, OC=OptiCell™, P=6, 12, 48 well plate, CT=culture tube, CF=copolymer foil, 

















2 MHz CW / 




12 % (v/v)  SR / CT (Ward, Wu et al. 1999) 
      
Optison® 
6.5 % (v/v)    




µg/ml S / PS 
(Mehier-Humbert, Yan et 
al. 2007) 
     2-34 sec Sonovue®    
500 KHz PW  
0.6MPa- 




1.7 %  (v/v)  S / PE 
(Guzmán, Nguyen et al. 
2001a) 
2.25 MHz PW 0.38 570 MPa  10 sec 
UCA by 
Bracco 
25-30x106/ml  S / PS 
(Mehier-Humbert, 
Bettinger et al. 2005b) 




µg/ml A / P 
(Fischer, Stanke et al. 
2006) 
1 MHz PW  0.4 MPa  5 sec 
lipid shell 
1-2x105/ml  A / OC 
(Van Wamel, Kooiman et 
al. 2006a) 
 
*acoustic power, *peak to peak pressure, *** peak positive pressure, CW=continuous wave, PW=pulsed wave, S=cells 
cultured in suspension, SR= cells cultured in suspension and rotating, A=cells cultured in monolayer fashion, Pl=plastic, 
PE=polyethylene, PS=polystyrene, OC=OptiCell™, P=6, 12, 48 well plate, CT=culture tube, CF=copolymer foil, 


















PW 0.4 0.4 MPa  5 sec 
BR14 
1-2x105/ml  A / OC 
(Van Wamel, Kooiman et 
al. 2006b) 
1 MHz PW  0.5 MPa***  30 sec 
Definity® 
30 % (v/v)  A / Pl (Han, Ikegami et al. 2007) 




W/cm2 1-60 sec  
50 
µg/ml A / P (Liang, Lu et al. 2004) 
500 kHz PW 0.7 
0.5 MPa- 






µg/ml S / PE 
(Zarnitsyn and Prausnitz 
2004) 




µg/ml S / P (Li, Tachibana et al. 2003) 
      
Optison® 
5-20 % (v/v)    
      
Albunex® 
5-20% (v/v)    




0.1 % (v/v)  S / PE (Zhou, Cui et al. 2008) 
 
*acoustic power, *peak to peak pressure, *** peak positive pressure, CW=continuous wave, PW=pulsed wave, S=cells 
cultured in suspension, SR= cells cultured in suspension and rotating, A=cells cultured in monolayer fashion, Pl=plastic, 
PE=polyethylene, PS=polystyrene, OC=OptiCell™, P=6, 12, 48 well plate, CT=culture tube, CF=copolymer foil, 

























9.3x107/ml  S 
(Guzmán, McNamara et 
al. 2003) 
1 MHz PW   
0.1-2 
W/cm2 1 min   A / P (Feril, Ogawa et al. 2005) 




 µg/ ml A / Pl 
(Greenleaf, Bolander et al. 
1998) 
 
*acoustic power, *peak to peak pressure, *** peak positive pressure, CW=continuous wave, PW=pulsed wave, S=cells 
cultured in suspension, SR= cells cultured in suspension and rotating, A=cells cultured in monolayer fashion, Pl=plastic, 
PE=polyethylene, PS=polystyrene, OC=OptiCell™, P=6, 12, 48 well plate, CT=culture tube, CF=copolymer foil, 
ATM=acoustically transparent membrane. 
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Appendix 3 List of parameters used in sonoporation experiments 
 
Experiment 1 (n=9) 
Chamber: Petri dish 
Place: bench 
Cells: SK Hep-1 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 12.5 µl, 25 µl, 50 µl, 75 µl  
Temperature: room temperature 
Machine: physiotherapy machine 
US duration: 1 min 
Intensity: 0.1-0.2-0.3-0.4-0.6-0.8 W / cm2 
Examine by: electron microscopy 
 
Experiment 2 (n=3) 
Chamber: OptiCell™ 
Place: tank 
Cells: SK Hep-1 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 12.5 µl, 25 µl, 50 µl, 75 µl  
Temperature: room temperature 
Machine: physiotherapy machine 
US duration: 1 min 
Intensity: 0.1-0.2-0.3-0.4-0.6-0.8 W / cm2 
Examine by: electron microscopy 
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Experiment 3 (n=3) 
Chamber: OptiCell™ 
Place: tank 
Cells: SK Hep-1 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 100, 300 µl  
Temperature: room temperature 
Machine: physiotherapy machine 
US duration: 1-3 min 
Intensity: 2.54 W / cm2 
Examine by: electron microscopy 
 
Experiment 4 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 
Angle: 37° 
Type of microbubbles: Definity® 
Amount of microbubbles: 100µl, 300 µl  
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 1-3 min 
Intensity: 2.54 W / cm2 




Experiment 5 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 
Angle: 37° 
Type of microbubbles: Definity® 
Amount of microbubbles: 100µl 
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 2-3 sec 
Intensity: 2.54 W / cm2 
DNA: 0.1, 0.3 µg / ml 
















Experiment 6 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 
Angle: 37° 
Type of microbubbles: Definity® 
Amount of microbubbles: 5 µl, 300 µl, 600 µl, 900 µl 
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 2-3 sec 
Intensity: 2.54 W / cm2 
Calcein: 10 µM 
Examine by: flow cytometry 
 
Experiment 7 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 
Angle: 37° 
Type of microbubbles: Definity® 
Amount of microbubbles: 300 µl 
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 2-3 sec 
Intensity: 2.54 W / cm2 
DNA: linearised, 0.3 µg / ml 
Examine by: flow cytometry, 24 hours after insonation 
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Experiment 8 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 (no serum in medium) 
Angle: 37° 
Type of microbubbles: Definity® 
Amount of microbubbles: 300 µl 
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 2-3 sec 
Intensity: 2.54 W / cm2 
DNA: linearised, 0.3 µg / ml 
Examine by: flow cytometry, 24 hours after insonation 
 
Experiment 9 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 
Angle: 37° 
Type of microbubbles: Definity® 
Amount of microbubbles: 300 µl 
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 2-3 sec 
Intensity: 2.54 W / cm2 
EGFP: 70mM, 700mM, 2.1M 
Examine by: flow cytometry 
 
 257 
Experiment 10 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: ACHN, HUH7 
Angle: 37° 
Type of microbubbles: Definity® 
Amount of microbubbles: 300 µl 
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 2-3 sec 
Intensity: 2.54 W / cm2 
DNA: linearised, 0.3 mg / ml 
















Experiment 11 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 
Angle: 37° 
Type of microbubbles: in-house microbubbles 
Amount of microbubbles: 0.9 ml, 1.8 ml, 3 ml, 5 ml 
Temperature: 37 °C 
Machine: physiotherapy machine 
US duration: 2-3 sec 
Intensity: 2.54 W / cm2 
Calcein: 10 µM 
Examine by: flow cytometry 
 
Experiment 12 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 (± serum in medium) 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 100 µl, 300 µl 
Temperature: 37 °C 
Machine: scanner 
US duration: 10 sec 
MI: 0.2-0.5-1.1 
DNA: linearised, 0.1, 1, 5 µg / ml 
Examine by: flow cytometry, 24 hours after insonation 
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Experiment 13 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 (no serum in medium) 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 100 µl, 300 µl 
Temperature: 37 °C 
Machine: scanner 
US duration: 10 sec 
MI: 0.2-0.5-1.1 
DNA: linearised, 0.1, 1, 5 µg / ml 
















Experiment 14 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 (no serum in medium) 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 300 µl 
Temperature: 37 °C 
Machine: scanner 
US duration: 10 sec 
MI: 1.3 
DNA: linearised, 20, 30 µg / ml 
















Experiment 15 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 (no serum in medium) 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 1 ml 
Temperature: 37 °C 
Machine: scanner 
US duration: 10 sec 
MI: 1.3 
DNA: linearised, 20 µg / ml 
















Experiment 16 (n=4) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 (no serum in medium) 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 300 µl 
Temperature: 37 °C 
Machine: scanner 
US duration: 10 sec 
MI: 1.3 
DNA: linearised, 20 µg / ml 
Cell culture method: suspension and adherent 















Experiment 17 (n=3) 
Chamber: OptiCell™ 
Place: tank, acoustic absorber 
Cells: SK Hep-1 
Angle: 90° 
Type of microbubbles: Definity® 
Amount of microbubbles: 5 µl, 300 µl, 600 µl 
Temperature: 37 °C 
Machine: scanner 
US duration: 10 sec 
MI: 1.3 
Calcein: 10 µM 
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